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Abstract 
Introduction of bowel cancer screening programmes internationally has resulted in a 
significant shift in diagnosis towards early stage disease. In addition, the number of patients 
diagnosed with complex benign colorectal polyps is increasing.  
Advanced endoscopic techniques including endoscopic mucosal resection (EMR) and 
endoscopic submucosal dissection (ESD) as well as transanal endoscopic microsurgery 
(TEMS) are being increasingly utilised for excision of early rectal neoplasia. An equivalent 
surgical technique is currently not available for colonic lesions, and endoscopic techniques 
are associated with a high risk of complications such as bleeding, perforation and recurrence 
than in the rectum. Hemicolectomy with en bloc mesenteric excision remains the gold 
standard treatment for patients with early, node negative colon cancer and large colonic 
polyps. Even when performed laparoscopically within an enhanced recovery protocol, 
problems such as death, anastomotic leakage and other complications occurring in up to 
40% of patients make colectomy a morbid intervention.  
The introduction to this thesis reviews the literature on the development and staging of 
colorectal cancer as well as currently available endoscopic and surgical techniques. In order 
to improve our understanding of the morbidity associated with hemicolectomy for the 
treatment of benign colonic polyps, two studies examined short term outcomes after surgery.  
The results suggest similar 30-day outcomes to those after cancer resection. In addition, a 
two-part study was designed to assess bowel function and related quality of life in patients 
who underwent hemicolectomy for colonic neoplasia, a subject that is poorly documented in 
the literature. As an introduction to the laboratory work, a systematic review of endoscopic 
full thickness excision techniques is presented. The final three chapters of the thesis 
describe ex-vivo development and outcome data after a porcine survival study of a laparo-
endoscopic excision technique for colonic lesions as a potential alternative to 
hemicolectomy.  
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Chapter 1 Introduction 
1.1 Colorectal cancer 
Colorectal cancer (CRC) is the third most common cancer in the UK with estimated lifetime 
risk of 1 in 15 for men and 1 in 19 for women1. It is the second most common cause of 
cancer death in England with over 30 000 new cases diagnosed each year and 
approximately 13 000 deaths1. Most of the tumours occur in the left side of the bowel with 
two-thirds of all cases in the colon. 
1.1.1 Development of colorectal neoplasia 
CRC is increasingly classified into specific phenotypes on the basis of molecular profiles2 
and at least three different pathogenic pathways have been implicated. The role of adenoma 
in CRC development was originally described by Vogelstein et al.3 who demonstrated that a 
stepwise accumulation of genetic alterations accompanies the adenoma-carcinoma 
sequence in the colon. The accumulation of genetic alterations occurs concomitantly with 
morphological changes resulting in formation of a small adenomatous polyp. This is followed 
by progression from low-grade dysplasia to a larger lesion with high risk features (high grade 
dysplasia) and finally invasive cancer. The earliest molecular aberration in this pathway is 
the loss of adenomatous polyposis coli (APC) which is the tumour suppressor gene 
responsible for mucosal hyperproliferation. This occurs at an early stage of tumourigenesis4. 
Increased DNA replication leads to accumulation of genetic ‘accidents’ and mutations in a 
number of genes including KRAS5 and P535, 6 in increasingly large adenomas and early 
cancer3. This pathway is thought to account for approximately 85% of all CRCs and it usually 
occurs over several years2. It also characterises familial adenomatous polyposis and is 
therefore often referred to as the APC pathway7. Alternatively, this pathway is also known as 
the chromosomal instability (CIN) pathway as tumours arising from it are characterised by 
gross chromosomal abnormalities including insertions, deletions and loss of heterozygosity7.  
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The most prevalent familial colorectal cancer syndrome is Lynch syndrome (previously 
known was hereditary non-polyposis colorectal cancer, HNPCC), accounting for about 2% of 
all CRCs8. It is inherited in an autosomal dominant pattern and is characterised with 
germline mutations in one of several DNA mismatch repair genes, most commonly MLH1, 
MLH2 and MSH62, 7. The loss of DNA mismatch repair function results in accumulation of 
mutations in microsatellite regions of the genome9 and therefore microsatellite instability 
(MSI) and tendency to malignant progression2, 7. Abnormalities in mismatch repair are also 
identifiable in approximately 15% of sporadic CRCs and the MSI occurs when the promoter 
region in the mismatch repair system is silenced by hypermethylation of CpG islands10. 
These tumours are more likely to be proximally located, to present at a more advanced age, 
to occur in women and tend to be associated with a favourable prognosis11.  
CRCs arising via the ‘serrated pathway’ form a heterogeneous group with respect to 
molecular alterations, precursor lesions and biological behaviour12, 13. A proportion of 
‘serrated adenocarcinomas’ are characterised by an activating mutation of the BRAF 
oncogene and defective DNA mismatch repair, resulting in microsatellite instability (MSI-
high), MLH1 inactivation and high CpG island methylator phenotype13. BRAF-associated 
tumours tend to develop from sessile serrated lesions, occur in the proximal colon and have 
a relatively good prognosis7, 12. CRCs arising from pedunculated or traditional serrated 
lesions are believed to evolve via the KRAS mutation. Tumours in this pathway are 
characterised by microsatellite stable (MSS) or MSI-low phenotype, retained MLH1 
expression and lower CpG island methylation than BRAF-associated lesions. The majority 
occur in the distal colon and are associated with rapid progression and poor prognosis12, 14, 
15.  
 
17 
1.1.2 Precursor lesions 
CRC arises primarily from adenomas and approximately 40% of patients over the age of 50 
have at least one small colorectal adenoma16. These mucosal lesions, pedunculated or 
sessile, are by definition neoplastic and must show at least low grade dysplasia17. 
Morphologically, adenomatous polyps are classified according to their predominant 
architectural pattern into tubular, villous and tubulovillous adenomas17. The risk of 
malignancy is highly correlated with increasing polyp size18, 19, villous or serrated 
morphology12 and the presence of high grade dysplasia12, 20. Serrated polyp is a general 
term for lesions that show serrated (saw tooth) architecture of the epithelial compartment21. 
Unlike classical adenomas, serrated lesions are often sessile and relatively flat and are 
therefore more difficult to detect than conventional adenomatous polyps. They are thought to 
account for up to 17.5% of proximal tumours15.  
High-grade dysplasia is usually focal and limited to the superficial portion of the polyp. 
Endoscopic removal is sufficient provided that the specimen is removed en bloc and 
histological examination demonstrates intact muscularis mucosae or lamina propria22. If 
however, neoplastic cells invade through the muscularis mucosae into the submucosa, the 
term malignant polyp is used and management of such lesions is debated. pT1 tumours 
invade submucosa to varying degrees and they have been sub-staged according to their 
morphology by Haggitt23 and Kikuchi24. Haggitt et al.23 described a classification system for 
pedunculated polyps with levels of invasion ranging from 0 (mucosal high grade dysplasia) 
to 4 (infiltration of the bowel wall below the stalk). This system, however, is unsuitable for 
sessile lesions and Kikuchi et al.24  described an alternative method whereby invasion of the 
submucosa is divided into thirds, ranging from superficial invasion (sm1) to deep invasion of 
the lower third (sm3) (Figure 1.1, adapted from Haggitt et al.23) The frequency of nodal 
disease increases with the  depth of invasion being 2%, 8% and 23% respectively for sm1, 
sm3 and sm3 lesions25. In addition, poor differentiation, lymphovascular invasion and 
inadequate resection margin clearance (<2mm)26 have also been associated with an 
18 
increased risk of residual intramural or nodal disease. The aim of pathological assessment is 
therefore to indicate the risk of residual disease and the need for subsequent surgical 
resection. 
Figure 1.1  Classification of polyps with invasive carcinoma  
 
Adapted from: Nivatvongs et al.25, as per Haggitt et al.23 and Kikuchi et al.24 
 
1.1.3 Spread of the disease 
The routes of spread of the primary tumour are by direct, lymphatic or haematogenous 
spread, or by shedding of viable malignant cells from serosal surface into the peritoneal 
cavity. Direct spread occurs in all directions within the bowel wall and may lead to invasion of 
both intra- and retroperitoneal structures. The lymphatic spread of colonic cancer progresses 
from the involvement of submucosal vessels followed by extramural spread to paracolic 
lymph nodes closest to the primary tumour. In advanced disease, the tumour cells 
metastasise along the main colonic vessels eventually reaching para-aortic lymph nodes. 
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Rectal cancer spreads to the lymph nodes in the mesorectum with the subsequent 
involvement of the nodes associated with the superior haemorrhoidal and inferior mesenteric 
vessels. Extra-mesorectal nodes are most commonly found along the middle rectal artery; 
the internal iliac chain; and the obturator, median sacral, and, less commonly, external or 
common iliac nodes27, 28. The commonest site for haematogenous spread of colorectal 
cancer is the liver, occurring in approximately 50% of all patients29. In addition, 10% of 
patients develop lung metastases at some stage, and other reported sites include adrenal 
gland, bone, kidney and brain. Peritoneal spread is rare and is associated with poor 
prognosis8. 
1.1.4 Staging and prognosis  
The prognosis is very much dependent on the stage of the CRC at the time of the diagnosis, 
with the depth of the wall invasion (T), presence of the lymph node (N) or distant metastases 
(M) being the major prognostic factors.  
Table 1.1 pTNM classification  of colorectal tumours 
Stage T N M 
 
    0 Tis No M0 
    I T1, 2 N0 M0 
   II 
 IIA 
 IIB 
 
T3 
T4 
 
N0 
N0 
 
M0 
M0 
   III* 
 IIIA 
 IIIB 
 IIIC 
 
T1, T2 
T3, T4 
Any T 
 
N1 
N1 
N2 
 
M0 
M0 
M0 
   IV Any T Any N M1 
Abbreviations: N1 = there are tumour cells in up to three regional lymph nodes; N2 = there are tumour cells in 
four or more regional lymph nodes 
 
The TNM staging system was initially developed to predict cancer prognosis, but its function 
has expanded and is now used to determine treatment and patient eligibility for clinical 
trials30. At present, the Royal College of Pathologists recommends that the 5th edition of the 
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TNM staging system31 is used for colorectal cancer reporting at a national level32, 33 (Table 
1.1). This version has been used in the most recent generation clinical trials and population 
studies30. Despite the advances in surgical techniques and adjuvant treatments however, the 
overall 5-year survival following a diagnosis of CRC in the UK is just over 50%34. As such, it 
is one of the lowest in Europe35. Worldwide introduction of screening programmes over the 
past decade however, is likely to change this in the near future.  
1.2 Management of CRC 
The advances in the management of CRC over the last two decades include introduction of 
colorectal screening, laparoscopic surgery and treatment planning through a multidisciplinary 
approach. Tumour stage is central to prognosis, operative approach, and the decision 
whether to administer neoadjuvant treatment. Accurate pre-operative staging is therefore 
essential for planning of optimal therapy.  
1.2.1 Pre-operative staging 
1.2.1.1 Endoscopic assessment of the lesion 
Although mucosal biopsy and histological assessment are the ‘gold standard’ for 
differentiating neoplastic from non-neoplastic lesions, lesion characterisation during 
diagnostic colonoscopy forms an integral part of staging and treatment decision making 
process. Kudo et al.36 developed a ‘pit pattern’ classification for polyps based on different 
morphological features using magnifying endoscopy and indigo carmine dyes. Pit patterns 
are categorized into five different groups which correlate with the final pathology (Figure 1.2, 
adapted from Kudo et al.36). The authors suggested that most lesions showing pattern types 
IIIS, IIIL and IV are adenomas or intramucosal carcinomas and as such are suitable for 
endoscopic treatment. Lesions with type V pit pattern however are most likely to harbour 
invasive carcinoma and as such, should be treated surgically. 
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Figure 1.2 Pit pattern classification 
 
Adapted from: Kudo et al.36 
Type 1. Normal roundish pits; Type II. Stella or papillary pits typical of hyperplastic polyps; Type IIIs. Small round 
or tubular pits (smaller than Type I); Type IIIL. Large round or tubular pits (larger than Type I); Type IV. Branch-
like or sulcus-like pits typical of tubulovillous adenomas; Type V. Loss of architecture typical of invasion or high 
grade dysplasia 
 
Multiple studies published since have confirmed that pit pattern classification has high 
accuracy in polyp differentiation37, 38 and good inter-observer and intra-observer 
reproducibility (mean kappa values 0.716 and 0.810 respectively)39. Although the 
classification is widely accepted, magnifying endoscopes are expensive, the examination 
process is time consuming and there is an appreciable learning curve requiring experience 
with approximately 200 lesions to overcome it40. The extra training and time required for 
magnifying chromoendoscopy have not made it popular in the West and the technique is 
therefore rarely utilised for lesion characterisation outside a research setting.  
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Narrow band imaging (NBI) is a new optical technique that highlights superficial vessels in 
the mucosa through the use of optical filters and allows a more detailed visualisation of the 
mucosal and vascular patterns. Using a system of vascular intensity, NBI has high sensitivity 
and specificity (92% and 86% respectively) in distinguishing neoplastic and non-neoplastic 
polyps41. The ‘blue light’ optical modality can be activated at the push of a button on the 
colonoscope head. As such, it is likely to overcome some of the issues encountered with 
chromoendoscopy and be more acceptable in a busy clinical setting.  
1.2.1.2 Computed Tomography (CT) 
Computed tomography (CT) is universally available, easily reproducible and therefore has 
been the principal investigation in the staging of CRC. It has a potential to visualise the 
tumour (site, size and infiltration into surrounding structures) in addition to detecting distant 
metastases. It also plays an important role in both assessing the response to treatment and 
post-operative disease surveillance.  
The main value of pre-operative CT scan is to diagnose metastatic disease rather than 
accurately measure the depth of local invasion42-44. In a recently published meta-analysis 
examining the diagnostic precision of CT in local staging of colon cancer, the pooled 
sensitivity, specificity and diagnostic odds ratio (DOR) for differentiating between T1/T2 and 
T3/T4 tumours were 86% (95% CI 78 - 92%), 78% (95% CI 71 - 84%) and 22.4 (95% CI 
11.9 - 42.4) respectively45. Identification of malignant lymph nodes also remains poor, with 
the overall sensitivity and specificity of 70% (95% CI 59 - 80%) and 78% (95% CI 66 - 86%), 
and DOR of 8.1 (95% CI 4.7 - 14.1)45.  
Generally, all patients with colonic malignancy undergo the same treatment regardless of the 
local stage of the disease, provided that they are fit for surgery, and any subsequent 
treatment is dependent on histological assessment of surgical specimen. Patients with rectal 
cancer, however, can be investigated with additional imaging modalities to increase 
accuracy of pre-operative staging and several treatment options are available. 
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1.2.1.3 Endoscopic Ultrasound (EUS) 
EUS is selectively used in pre-operative staging of rectal lesions46-48. It is usually performed 
to assess the depth of invasion (T stage), identify those suitable for local excision or even 
those in whom neo-adjuvant treatment is indicated. In a recent meta-analysis comparing 
EUS, CT and MRI in staging of rectal cancer, transrectal EUS had the highest sensitivity and 
specificity, 94% (95% CI 90 - 97%) and 86% (95% CI 80 - 90%) respectively, for assessment 
of invasion of muscularis propria49. Sensitivity and specificity values for nodal involvement 
however were comparably low for all three modalities 67% (95% CI 60 - 73%) and 55% 
(95% CI 43 - 67%); 66% (95% CI 54 - 76%) and 78% (95% CI 71 - 84%) and 74% (95% CI 
67 - 80%) and 76 % (95% CI 59 - 87%) respectively49.  
In contrast, EUS has not gained widespread use for local staging of colonic lesions because 
until recently, accurate pre-operative local staging of colonic cancer had no therapeutic 
consequences. With advances in endoscopic techniques and success of the screening 
programmes however, accurate staging of colonic lesions has become more relevant. 
Several authors have reported varying degrees of success with using ultrathin mechanical 
radial scanning probes that can be passed through a 2.8mm endoscopic channel for 
assessment of early stage colonic tumours. Akahoshi et al.50 used a 12 MHz scanning probe 
in patients with colonic cancer (n = 83) and reported accuracy of 88% for T1 tumours, 64% 
for T2, 95% for T3 and 100% for T4 colonic lesions respectively. Similar results were 
reported by Tseng et al.51, Matsumoto et al.52 and Stergiou et al.53 with the overall accuracy 
for T stage being  85%, 91.4% and 94% respectively. Nodal assessment however remains 
suboptimal and reported overall accuracy is inconsistent ranging from 24%52 to 84%53.   
Major limitations of the studies published to date, however, are the small number of patients 
involved and some authors including patients with rectal or even gastric cancer50, 51, 54, 
limiting the validity of the data. The results are operator dependant and technical challenges 
encountered include limited depth of tissue penetration using high frequency transducers 
and unsatisfactory water immersion coupling for lesions located at flexures51. Although EUS 
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may have a role in assessment of the depth of the invasion of colonic lesions, at present, low 
accuracy for nodal assessment limits its role in routine practice even in expert hands. EUS 
however allows local evaluation of the depth of invasion of rectal lesions and enables 
identification of patients suitable for local excision. 
1.2.1.4 Magnetic Resonance Imaging (MRI) 
In patients with advanced rectal cancer, circumferential extent of the tumour through the 
rectal wall into the surrounding mesorectum is one of the most important features when 
considering suitability for total mesorectal excision (TME) or need for extended resection55. 
The relationship between the tumour and the circumferential resection margin (CRM) can be 
easily assessed with MRI in order to determine if surgery is adequate primary treatment or 
whether neo-adjuvant therapy should be considered. The largest study reported to date 
designed to examine the accuracy of MRI in predicting the presence or the absence of 
tumour at the surgical CRM in patients with rectal cancer is the MERCURY trial56. Over 400 
participants were recruited prospectively from 12 colorectal units in four European countries. 
The authors demonstrated that MRI is highly accurate and reproducible in the multicentre 
setting with specificity of 92% (327/354, 95% CI 90 – 95) for prediction of clear CRM.  
1.2.2 Principles of surgery for CRC 
1.2.2.1 Management of rectal cancer 
The anatomical position of the rectum deep within the pelvis surrounded by pelvic nerves 
and the associated anal sphincter complex makes surgical management particularly 
challenging. The factors governing the choice of procedure include local extent of the 
tumour, proximity to the sphincter, presence of distant metastases and patient co-
morbidities. The mesorectal fascia encloses the mesorectum including its associated 
lymphatic drainage and vasculature, providing a natural boundary for the tumour. The 
objective of total mesorectal excision (TME), originally described by Heald et al.57, is to 
remove the mesorectum and its fascia intact as an en bloc specimen containing the cancer 
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in the middle or lower rectum. This involves identification of the fascial plane followed by 
meticulous sharp dissection around it both circumferentially and distally. Adoption of this 
technique reduces the rate of local recurrence and cancer related death29, 57, 58.   
Acquisition of advanced laparoscopic skills and optimisation of surgical technique over the 
past decade have led to an interest in utilising this approach in patients with rectal cancer. 
Although laparoscopic procedures for excision of the rectum are regarded as technically 
demanding, several studies59-62 have demonstrated short-term benefits of minimally invasive 
surgery. Despite growing enthusiasm however, laparoscopic proctectomy is not universally 
accepted due to the lack of good quality data and concerns regarding oncological safety. 
The UK Medical Research Council trial of conventional vs. Laparoscopic-Assisted Surgery in 
Colorectal Cancer (UK MRC CLASICC)59 was the first multicentre, randomised controlled 
trial (RCT) for laparoscopic surgery including patients with rectal cancer and the long-term 
data were recently published63, 64. In the original study59, the authors reported no difference 
in short term endpoints between the groups, with a shorter hospital stay observed in the 
laparoscopic group (median 10 days vs. 13 days). A trend towards higher CRM involvement 
in patients undergoing anterior resection laparoscopically (6% open vs. 12% laparoscopic 
group, p 0.19) raised the possibility that laparoscopic procedure may be associated with an 
increased risk of local recurrence. At 3-63 and 5-year64 follow-up however, this had not 
translated into an increased incidence of local recurrence and no difference was observed in 
the overall survival (OS), disease-free survival (DFS) and distant recurrence rates. Although 
similar findings were reported in a recently published meta-analysis65, the verdict on 
laparoscopic rectal cancer surgery is expected upon completion of two large, multicentre 
RCTs  in Europe (COLOR II)66 and North America (ACOSOG-Z6051)67 specifically designed 
to compare outcomes of laparoscopic-assisted and open surgery for rectal cancer. 
1.2.2.2 Management of early rectal cancer 
Although TME is the gold standard for treatment of rectal cancer, the benefits of radical 
surgery are offset by relatively high rate of complications59, mortality59 and poor functional 
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outcomes68. Endoluminal therapeutic options are greater in the rectum than in the colon due 
to easy access and as a result, localised excision (LE) techniques for rectal lesions were 
developed in parallel with the advent of TME. Parks69 described a technique for transanal 
excision of rectal adenomas which has been increasingly used for treatment of selected 
early rectal cancers. You et al.70 reported that the rate of LE increased from 26.6% to 43.7% 
and 5.8% to 16.8% for T1 and T2 cancers respectively in the United States between 1989 
and 2003. In the same study, patients undergoing LE had a significantly lower 30-day 
morbidity when compared to radical surgery (RS) (5.6% vs. 14.6%, p <0.001). The major 
problem with this approach in treatment of rectal cancer however is non-radical resection. 
The mesorectum and its associated lymph nodes remain intact increasing the risk of 
understaging and under treatment of nodal disease, and therefore the likelihood of local 
recurrence and distant metastases.  
Table 1.2 Oncological outcomes of LE according to Parks vs. RS for early rectal 
cancer  
Author, year Type of study LE vs. RS (n) LR (5-yrs) OS (5-yrs) 
 
Mellgren et al.,  
200071  
Retrospective 
T1 69 vs. 30 
T2 39 vs. 123 
T1 18% vs. 0%‡ 
T2 47% vs. 10%‡ 
T1 72% vs. 80% 
T2 65% vs. 81%‡ 
Nascimbeni et al.,  
200472 
Retrospective T1 70 vs. 74 T1 7% vs. 3% T1 72% vs.90%‡ 
Ptok et al.  
200773  
Prospective T1 105 vs. 312 T1 6% vs. 2%‡ T1 91% vs. 92% 
You et al.  
200770 
Retrospective 
T1 601 vs. 493 
T2 164 vs. 866 
T1 13% vs. 7%‡ 
T2 22% vs. 15%‡ 
T1 77% vs. 82% 
T2 68% vs. 77%‡ 
Abbreviations: LE = local excision; RS = radical surgery; LR = local recurrence; OS = overall survival 
‡statistically significant (p <0.05) 
 
Local recurrence rates at 5-years reported by You et al.70 were significantly higher following 
LE but the OS was comparable between the groups for patients with T1 cancer (Table 1.2). 
The risk of mortality in this series70 was influenced by age, high tumour grade and 
comorbidities rather than the type of surgery. Although this is the largest series published to 
date, interpretation of the remaining literature is difficult due to the retrospective nature of the 
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studies reported, patient selection (high risk vs. low risk early cancers) and small study 
samples (Table 1.2). 
Utilisation of transanal endoscopic microsurgery (TEMS) has been shown to result in lower 
recurrence rates compared to LE due to better access and exposure of rectal lesions74. 
During TEMS, the rectum is insufflated with carbon dioxide and special instruments are 
introduced through airtight ports for sharp dissection under direct vision. The procedure is 
suitable for lesions located throughout the rectum with the lower border of adenoma between 
1cm and 15cm from the anal verge75.  The margin of normal tissue should be 5mm from the 
macroscopic tumour edge for benign lesions and 10mm if malignancy is suspected76. 
Serious morbidity and mortality occur in less than 15% 77, 78 and 1.4%77 respectively, and the 
reported median hospital stay of three days 78, 79 is significantly shorter than after RS. The 
‘ideal’ rectal tumour for local excision is a small (T1) lesion with invasion confined to the 
superficial submucosa (sm1) in the absence of adverse histopathological features (poor 
differentiation, vascular, lymphatic or perineural invasion and tumour and/or budding)80. 
Several comparative series of TEMS vs. RS have been reported to date78, 81 including one 
small randomised controlled trial82. Winde et al.82 randomised 50 patients with T1 rectal 
cancer either to TEMS or RS and after a median follow-up of more than 40 months, the local 
recurrence rate after TEMS was 4.1% compared to 0% in the RS group. Other groups (Table 
1.3), in addition to abundance of single or multi-institution case series published to date77, 83, 
84, have reported significantly higher local recurrence rates after TEMS.  
The ability to avoid laparotomy and preserve the rectum however, is an attractive treatment 
option for a select group of patients despite the risk of local recurrence. With the reported 
incidence of nodal involvement for T1 and T2 lesions of 12.7% and 19% respectively85, 
oncological compromise may be acceptable to those with concomitant comorbidity or 
unwilling to have a temporary or a permanent stoma. Although TEMS may be a definitive 
treatment for a significant proportion of patients with early disease, the procedure itself 
results in a large biopsy specimen. If post-TEMS pathology is unfavourable, treatment 
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options including completion surgery or adjuvant chemoradiotherapy can be carefully 
discussed.  
Table 1.3 Oncological outcomes of TEMS vs. RS for early rectal cancer  
Author, year Type of study LE vs. RS (n) LR (5-yrs) OS (5-yrs) 
 
Winde et al.  
199682 
RCT T1 24 vs. 26 T1 4% vs. 0% T1 96% vs. 96%‡ 
Lee et al. 
200381 
Prospective 
T1 52 vs. 17 
T2 22 vs. 83 
T1 4% vs. 0% 
T2 20% vs. 9%‡ 
T1100% vs.93% 
T2 95% vs. 96% 
De Graaf et al.  
200978 
Prospective T1 80 vs. 75 T1 24% vs. 0%‡ T1 75% vs. 77% 
Abbreviations: LE = local excision; RS = radical surgery; LR = local recurrence; OS = overall survival; NS = not 
specified 
‡statistically significant (p <0.05) 
 
1.2.2.3 Surgical management of colonic cancer 
Optimal treatment for colonic cancer remains a hemicolectomy with en bloc removal of all 
regional lymph nodes to eliminate the disease and allow accurate staging. Over the past two 
decades there have been two major developments in elective colonic surgery: the 
introduction of laparoscopy and enhanced recovery after surgery (ERAS) protocol. The 
safety and advantages of laparoscopic colectomy for colon cancer have been demonstrated 
by several RCTs. In a recently published meta-analysis laparoscopic surgery was associated 
with lower morbidity, less pain, faster recovery and reduced hospital stay without 
compromising oncological clearance86. In addition, the equivalence of medium-term cancer 
outcomes following open or laparoscopic colonic resection has been demonstrated by 
several research groups63, 64, 87, 88. The long-term follow-up data from the MRC CLASICC 
trial89 showed no difference in the OS (78.3% for open vs. 82.7% for laparoscopic approach, 
p 0.780) or DFS (89.5% vs. 77.0% respectively, p 0.589) between the two groups. However 
intraoperative conversion to open surgery was associated with worse outcomes (OS hazard 
ratio 2.28, p <0.001 and DFS hazard ratio 2.20, p 0.007)89.  
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ERAS was pioneered by Henrik Kehlet90, 91 and developed in parallel with laparoscopic 
surgery. This ‘fast track’ perioperative care pathway consists of a multidisciplinary approach 
involving clinicians, nurses, dieticians and anaesthetists with the aim to reduce surgical 
stress response and organ dysfunction by promoting faster post-operative recovery with 
fewer complications. The advantages of ERAS have been demonstrated in several 
randomised controlled trials92-94. The combination of laparoscopic surgery with enhanced 
recovery in the LAFA trial (LAparoscopy and/or Fast-track multimodal management vs. 
standard care) resulted in a significant reduction in hospital stay when compared to open 
surgery and standard care (median 5 days vs. 7 days, p <0.001)94. All treatment groups in 
this trial had similar morbidity, mortality, reoperation and readmission rates (Table 1.4). 
Table 1.4  Post-operative outcomes of laparoscopic and open colonic cancer 
surgery with or without ERAS care   
 Laparoscopic 
surgery & ERAS 
Open surgery & 
ERAS 
Laparoscopic 
surgery & 
standard care 
Open surgery & 
standard care 
Median (IQR) LOS, days 5 (4 – 8) 7 (5 – 11) 6 (4.5 – 9.5) 7 (6 – 13)‡ 
30-day morbidity 34.0% 46.2% 33.9% 40.8% 
30-day reoperation 10.0% 14.0% 10.1% 18.4% 
30-day readmission 6.0% 7.5% 6.4% 2.0% 
Mortality 2.0% 4.3% 1.8% 2.0% 
Vlug et al. 201194 
 ‡statistically significant (p <0.05) 
 
Although the provision of laparoscopic service with ERAS programme is more expensive in 
comparison to standard care, these costs are likely to be counterbalanced by reduction in 
hospital stay93, 94. Provision of laparoscopic surgery for cancer resection in patients suitable 
for this approach was supported by NICE in 2006, provided that the procedures are 
undertaken by appropriately trained surgeons95. In order to facilitate introduction of 
laparoscopic colorectal surgery in England in a safe and structured way, the National 
Training Programme was set up in 200896. This has resulted in a significant increase in the 
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number of colorectal procedures performed laparoscopically from only 5% in 2006 to 40% in 
201297.  
1.2.3 Adjuvant and neo-adjuvant treatment of CRC 
1.2.3.1 Radiotherapy in management of rectal cancer 
Treatment strategy for rectal cancer depends on pre-operative MRI assessment of the 
CRM56. Radiotherapy is employed in four main modalities: pre-operative short course 
neoadjuvant radiotherapy (SCRT) or long course usually with chemotherapy; post-operative 
regimen when directed by unfavourable histology and palliative treatment for symptom 
control98. A positive CRM is not sufficiently controlled with post-operative treatment99 and 
pre-operative regimens are thought to offer several advantages. These include improved 
response of the target tissue which has not been rendered hypoxic by previous surgery, 
lower rate of early toxicity and potential downstaging of the tumour resulting in reduction of 
involved surgical margins and improved sphincter preservation rates98.  
Although the radiation techniques are similar between neoadjuvant SCRT and long course 
chemoradiotherapy (CRT), the fractionation and timing of surgery differ. Traditionally, the 
SCRT is delivered in 25Gy over 5 days followed by surgery within 10 days. Neoadjuvant 
CRT course delivers 45 to 54Gy of radiation over 5 weeks concurrently with chemotherapy 
(several regimens), followed by surgery 4 to 12 weeks later. These competing approaches 
have evolved in parallel; SCRT was developed in Northern Europe and long-course CRT in 
the United States and several European countries.  
The Stockholm Colorectal Cancer Study Group (SCCG) conducted two randomised trials 
(Stockholm I and II)100, 101 evaluating SCRT vs. surgery alone, demonstrating a significant 
decrease in the incidence of pelvic recurrence (12% vs. 25%, p <0.001) and improvement in 
the OS (45% vs. 39%, p <0.03). This trial was followed by the Dutch TME trial102 where the 
same design was applied in addition to high quality standardised surgery. The results of this 
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trial demonstrated a further reduction of local recurrence rate (2.4% vs. 8.2%, p <0.001) with 
no effect on the OS. 
Although SCRT is less expensive and more convenient, it offers less downsizing effect as 
the delay to surgery is short. Pre-operative CRT is indicated when CRM is thought to be 
threatened or involved on pre-operative imaging. This regimen is more effective at reducing 
the tumour bulk, making restorative surgery more feasible. The German Rectal Cancer 
Group103 assessed the efficacy of pre-operative and post-operative CRT in a randomised 
study, reporting significantly lower local recurrence (6% vs. 13%, p 0.006), increased 
sphincter preservation rate (39% vs. 19%, p 0.004) and fewer acute and long-term side 
effects following the pre-operative regimen. In a randomised trial by Bujko et al.104, 
neoadjuvant CRT resulted in a lower incidence of CRM involvement (4.4% vs. 12.9%, p 
0.017) and higher rate of complete pathological response (16.1% vs. 0.7%) when compared 
to SCRT. This, however, had no effect on the local recurrence or the OS. The effect of 
treatment schedules on tumour response, resectability, complications and local recurrence 
rates are being investigated for both neo-adjuvant regimens105, 106. The preliminary results 
recently published on behalf of the Timing of Rectal Cancer Response to Chemoradiation 
Consortium suggest that neoadjuvant CRT followed by additional chemotherapy 
(mFOLFOX-6) and delay in surgery in patients with evidence of clinical response may result 
in an increase of pathological complete response rate105.  
Several studies107 have reported complete tumour regression following neo-adjuvant CRT for 
distal rectal cancer defined as the absence of residual cancer cells in the definitive surgical 
specimen108. This outcome, however, requires a radical procedure associated with a 
significant risk of morbidity and mortality and its necessity is debated. Patients who exhibit 
such a profound response to neoadjuvant CRT may represent a distinct group with a 
particularly favourable outcome. In the absence of tumour on post-treatment endoscopic or 
MRI assessment, these patients are potential candidates to alternative treatment options 
such as TEMS or strict surveillance programme alone (watch-and-wait policy)109 avoiding 
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surgery altogether. The safety and efficacy of this approach is currently being 
investigated110. 
1.2.3.2 Adjuvant treatment for CRC 
Surgery is the cornerstone of cure of CRC localised to the bowel wall. The benefits of 
adjuvant treatment with fluorouracil/leucovorin (5-FU/LV) in reducing the risk of relapse and 
prolonging survival of patients with node positive (Stage III) colon cancer are well 
established111, 112. The MOSAIC113 study demonstrated that addition of oxaliplatin to  5-
FU/LV results in an additional 7% increase in 3-year DFS for stage II and III disease, leading 
to a 4.2% increment in the OS at 6 years for patients with stage III disease114.  
Adjuvant therapy for patients with stage II disease remains controversial due to the lack of 
adequately powered RCTs. A subgroup analysis of the MOSAIC trial participants (n = 899) 
showed that patients with low-risk stage II colon cancer (n = 330) or those over the age 70 (n 
= 315) do not benefit from additional oxaliplatin115. High-risk stage II patients, defined as 
those with T4 staging, tumour perforation, bowel obstruction, poorly differentiated tumour, 
venous invasion, or fewer than 10 lymph nodes examined, however, had a significantly 
improved time to recurrence (hazard ratio 0.62; 95% CI, 0.41 – 0.93; p 0.02) although this 
did not translate into better OS and DFS rates. In contrast, the results of the QUASAR 
study116 showed a small but significant OS gain of 3.6% with a similar benefit for both colon 
and rectal cancers. Therefore the risks of treatment toxicities need to be carefully weighed 
against the potential small benefit of adjuvant chemotherapy for patients with Stage II 
disease. 
Although recombinant monoclonal antibodies to epidermal growth factor (cetuximab and 
panitumumab) and vascular endothelial growth factor (bevacizumab) are licensed for the 
treatment of metastatic disease, there is a growing interest in applying them in adjuvant and 
even neoadjuvant settings. Early results of the recently published FOxTROT trial117 suggest 
that neoadjuvant therapy (oxaliplatin, 5-FU/LV with or without panitumumab) is associated 
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with significant downstaging (p 0.04), resulting in fewer incomplete resections (p 0.002) and 
reduced apical lymph node metastasis (p <0.0001) in patients with locally advanced (T3 and 
T4) resectable colonic tumours. Two patients in this trial had a complete pathological 
response and the long-term results are awaited. In addition, recruitment of patients with 
high-risk stage II and stage III disease for the QUASAR 2 study118 is now completed. This 
multicentre RCT was designed to compare the effect of adjuvant capecitabine with 
bevacizumab vs. capecitabine alone at 3-year DFS and the results are currently awaited. 
1.3 Recent developments  
1.3.1 Screening for CRC 
The lifetime risk for developing CRC in the Western world is approximately 5%. Almost 80% 
of cancers are thought to arise from benign adenomas and the slow transition from a polyp 
to a carcinoma makes it one of the most preventable cancers. The aim of CRC screening 
programmes is to prevent development of advanced disease through detection of adenomas 
and cancers confined to the bowel wall. Although several screening methods are available, 
guaiac-based faecal occult blood test (FOBT) is the most extensively studied. A Cochrane 
review119 of several randomised trials has provided high quality evidence that when offered 
biennially, this non-invasive test has the potential to reduce CRC-related mortality by 16%. 
Colonoscopy, the current gold standard for detection of neoplastic lesions, is recommended 
if a certain number of test cards are positive. In conjunction with adequate bowel 
preparation, colonoscopy is safe, accurate and is well tolerated by patients. Polyps detected 
during the procedure are removed, thereby interrupting the adenoma carcinoma sequence. 
The further surveillance schedule is arranged depending on histological examination of the 
specimen120.  
Following the success of other screening programmes, the NHS Bowel Cancer Screening 
Programme (BCSP) was introduced in 2006 and over 1 million tests have been performed to 
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date121. The results of the pilot study suggested a substantial shift in the diagnosis towards 
early stage of the disease122. Logan et al.121 subsequently reported that a significant  
proportion of the screened population are now diagnosed with Stage I and II disease (Table 
1.5). In addition, small studies have reported a higher incidence of colonic polyps and 
adenomas within the BCSP when compared to symptomatic population (47% vs. 30% and 
79% vs. 47% respectively, p <0.005)123. Polyps detected through screening are also likely to 
be larger when compared to symptomatic population124 requiring more complex endoscopic 
intervention. 
Table 1.5 Dukes’ staging of CRC detected after first investigation of the first 
million people screened in England  
 Males Females Total  
 
Polyp cancer 114 41 155 9.8% 
Dukes’ A 349 154 503 32.0% 
Dukes’ B 316 148 464 29.5% 
Dukes’ C 272 133 405 25.7% 
Dukes’ D 37 10 47 3.0% 
Total  1088 486 1574 100% 
Logan et al.121 
 
Almost 80% of cancers diagnosed through the NHS BCSP until 2011 were left-sided 
supporting the need for a national flexible sigmoidoscopy screening programme. Atkin et 
al.125 recently published results of the once-only flexible sigmoidoscopy trial with 170,432 
participants. The intention-to-treat analysis demonstrated that the incidence of CRC in the 
intervention group was reduced by 23% (hazard ratio 0.77, 95% CI 0.70 – 0.84) and 
mortality by 31% (hazard ratio 0.69, 0.59 – 0.82)125 and similar findings have been reported 
by other research groups126-128. However, when adjusted for self-selection bias, the 
incidence in participants attending screening was further reduced by 33% and mortality by 
43%. As a result, a one-off flexible sigmoidoscopy will incorporated into the national 
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screening programme in England from 2013 and will be offered to those aged between 55 
and 64. 
1.3.2 Advances in endoscopic techniques 
Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are 
advanced endoscopic techniques developed for minimally invasive removal of benign and 
early malignant lesions with preservation of gastrointestinal wall. 
EMR is typically used for removal of flat lesions confined to the muscularis mucosa. The 
procedure involves injection of a mixture of normal saline, adrenaline and methylene blue 
dye into the submucosa in order to lift the mucosa (and the polyp) away from the muscle 
layer. This fluid filled ’safety cushion’ facilitates the removal of a flat lesion, minimising the 
risk of mechanical or thermal damage to the thin colonic wall. The rate of EMR-associated 
adverse events is low and the most frequently encountered complications are bleeding 
(range 0.8% - 10.8%)129, 130 and colonic perforation (range 0% - 3.1%)129, 131. The main 
disadvantage of this technique is that en bloc excision can only be performed for lesions 
smaller than 2cm in diameter (Table 1.6). Larger lesions are removed in a piecemeal fashion 
instead, compromising the quality of histopathological examination as accurate assessment 
of the lateral and vertical tumour clearance margins using multiple tissue samples is difficult. 
In addition, the risk of local recurrence is significantly increased with this approach (Table 
1.7).   
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Table 1.6 Efficacy of EMR and ESD  
Author, year Procedure No. of polyps Mean (SD) size of 
the lesion, mm 
En-bloc 
excision 
Completeness 
of excision 
Bories et al., 
2006132 EMR 52 29.8 45% 98% 
Lim et al.,  
2010130 
EMR 239 19.6 (12.4) 72% 86% 
Yoshida et al., 
2012133 EMR 614 
Median 8.3 
(5 – 20) 
94% 78% 
Nishiyama et al., 
2010134 ESD 204 
Median 27.4 
(10 – 75) 
87% 78% 
Saito et al.,  
2010135 
ESD 1111 35 (18.0) 88% 89% 
Saito et al.,  
2010131 
EMR vs. ESD 228 vs. 145 
28 (8.0) 
37 (14.0) 
33% vs. 84%‡ - 
Tajika et al.,  
2011136 
EMR vs. ESD 104 vs. 85 
25 (6.8) 
31 (9.0) 
48% vs. 83%‡ - 
‡statistically significant (p <0.05) 
 
ESD technique was developed in Japan for treatment of early gastric lesions but over the 
recent years it has been found to be effective for treatment of large colorectal neoplasms. 
The margins of the lesion are usually marked by electrocautery and a deep submucosal lift is 
created with injection of a viscous solution such as hyaluronic acid which provides a longer 
lasting lift133. A circumferential incision into the submucosa is performed around the lesion 
using a specialised needle knife for dissection. Tissue retraction and view of the submucosa 
are maintained by a transparent cap that is attached to the tip of the endoscope. The 
effectiveness of this approach is therefore less limited by the size of the lesion or its 
configuration. Deeper excision results in a specimen of superior quality when compared to 
piecemeal EMR114, 118, reducing the risk of local recurrence (15.4 vs. 2.0, p 0.002)136 at the 
expense of higher complication rates (Table 1.7). In addition, intact specimen enables 
thorough histopathological evaluation of the depth of invasion as well as assessment of 
lateral margins.  
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Table 1.7 Complications associated with EMR and ESD  
Author, year Procedure Median (SD) 
duration of the 
procedure, min 
Bleeding Perforation Recurrence 
Conio et al.,  
2004129 
EMR - 10.8% 0% 21.9% 
Bories et al., 
2006132 
EMR - 5.8% 2.0% 15.0% 
Lim et al.,  
2010130 
EMR - 0.8% 0.8% 20.1% 
Yoshida et al.,  
2012133 
EMR 2.1 (1.5) 1.1% 0% - 
Nishiyama et al., 
2010134 ESD - 1.0% 9.8% 0% 
Saito et al., 
2010135 
ESD 116 (88.0) 1.5% 4.9% - 
Saito et al.,  
2010131 
EMR vs. ESD 
29 (25.0) vs. 
108 (71.0)‡ 
3.1% vs. 1.4% 1.5% vs.% 14.0% vs. 2.0%‡ 
Tajika et al.,  
2011136 
EMR vs. ESD 29.4 (26.1) vs. 87.2 (49.7) 2.9% vs. 2.4% 0% vs. 5.9%
‡ 15.4% vs. 2.0% ‡ 
‡statistically significant (p <0.05) 
 
Both procedures offer a less invasive, alternative treatment option when compared to 
standard surgery. Unlike TEMS, EMR and ESD require sedation only and are associated 
with fewer complications137, 138. To date, only one study comparing the effectiveness of ESD 
vs. laparoscopic resection of early colorectal cancer has been published. Kiriyama et al.139 
reported a retrospective review of 297 colorectal ESD procedures and 292 laparoscopic 
colorectal resections performed for treatment of T1 cancers. The tumour size in the ESD 
group was larger (37mm vs. 20mm, p <0.001) but the procedure time, hospital stay and 
complication rate were significantly lower when compared to laparoscopic surgery139. In 
addition, 3-year survival rates of 99.2% and 99.5% respectively were comparable. Although 
these results question the role of radical surgery in treatment of early CRC, the risk of 
residual disease (intramural or nodal) has to be considered. Gill et al.140 recently published 
the outcomes of patients diagnosed with malignant colorectal polyps on behalf of the 
Northern Colorectal Cancer Audit Group. Of the 184 patients managed by polypectomy at 
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the initial procedure: 71 (38.6%) had subsequent surgery and residual tumour at the 
polypectomy site was found in nine (12.7%) patients, with four (5.6%) having positive lymph 
nodes alone.  
1.3.3 Development of localised excision techniques for colonic lesions 
The majority of the colonic polyps diagnosed during diagnostic colonoscopy are suitable for 
EMR or ESD. Both however, require good visualisation of the lesion and maintenance of a 
stable position throughout the polypectomy. Difficulties are encountered with large colonic 
adenomas or those located behind a mucosal fold, and although endoscopic intervention 
may still be viewed as an option, obtaining a good view to snare the polyp safely can be 
challenging. The perceived risk of uncontrollable bleeding, perforation and incomplete 
resection may prevent an attempt at polypectomy and traditionally, these patients are 
referred for hemicolectomy.  
In parallel with the advances in laparoscopy, a number of published series have described 
laparo-endoscopic approaches for lesions with benign pre-operative histology. Several 
combinations of laparo-endoscopic ‘rendezvous’ procedures have been described including 
laparoscopically assisted endoscopic polypectomy (LAEP), endoscopically assisted wedge 
or transluminal resection (EAWR and EATR respectively) and endoscopically assisted 
segmental resection (EASR)141-145. LAEP is the least invasive procedure, indicated when the 
view of the lesion is limited either due to the tortuous colon or for lesions at acutely 
angulated locations. Laparoscopic mobilisation of flexures or adhesions facilitates the 
passage of the endoscope towards the previously inaccessible polyp. Furthermore, applying 
two points of fixation using laparoscopic graspers can facilitate straightening and rotation of 
the colonic segment146, optimising intraluminal exposure of the polyp. Standard endoscopic 
polypectomy is performed using electrosurgical snare and the serosal surface inspected 
throughout the procedure for changes suggestive of thermal damage. In the event of an 
injury, the breach can be controlled laparoscopically either by placement of sutures or 
application of a linear stapling device.  
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In cases where LACP is not feasible, EAWR can be performed using a laparoscopic linear 
stapler. The lesion is visualised endoscopically to ensure complete excision and advancing 
the endoscope beyond the resection area protects the lumen during wedge resection. This is 
particularly relevant for caecal polyps where utilisation of endoscopy intra-operatively 
ensures that the ileo-caecal valve is protected during stapling147. Colonic lesions located 
near the mesentery, however, are not suitable for this approach and laparoscopic colotomy 
is performed instead with endoscopic guidance (EATR)141. The bowel segment is 
exteriorised though a mini-laparotomy and the colotomy site is closed either by laparoscopic 
sutures or application of laparoscopic stapling device. Endoscopic assistance is valuable for 
both approaches as it ensures completeness of excision and that the suture line does not 
leak144. EASR can also be used  for lesions unsuitable for any of the aforementioned 
techniques, but endoscopic assistance was also utilised for lesion localisation prior to routine 
use of colonic tattooing. The term EASR is used interchangeably for a limited segmental 
resection and formal hemicolectomy with en bloc mesenteric resection.  
Although these approaches are technically demanding, the advantages over standard 
surgical resection are obvious. The LACP maintains integrity of the colonic wall and 
mesenteric blood supply, potentially avoiding surgery in over 80% of patients (Table 1.8). 
However most benign polyps that require surgery do so because of their size and therefore 
carry a risk of containing a focus of malignancy148. Franklin et al.143 performed frozen section 
on all LACP specimens so that definitive surgery could be performed during the same 
procedure in the presence of invasive malignancy. The authors recently published their long 
term outcomes concluding that LACP performed for 209 polyps is a safe and efficient 
procedure with short hospital stay and low recurrence rates149. Clinical applicability of EAWR 
and EATR however is yet to be demonstrated. Tangential excision during EAWR cannot 
guarantee adequate lateral tumour clearance margin even with endoscopic assistance, 
whereas the risk of seeding of malignant cells during EATR is a concern. These issues could 
potentially explain the low uptake of these procedures.  
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Table 1.8 Results of laparo-endoscopic procedures for colonic lesions  
Author, year No. 
patients 
No. 
polyps 
Procedures Surgery avoided Median (range) 
LOS, days 
Complications Malignancy Recurrence 
Feussner et al., 
2003141 75 80 
9 LAEP 
28 EAWR 
22 EATR 
21 EASR 
56 (74%) 6 (1-18) 6 (8.0%) 7 (9.3%) - 
Winter et al., 
2007142 
38 38 
8 LACP 
23 EAWR 
2 EATR 
5 EASR 
33 (87%) 
4 (2 - 9) 
8 (2 – 39) 
 
2 (5.3%) 5 (13.2%)‡ 2 metastatic disease 
Franklin et al., 
2007143 
110 149 
130 LACP 
1 EATR 
18 EASR 
98 (89%) 
LAPC average 1.14 
EASR average 5 
4 (3.6%) 11 (10.0%) - 
Wilhelm et al., 
2009144 
146 154 
8LACP 
72 EAWR 
40 EATR 
26 EASR 
121 (83%) 8 (3 – 35) 36 (24.7%) 17 (12.0%) 
1 adenoma 
2 metastatic 
disease 
Wood et al., 
2011145 
16 16 
9 LACP 
4 EASR 
12 (75%) 2 2 (13.0%) 1 (6.3%) - 
‡Advanced disease was diagnosed in two patients prior to surgery 
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1.3.4 Feasibility of sentinel lymph node mapping in CRC 
Standard surgical treatment for colon cancer remains hemicolectomy with en bloc 
mesenteric resection of the regional lymph nodes, as metastatic status of these nodes 
remains the most important factor for determining adjuvant treatment. This of course was 
appropriate when approximately 90% of patients diagnosed with CRC presented with 
symptomatic, locally advanced disease122. In the view of the recently published data from the 
screening programmes however, many have started to question whether radical resection is 
the ‘best’ treatment option for this group of patients and an appropriate use of healthcare 
resources. The reported incidence of nodal disease in patients with T1 and T2 colon cancer 
is 5% and 19% respectively150 and therefore lymphadenectomy provides no additional 
therapeutic benefit for over 80% of patients with original diagnosis of Stage I disease. 
Provided that nodal negativity could be assured prior or during surgery, the operative extent 
of surgery could potentially be reduced considerably. 
SLN mapping technique is based on the principle that the first possible sites of metastasis 
along the lymphatic drainage route from the primary lesion are known as sentinel lymph 
nodes (SLNs). The nodes can be identified using injection of dyes, radioisotopes or a 
combination of both. Following this, the nodes are evaluated by multilevel sectioning and 
immunohistochemistry for metastases that might have otherwise been missed by 
conventional methods. Evaluation of the SLNs can result in an accurate assessment of the 
nodal status in the entire lymphatic basin and as such enables identification of node-
negative patients with melanoma, breast and more recently gastric cancer151-154, sparing 
them the morbidity of lymphadenectomy. Its feasibility and diagnostic accuracy in patients 
with CRC however remains unclear mainly due to the high false negative rates (Table 1.9). 
In a recently published meta-analysis155 including 52 studies, the overall sensitivity rates for 
both colonic and rectal cancer were low (86% and 82% respectively) regardless of T stage, 
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Table 1.9 Feasibility of SLN mapping in CRC 
Author, year No. 
patients 
Tumour location 
 
Stage of the disease Detection Accuracy Sensitivity False negative  
Tis T1 T2 T3 T4 
Wood et al., 
2002145 
100 
Colon 88% 
Rectum 22% 
0 25 23 46 6 97% 95% 92% 8% 
Kitagawa et al., 
2002156 
56 
Colon 21% 
Rectum 79% 
Data not provided 91% 92% 82% 18% 
Braat et al., 
2004157 
35 Colon 100% 0 6 20 51 23 94% 97% 91% 9% 
Saha et al., 
2006157 
500 
Colon 82% 
Rectum 18% 
15 11 16 52 5 98% 96% 90% 10% 
Bilchik et al., 
2006158 
132 
Colon 72% 
Rectum 28% 
0 17 15 65 3 100% 95% 88% 12% 
Stojadinovic et al., 
2007159 84 Colon 100% 6 7 20 65 2 98% 90% 69% 31% 
Bembenek et al., 
2007160 
315 Colon 100% Data not provided 85% 86% 54% 46 
 
43 
 
tumour localisation or histological technique utilised. Others however have suggested that 
the outcomes are significantly affected by the study design, tumour stage and size, patient 
selection and variation in surgical experience150, 161, 162. Mapping agents utilised in the 
previous studies are not ideal. Blue dyes are difficult to localise in patients with a high body 
mass index (BMI), who unfortunately comprise a large proportion of our patient population, 
thus producing only limited (if any) visualisation of the afferent lymphatic vessels and 
SLN(s). Radioactive colloids require involvement of a nuclear medicine physician and lack 
the ability to visualise the nodes and lymphatic channels in real time. In addition, signal 
interference occurs if the SLN(s) is too close to the injection site. Some authors150, 161 
advocate that the procedure might be more effective in patients with early stage colonic 
cancer as in advanced disease nodes are replaced by tumour forcing lymphatic drainage to 
take alternative routes and therefore increasing the false negative rates. In order to address 
some of the aforementioned issues a number of researchers have utilised optical imaging 
using the near-infrared (NIR) fluorescence lymphatic tracer indocyanine green (ICG) that 
enables real-time intraoperative visualisation of lymphatic channels and SLNs with promising 
results163-165. 
Traditionally, the role of SLN mapping in CRC was not to minimise the operative extent, but 
to identify lymph nodes situated outside the standard operative field or metastases 
overlooked by traditional histopathological assessment. Adjuvant chemotherapy is not 
usually offered to patients with node-negative disease, however approximately 30% of all 
apparently pN0 CRC patients develop loco-regional and/or distant recurrence166. Utilisation 
of SLN mapping would enable application of ultra-sectioning techniques on a select group of 
lymph nodes most likely to harbour metastases with the potential to upstage approximately 
15% of patients155. Although the prognostic impact of micrometastases and occult tumour 
cells (OTC) is still unclear, some studies have suggested that they may have a negative 
impact on the OS167, 168. Recruitment into the EnROUTE study166 designed to delineate a 
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subset of pN0 patients with micrometastases (pN0micro+) and evaluate the benefits from 
adjuvant chemotherapy is currently on-going. 
1.4 Summary 
Treatment of CRC is complex. At present, good pre-operative staging and minimally invasive 
treatment options are available for patients with large rectal polyps and early rectal cancer. 
Localised excision techniques for treatment of rectal lesions are associated with lower 
morbidity, mortality and hospital stay and are being increasingly utilised as definitive 
treatment for a select group of patients. The equivalent treatment options for patients with 
complex, early colonic lesions are limited and further developments in surgical techniques 
and technology as well as local staging are necessary to improve outcomes in this patient 
group.  
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Chapter 2 Aims of work presented in this thesis 
2.1 Clinical problem 
Almost 50% of patients diagnosed through screening have Stage I CRC of which 
approximately 80% have node-negative disease. In addition, the screened population tends 
to present with higher number of complex benign polyps123, 124.  
The availability of minimally invasive therapeutic approaches such TEMS, EMR and ESD in 
addition to pre-operative chemoradiotherapy enable clinicians to present treatment options 
other than proctectomy to patients diagnosed with certain rectal lesions. Although the risk of 
invasion increases with the size of the polyp, localised excision can be a definitive treatment 
for a significant proportion of these patients without a considerable risk of morbidity, mortality 
and protracted recovery period169.  
Endoluminal treatment options for colonic lesions however are limited. Histological 
examination of the specimen following piecemeal EMR is challenging and the procedure is 
associated with relatively high polyp recurrence rates. ESD requires high level of expertise to 
correctly perform submucosal dissection and promptly control any procedure related 
complications170. In addition to the limited experience of Western endoscopists, the 
procedure is not adequately reimbursed at present time171 making it difficult to assess its 
cost-effectiveness. For lesions unsuitable for endoscopic treatment, hemicolectomy with en 
bloc mesenteric excision is generally the only surgical treatment option available. 
Approximately 2 000 patients per year in England alone undergo surgery for benign 
colorectal polyps172 and the number is likely to increase following implementation of the 
national one-off flexible sigmoidoscopy programme. In addition, data for short- and long-term 
outcomes following surgery are poorly documented and if similar to those following colonic 
cancer resections, the risks are quite significant. The need for a less invasive treatment 
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option for treatment of benign colonic lesions and node-negative colon cancer is becoming 
increasingly clear.  
2.2 Hypothesis 
The aim of the work in this dissertation was to examine the hypothesis that localised full 
thickness excision of colonic lesions is a feasible and safe alternative to hemicolectomy. 
2.2.1 Clinical studies 
The clinical studies began with the review of patients undergoing surgery for benign colonic 
polyps to determine their short-term outcomes when compared to patients with colon cancer 
(Chapter 3). This was a retrospective, case matched study from two institutions.  
In the second study (Chapter 4), a retrospective analysis of the Health Episodes Statistics 
(HES) database was conducted with the aim to compare short-term outcomes following 
colorectal resection for benign polyps with those performed for CRC at a national level. 
Access to a large number of patients is likely to provide data that more accurately reflect 
current practice than data from single institutions. 
The aim of the third study (Chapters 5) was to determine the effects of hemicolectomy on 
patients’ bowel function and related quality of life in a prospective manner when compared to 
healthy controls. If the effect is significant, the results of the study would not only improve 
consent process for patients undergoing surgery, but it would also add impetus to the 
development of alternative treatment options for those with localised colonic disease. 
2.2.2 Laboratory studies 
The first chapter in the second part of this dissertation (Chapter 6) is a systematic review of 
localised full thickness resection techniques for colonic lesions described to date. This 
systematic review includes the inversion full thickness excision technique previously 
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described at St. Mark's Hospital and Northwick Park Institute for Medical Research 
(NPIMR)173. 
In Chapter 7, the laboratory experiments were set out to assess technical deficiencies in the 
previously described inversion technique in order to determine whether the procedure time 
and the size of the excised specimen could be improved in comparison to the original study. 
In chapter 8 of the thesis, further experiments aimed to describe ex vivo development of the 
inversion Full thickness Laparo-endoscopic EXcision (FLEX) technique to the eversion 
technique are presented. Finally, a survival study in porcine models is described in Chapter 
9 with the aim to assess the feasibility and safety of the modified eversion FLEX technique in 
vivo. 
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Chapter 3 Short-term outcomes after hemicolectomy 
for benign colonic polyps: a prospective 
case-matched study  
3.1 Introduction 
Colonoscopic polypectomy is a definitive treatment for the majority of colonic adenomas 
encountered in routine practice. It is associated with low morbidity and mortality, and is 
usually performed as an outpatient procedure. The effectiveness of this approach however 
may be limited for complex colonic lesions defined as: those exceeding 3cm in diameter, 
located at colonic flexures, crossing two haustral folds or two thirds of the circumference, or 
those with suspicious morphology. Increased risk of complications, incomplete resection and 
recurrence associated with polypectomy procedures must be carefully weighed against the 
disadvantages of surgery. Due to the risk of malignant transformation or the chance that the 
polyp may contain invasive malignancy even in the context of negative biopsy, a large 
proportion of these patients is referred for definitive surgery.   
In parallel to developments in laparoscopy and advanced endoluminal therapies, several 
laparo-endoscopic hybrid procedures have been described142-144 as potential alternatives to 
laparotomy. Their clinical application however is limited to few centres only, most likely due 
to the fact that the risk of incidental malignancy in such lesions is reported to be up to 
18%174-176. Instead, laparoscopic hemicolectomy has become a treatment of choice for 
patients with colonic polyps unsuitable for endoscopic management. Routine use of 
endoscopic tattooing improves intraoperative localisation regardless of the size of the lesion 
whereas short- and long-term benefits of the laparoscopic approach over laparotomy for 
cancer resections are well documented86, 89, 177. Although several small studies have been 
published looking specifically at patients undergoing colectomy for unresectable polyps, their 
focus has mainly been on the feasibility of laparoscopic approach, tumour localisation and 
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incidence of invasive carcinoma174-176, 178. Short-term outcomes of these patients in 
comparison to those undergoing laparoscopic resections for malignancy have not been 
reported to date.  
The study described in this chapter was designed to compare 30-day outcomes of patients 
undergoing hemicolectomy for the treatment of complex benign colonic polyps to those 
undergoing comparable cancer resections. The primary outcomes in this study were 
morbidity, mortality, reoperation, readmission rates and the length of stay (LOS). Other 
outcomes recorded were duration of the procedure, intra-operative blood loss, size of the 
excised specimen and the lesion following fixation in formalin.  
3.2 Methods 
3.2.1 Patient selection  
Consecutive patients who underwent surgery for benign colonic polyps were identified from 
prospectively maintained surgical databases at two teaching hospitals, St. Mark’s Hospital, 
London, England and Beaumont Hospital, Dublin, Ireland. The study was conducted 
following appropriate departmental approval in each hospital. Both centres are tertiary 
referral centres for endoscopy. Data from the hospital in Ireland were collected during a 
period between September 2010 and October 2012. The database in the English centre was 
commenced in March 2006 and patient details were recorded prospectively until October 
2012. In order to identify missing patients in the hospital with the longest data collection 
period, the hospital clinical coding system was searched for surgical procedures using the 
Office of Population Consensus and Surveys Classification of Surgical Operations and 
Procedures fourth revision (OPCS-4)169 in addition to the terms ‘benign’, ‘elective’, and 
consultant codes. Procedure categories and respective OPSC-4 codes were as follows: right 
hemicolectomy: H07; extended right and transverse colectomy: H06 and H08, respectively; 
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left hemicolectomy: H09; sigmoid colectomy: H10 and anterior resection: 
H33.2/H33.3/H33.4/H33.8/H33.9)169.  
3.2.2 Eligibility criteria and matching process 
In order to evaluate clinical outcomes of patients with truly benign disease, only patients 
diagnosed with a benign colonic adenoma on histological evaluation of the surgical 
specimen were selected for the study. Patients with rectal lesions, synchronous lesions, 
inflammatory bowel disease or those with a polyposis syndrome were excluded from the 
study.  
Once all suitable patients were identified, we attempted to match each patient undergoing 
surgery with two consecutive patients having resections for malignancy (IUCC Stage I to III) 
from prospectively maintained colorectal cancer databases in the respective institutions. 
Patients with disseminated disease or those undergoing palliative surgery were excluded. 
Matching criteria used were age (+/-5 years), sex, ASA grade, surgical procedure and 
resection type (laparoscopic/open/converted). 
3.2.3 Data collection 
Data were collected from case notes, endoscopy and pathology reports for all patients. 
Dataset included the following: gender, height and weight, endoscopic location/appearance 
of the polyp, pre-operative and post-operative histology, details of intra-and post-operative 
care, LOS, 30-day complications, readmission and reoperation details. Both the endoscopy 
report and case notes were consulted to establish the reason for surgery. Post-operative 
complications were classified using the Claiven-Dindo classification of surgical 
complications179. The complications are graded I to V and the risk and invasiveness of the 
therapy used to correct a specific complication is the cornerstone to rank the complication.  
3.2.4 Statistical analysis 
To account for the case matched design of the study, all analyses were performed using 
multilevel statistical methods with input from a medical statistician. Multilevel linear 
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regression was used to compare continuous variables between the groups and multilevel 
logistic regression was used for binary variables. Log transformation was performed for 
continuous variables with skewed distribution prior to analysis. All outcomes were adjusted 
for potentially confounding variables. Where possible, further analyses were performed to 
adjust for potential confounding demographic factors not accounted for during the matching 
process.  
3.3 Results 
3.3.1 Patient characteristics 
A total of 57 patients met our inclusion criteria and 46 were successfully matched with one or 
two patients who underwent surgery for colonic cancer for all the matching criteria. Eleven 
patients were not eligible for the study for the following reasons: no suitable matching 
patients available (n = 6), colotomy or wedge excision performed (n = 2), surgery performed 
in a different hospital (n = 1), extensive surgery performed due to diverticular disease (n = 1) 
and case notes not available (n = 1). Patients were operated on by one open (PM) and two 
experienced laparoscopic surgeons at St. Mark’s Hospital, London, RHK (n = 28) and JTJ (n 
= 5), and one surgeon in the Irish centre (RC, n = 12). A bowel cancer screening programme 
was available in the English centre only and 12/34 patients (35%) were detected through 
screening. Mean age of patients with benign colonic polyps was 63.7 years (SD 8.9) with five 
patients (11%) under the age of 60, 24 (52%) patients 60 to 70 years of age, 13 (28%) 
patients 70 to 80 years of age and three patients (7%) over 80 years of age. There was no 
significant difference between the groups for body mass index (BMI) or history of previous 
abdominal surgery (Table 3.1).  
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Table 3.1 Pre-operative characteristics of patients in both groups 
 Patients with benign 
colonic polyps 
(n = 46) 
Patients with colonic 
cancer 
(n = 81) 
P 
Gender 
 Male  
 Female 
 
28 (61%) 
18 (39%) 
 
49 (60%) 
32 (40%) 
(*) 
Mean (SD) age, years 67.3 (8.9) 67.9 (8.4) (*) 
Mean (SD) BMI 28.0 (4.9) 27.0 (3.9) 0.11 
ASA 
 I 
 II 
 III 
 
16 (35%) 
25 (54%) 
5 (11%) 
 
24 (30%) 
47 (58%) 
10 (12%) 
(*) 
Previous abdominal  
surgery 
15 (33%) 26 (32%) 0.66 
(*) No formal statistical comparison made as part of the matching criteria 
 
3.3.2 Lesion characteristics 
On pre-operative histological evaluation, five lesions (11%) were tubular adenomas, three 
(7%) were villous, 34 (74%) were tubulovillous, two (4%) were serrated and two (4%) were 
adenomas not specified. Of 46 patients, 10 (22%) had high-grade dysplasia, 11 (24%) had 
moderate and 20 (44%) had low-grade dysplasia. Histological features were similar in the 
final surgical specimen (Table 3.2). The majority of the polyps were sessile lesions located in 
the right side of the colon (61%). The size of the polyps was poorly documented in 
endoscopy reports and therefore the size of the lesion documented in histopathology reports 
was collected instead.  
The median size of the lesion following fixation of the surgical specimen was 4cm (IQR 2.5, 
5.4). Over 50% of patients referred for surgery had polyps exceeding 3.5cm in diameter and 
the most common indication for surgery were the size of the lesion (31%), difficult 
anatomical position (26%) and suspicious endoscopic or histological findings (26%). A small 
proportion of resections (15%) were performed for polyps smaller than 2.5cm in diameter, all 
of which were difficult to access and were therefore deemed unsuitable for endoscopic 
therapy.  
53 
Table 3.2 Polyp characteristics 
 Pre-operative Post-operative 
 
Pre-operative histology 
 Tubulous adenoma 
 Villous adenoma 
 Tubulovilous adenoma 
 Serrated adenoma 
 Not available  
 
5 (11%) 
3 (7%) 
34 (74%) 
2 (4%) 
2 (4%) 
 
6 (13%) 
4 (9%) 
35 (76%) 
1 (2%) 
0 (0%) 
Dysplasia 
 None 
 Low grade 
 Moderate 
 High/Severe 
 Not available 
 
4 (9%) 
20 (44%) 
11 (30%) 
10 (22%) 
1 (2%) 
 
0 (0%) 
13 (28%) 
8 (17%) 
12 (26%) 
13 (28%) 
 
Table 3.3 Pre-operative polyp characteristics 
 Lesion n  
 
Endoscopic location 
 Caecum 
 Ascending colon 
 Hepatic flexure 
 Transverse colon 
 Splenic flexure 
 Descending colon 
 Sigmoid 
 
19 (41%) 
6 (13%) 
1 (2%) 
3 (7%) 
3 (7%) 
4 (9%) 
10 (22%) 
Morphology 
 Sessile 
 Pedunculated 
 Not recorded 
 
34 (74%) 
8 (17%) 
4 (9%) 
Indication for surgery 
 Polyp size 
 Difficult anatomical position 
 Incomplete removal 
 Recurrent polyp 
 Suspicious +/- high grade dysplasia 
 Not clear 
 
14 (31%) 
12 (26%) 
4 (9%) 
2 (4%) 
12 (26%) 
2 (4%) 
Polyp size (maximum dimension) on post-operative  
specimen 
 <2.5cm 
 2.5 – 3.4cm 
 3.5 – 4.4cm 
 4.5 – 5.4cm 
 >5.5cm 
 Unavailable  
 
 
7 (15%) 
13 (28%) 
5 (11%) 
8 (17%) 
11 (24%) 
2 (5%) 
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3.3.3 Surgical outcomes 
Right hemicolectomy was the most commonly performed surgical procedure (63%), followed 
by sigmoid colectomy (22%) and left hemicolectomy (15%). The majority of the procedures 
were laparoscopic (91%) and two cases (4%) were converted to open procedure due to 
either poor view of the splenic flexure or adhesions (Table 3.4). No intra-operative 
complications were encountered. Blood loss was slightly higher for patients undergoing 
cancer surgery (40ml vs. 25ml, p 0.01) however no difference was observed in the 
procedure duration between the two groups (p 0.67).  
Table 3.4 Operative details 
 Patients with benign 
colonic polyps 
(n = 46) 
Patients with colonic 
cancer 
(n = 81) 
P 
Side of resection 
 Right  
 Left 
 
29 (63%) 
17 (37%) 
 
52 (64%) 
29 (36%) 
 
(*) 
Operation  
 Laparoscopic 
 Open¥ 
 Converted 
 
42 (92%) 
2 (4%) 
2 (4%) 
 
76 (94%) 
3 (4%) 
2 (2%) 
 
(*) 
Median (IQR) blood loss, ml 
25 (0,80) 
 
40 (20, 90) 0.01 
Median (IQR) operation time, 
minutes 180 (125, 215) 180 (140, 200) 0.67 
Median (IQR)  length of excised 
specimen (right), cm 34 (17, 43) 38 (22, 50) <0.001 
Median (IQR)  length of excised 
specimen (left), cm 29 (22, 40) 26 (24, 39) 0.42 
(*) No formal statistical comparison made as part of the matching criteria 
(¥) One patient chose to have an open procedure and the second patient was operated on by a surgeon who 
only practices open surgery 
 
Surgical specimens were slightly longer in patients undergoing right sided resections for 
malignancy (38cm vs. 34cm, p <0.001) although no difference between the groups was 
observed for left-sided resections. Principles of ERAS were followed for all patients during 
the post-operative period93. 
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In the unadjusted analysis the LOS was similar between the two groups with a median of 5.5 
days (IQR 4, 8) for the benign group and 5 days (IQR 3, 6) for the colon cancer group (Table 
3.5). Following multilevel linear regression with adjustment for confounding variables (blood 
loss, size of the excised specimen) however, hospital stay was significantly shorter following 
cancer surgery (ratio 1.25, 95% CI 1.02, 1.56, p 0.04). The overall rate of complications was 
46% (21/46) and 31% (25/81) respectively and the difference between the groups was not 
statistically significant (OR 2.11, 95% CI 0.82, 5.41). Some patients developed more than 
one complication during the post-operative period and the majority were minor (Clavien 
Dindo179 Grade II, 81% and 71% respectively) (Table 3.5). The most common complication 
was post-operative ileus (nine and eight patients respectively) followed by wound infection 
(five and four patients respectively) (Table 3.6). 
Table 3.5 Surgical outcomes 
Outcome 
n 
Unadjusted(*) Adjusted(**) 
OR (95% CI) P OR (95% CI) P 
Median (IQR) LOS, (days)(†) 
 Cancer 
 Benign Polyps 
 
5 (3, 6) 
5.5 (4, 8) 
 
1 
1.17 (0.97, 1.42) 
 
 
0.10 
 
1 
1.26 (1.02, 1.56) 
 
 
0.04 
Complications 
 Cancer 
 Benign Polyps 
 
25 (31%) 
21 (46%) 
 
1 
1.89 (0.88, 4.08) 
 
 
0.10 
 
1 
2.11 (0.82, 5.41) 
 
 
0.12 
Reoperations  
 Cancer 
 Benign Polyps 
 
1 (1%) 
4 (9%) 
 
1 
7.62 (0.83, 70.3) 
 
 
0.07 
 
 
(#) 
 
Readmission 
 Cancer 
 Benign Polyps 
 
2 (2%) 
3 (7%) 
 
1 
2.76 (0.44, 17.1) 
 
 
0.28 
 
 
(#) 
 
(*) Analysis accounts for all matching variables (age, sex, ASA score, side & type of resection) 
(**) Further adjusted for, blood loss and size of the excised specimen  
(†) Differences in outcome between groups are presented as ratio (95% CI) 
(#) Adjusted analysis not performed due to insufficient occurrences of outcome 
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Table 3.6  Post-operative complications 
 Patients with benign 
colonic polyps 
(n = 21/46) 
Patients with colonic 
cancer 
(n = 25/81) 
Clavien Dindo Classification 
 I 
 II 
 IIIb 
 IVa 
 Total 
 
1 (4%) 
21 (81%) 
4 (15%) 
0 (0%) 
26 (100%) 
 
6 (21%) 
20 (71%) 
1 (4%) 
1 (4%) 
28 (100%) 
Complications* 
 Ileus 
 Wound infection 
 Anastomotic leak 
 Pneumonia 
 Unexplained fever/raised 
 inflammatory markers (normal CT) 
 Atrial fibrillation 
 Adhesive small bowel obstruction 
 Acute coronary syndrome 
 Bleeding per rectum 
 Laryngeal ulcer 
 Urinary tract infection 
 Ischaemic stroke 
 Unexplained tachycardia 
 Bradycardia 
 Right bundle branch block 
 Port haematoma 
 Non-infectious diarrhoea 
 Anaemia requiring transfusion 
 
9 
5 
4 
2 
1 
1 
1 
1 
1 
1 
0 
0 
0 
0 
0 
0 
0 
 0 
 0 
 
8 
4 
1 
2 
2 
2 
1 
0 
0 
0 
1 
1 
1 
1 
1 
1 
1 
 1 
 1 
(*) Some patients had more than one complication 
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Table 3.7 Demographic details of patients with anastomotic leak  
Patient Histology Age ASA BMI Procedure Reason for 
surgical referral 
Pre-operative 
histology 
(benign patients) 
Post-operative 
histology 
(benign patients) 
Size of the lesion 
(benign patients) 
1 Benign 67 2 38.2 
Lap right 
hemicolectomy 
Polyp in a difficult 
anatomical position 
TVA with low-grade 
dysplasia 
TVA with low-grade 
dysplasia 5cm 
2 Benign 83 3 38.0 
Lap sigmoid 
colectomy 
Suspicious polyp in 
a difficult anatomical 
position 
TVA with high-grade 
dysplasia 
TVA with high-grade 
dysplasia 2cm 
3 Benign 66 1 28.0 
Lap sigmoid 
colectomy 
Polyp in a difficult 
anatomical position 
TVA with moderate 
dysplasia 
TVA with moderate 
dysplasia 10cm 
4 Benign 69 2 23.0 
Lap sigmoid 
colectomy 
Incomplete excision of 
TVA with high grade 
dysplasia 
TVA with high grade 
dysplasia 
TVA with high grade 
dysplasia 4cm 
5 Cancer 75 3 21.9 
Lap sigmoid 
colectomy 
Carcinoma NA NA NA 
Abbreviations: TVA = tubulovillous adenoma 
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Anastomotic leakage occurred in four (9%) patients with benign pathology and one (1%) 
patient in the colonic cancer group (OR 7.62, 95% CI 0.83, 70.3, p 0.07) (Table 3.7). All 
patients had International Classification grade C leakage180, defined as requiring a 
laparotomy. Three patients (7%) in the benign group were readmitted to hospital within 30 
days of the initial surgery for: unexplained fever (normal CT scan, treated with empirical 
antibiotics); adhesive bowel obstruction (treated conservatively); anastomotic leak (surgery). 
Two patients (2%) in the colon cancer group were readmitted for adhesive bowel obstruction 
(treated conservatively) and anastomotic leakage (Hartmann’s procedure). No deaths were 
observed in either group. 
3.4 Discussion  
With the improvements in technology and experience gained over the past decade, 
laparoscopic hemicolectomy performed within an enhanced recovery protocol has become 
the gold standard surgical treatment for complex colonic polyps. In the absence of a 
definitive diagnosis of cancer however, this might seem overly aggressive. To our 
knowledge, this is the first study designed to examine whether hemicolectomy for benign 
polyps is safer than for cancer and by aggregating the experience from two tertiary centres, 
we were able to review the outcomes of 46 patients from prospectively maintained 
databases. The results of this study suggest that the short term outcomes after this 
intervention are similar in patients with benign polyps and those undergoing potentially 
curative surgery for colonic malignancy. No statistically significant differences were observed 
between the groups for any of the primary outcomes other than a slight increase in hospital 
stay in the benign group following adjustment for potential confounders. This could be 
explained by the small study sample. A similar range of complications was observed 
between the two groups. In addition, the morbidity reported in this study is comparable to the 
outcomes of the recently published LAFA trial94 in which complications occurred in 34%, 
readmission in 6% and anastomotic leakage of 7% of patients.  
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All polyps included in this series were deemed unsuitable for endoscopic treatment by expert 
endoscopists with advanced therapies, complex EMR and ESD, being routinely performed in 
both institutions. Although the commonest indication for surgery was the size of the polyp, 
over two thirds of the lesions were located in the right colon. Performing polypectomy in the 
right colon that is thin walled is challenging and the risk of perforation or bleeding is high181. 
The results of a recently published study suggest that delayed haemorrhage most commonly 
occurs following right sided polypectomy (OR 4.67, 95% CI 1.88, 11.61, p 0.001) and the risk 
of bleeding increases by 13% for every 1mm increase in polyp diameter (OR 1.13, 95% CI 
1.05, 1.20, p<0.001)182. In addition, many argue that the risk of perforation in patients with a 
potentially malignant lesion is unacceptable, as peritoneal seeding has a potential to convert 
a Stage I cancer into potentially incurable disease. Although most of the studies looking 
specifically at patients undergoing colectomy for unresectable polyps have typically been 
small, Bertelson et al.183 reported the outcomes of 750 patients, which is the largest 
described to date. The aim of their study was to determine the incidence of malignancy in 
surgically resected benign polyps and 17.7% (133/750) had invasive colonic carcinoma of 
which 23% (31/133) had nodal disease. If malignancy or even nodal disease have been 
accurately excluded pre- or intra-operatively, and a suitable full thickness excision performed 
instead, more than three quarter of the patients in this study would have been spared the 
attendant morbidity of hemicolectomy.  
The strengths of this study include prospective data capture reducing the observation bias. 
Potential confounding factors were addressed during the matching process and by statistical 
analysis where possible. Our data collection occurred during a period when laparoscopic 
surgery within an ERAS protocol was standard treatment in both institutions and all 
procedures were performed by experienced laparoscopic surgeons. Despite both centres 
being tertiary referral hospitals, the small number of patients undergoing surgery reflects the 
endoscopic expertise. High rate of anastomotic leakage in the benign cohort is difficult to 
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explain as both groups were treated by experienced surgeons. Although this is likely to be 
due to the small number of patients in this study, a larger series is required to confirm this.  
3.5 Conclusion 
In conclusion, the results from this study represent a step forward towards understanding the 
risks associated with hemicolectomy in patients with benign colonic polyps with a study 
sample that is similar to the previously published single-institution series178, 184, 185. Despite a 
small study sample, our results suggest that laparoscopic hemicolectomy, even for benign 
disease, causes significant morbidity in at least one third of the patients. Undertaking 
hemicolectomy in this cohort therefore needs to be carefully considered.  
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Chapter 4 Short term outcomes of surgical 
polypectomy: interrogation of the Hospital 
Episodes Statistics 
4.1 Introduction 
As discussed in the previous chapter, large studies reporting outcomes after surgery for 
benign colonic polyps are relatively uncommon, and to date have included small, 
retrospective series only174, 176, 178, 186. The results of the study described in Chapter 3 
suggest that morbidity following laparoscopic hemicolectomy for treatment of complex 
colonic polyps is similar to that observed in patients undergoing potentially curative cancer 
resection. Despite collaboration between two tertiary centres however, our study sample was 
relatively small. The most reliable outcome data following colorectal resection published to 
date is derived from large randomized trials of laparoscopic vs. open surgery for cancer59, 87, 
94. In order to find more meaningful differences between the two cohorts and establish the 
true risk of morbidity, a larger study sample is required. 
The study presented in this chapter was designed to examine the short-term outcomes 
following colorectal resection for benign polyps with those performed for CRC using the 
Hospital Episodes Statistics (HES) database in England.  
4.2 Methods 
4.2.1 Health Episode Statistics  
The HES database has been described in several publications169, 187-189.  This record based 
system was established in 1987 and it collates the data for all patients admitted to English 
NHS Trusts using hospitals’ Patient Administration System (PAS). The records contain 
information regarding geographic, demographic, diagnostic and procedural data for 
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individual patient attendance at an NHS hospital. Each episode contains one primary and up 
to 13 secondary diagnoses189, categorized according to the International Classification of 
Disease 10th revision (ICD-10). In addition, up to 12 procedural fields are coded using the 
Office for Population Census and Surveys Classification of Surgical Operations and 
Procedures 4th revision (OPCS-4)169, 189. The Charlson comorbidity index derived from 
secondary diagnoses is a marker of comorbidity and greater scores are associated with 
worse outcomes190. In addition, the Carstairs index of deprivation is a composite 
socioeconomic deprivation score that is linked to HES according to patient postal code169 
and specifically uses four variables: unemployment, overcrowding, car ownership and social 
class191.  
4.2.2 Patient selection 
All patients that underwent an elective primary colorectal procedure with a diagnosis of CRC 
or benign colorectal neoplasia between April 2000 and March 2007 in English NHS trusts 
were included in this study. This dataset was already available. Patients were selected using 
the relevant ICD-10 codes for benign colorectal polyps as well as those for CRC (Table 4.1). 
Benign and malignant neoplasms of the anus and anal canal were excluded. Procedure 
categories and respective OPCS-4 codes used for patient selection are also presented in the 
Table 4.2. Cases with missing data for operative procedures but with a diagnosis of CRC or 
benign colorectal polyp were excluded. Patients were categorised into five age cohorts for 
analysis: <50, 51 – 60; 61 – 70; 71 – 80 and >81 years.  
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Table 4.1 ICD-10192codes used for data selection  
ICD-10  
Code 
Description for 
benign lesions 
ICD-10  
Code 
Description for malignant 
lesions 
D12.0 Benign neoplasm of caecum C18.0 Malignant neoplasm of caecum 
D12.2 Benign neoplasm of ascending colon C18.2 Malignant neoplasm of ascending colon 
D12.3 
Benign neoplasm of transverse colon 
(applicable to splenic and hepatic 
flexure) 
C18.3 Malignant neoplasm of hepatic flexure 
D12.4 Benign neoplasm of descending colon C18.4 
Malignant neoplasm of transverse 
colon 
D12.5 Benign neoplasm of sigmoid colon C18.5 Malignant neoplasm of splenic flexure 
D12.6 Benign neoplasm of colon, unspecified C18.6 
Malignant neoplasm of descending 
colon 
D12.7 
Benign neoplasm of  
recto-sigmoid junction  
C18.7 Malignant neoplasm of sigmoid colon 
D12.8 Benign neoplasm of rectum C18.8 Malignant neoplasm of overlapping sites of colon 
  C18.9 Malignant neoplasm of colon, unspecified 
  C19 Malignant neoplasm of recto-sigmoid junction 
  C20 Malignant neoplasm of rectum 
 
Table 4.2 OPCS-4193 codes used for data selection  
OPCS-4  
Code 
Description for surgical procedures 
H07.1 to H07.4, H07.8, H07.9 Right hemicolectomy 
H06.1 to H06.4, H06.8, H06.9 Extended right hemicolectomy 
H08.1 to H08.5, H08.8, H08.9 Transverse colectomy 
H09.1 to H09.5, H09.8, H09.9 Left hemicolectomy 
H10.1 to H10.5, H10.8, H10.9 Sigmoid colectomy 
H33.5, H33.6  Hartmann’s procedure; anterior resection and stoma formation  
H33.2 to H33.4, H33.8, H33.9 Anterior resection  
H33.1 Abdominoperineal resection (APER) 
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4.2.3 Outcome measures 
30-day in-hospital mortality (defined as death from all causes occurring within 30 days of 
admission), 28-day readmission rates and LOS were primary end-points. LOS describes the 
time (days) that a patient spent as an inpatient during their index admission whereas 
readmissions were considered as subsequent emergency admissions within 28-days of the 
date of discharge after their original procedure169. 
4.2.4 Ethical approval  
The study was approved under Section 251 by the National Information Governance Board 
for Health and Social Care (formerly section 60 by the Patient Information Advisory Group), 
and by the South East Ethics Committee187.  
4.2.5 Statistical analysis 
Categorical variables were assessed using χ2 test including age (recoded in age bands). 
Length of stay was analysed by log-normal transformation and independent t test with back 
exponentiation due to its non-normal distribution. Logistic regression models were 
constructed to evaluate 30-day mortality after adjustment for age, sex, comorbidity, social 
deprivation index, lesion location (rectum/colon) and diagnosis (benign/malignant). Co-
variables with significance of p ≤0.100 on univariable analysis were included in multifactorial 
regression analysis. SPSS version 20 for Windows (SPSS, Chicago, Illinois, USA) was used 
for the statistical analyses.  
4.3 Results 
A total of 8 659 patients were identified having undergone major colorectal resection for 
treatment of benign colorectal polyps between 1st April 2000 and 31st March 2007. Over the 
same period, 111 047 patients underwent surgery for CRC. Both groups had similar sex 
distribution but a significantly higher proportion of patients with benign diagnosis had colonic 
disease (p <0.001) (Table 4.3). A similar proportion of right sided resections was noted in 
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each group (28.4% in the benign vs. 25.2% in the CRC group, p <0.001) (Figure 4.1). Co-
morbidity scoring differed significantly between the two groups (p <0.001) with the benign 
group having fewer patients with high co-morbidity index (p <0.001) whereas patients 
diagnosed with CRC tended to be older (Figure 4.2). In addition, patients in the benign 
category were less likely to undergo a laparoscopic procedure (4.43% vs. 5.23%, p <0.001) 
although the observed numbers were very low in both groups.  
Table 4.3 Demographic data  
 Patients with benign 
colorectal polyps 
(n = 8 659) 
Patients with CRC 
(n = 111 047) 
P 
Gender 
 Male 
 Female 
 
4 466 (51.6%) 
4 193 (48.4%) 
 
63 681 (57.3%) 
47 366 (42.7%) 
<0.001 
Location 
 Colon 
 Rectum 
 
6 635 (76.6%) 
2 024 (23.4%) 
 
54 086 (48.7%) 
56 961 (51.3%) 
<0.001 
Charlson score ≤2 
 Colon 
 Rectum 
 
6 251 (97.7%) 
1 906 (97.7%) 
 
31 193 (57.7%) 
35 099 (61.6%) 
<0.001 
Charlson score >2 
 Colon 
 Rectum 
 
149 (2.3%) 
44 (2.3%) 
 
22 887 (42.3%) 
21 856 (38.4%) 
<0.001 
Laparoscopy 384 (4.43%) 5 809 (5.23%) <0.001 
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Figure 4.1 Operative procedures for both groups 
 
Figure 4.2 Age distribution in each group 
 
 
The overall readmission rates were similar between the groups (8.9% for benign vs. 8.6% for 
CRC cohort; p 0.372) (Table 4.4). Higher 28-day readmission rate was noted following 
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colonic surgery in the benign cohort (8.7% vs. 7.2% respectively, p <0.001) however no 
difference between the groups was observed following rectal surgery. The risk of in-hospital 
death within 30-days of admission was lower for patients undergoing surgery for benign 
colonic and rectal polyps when compared to CRC patients (1.7% and 2.2% vs. 4.0 and 3.6% 
respectively, p <0.001). The risk of mortality, however, increased significantly with age for 
both groups irrespective of the lesion location (rectum or colon) (Figure 4.3), with the highest 
observed mortality for patients over the age of 81 in both groups, (4.88% for benign and 
8.66% for CRC patients, p <0.001). Both groups had a long hospital stay for colonic and 
rectal resections (p <0.001) (Table 4.4).  
Table 4.4 Study end points 
 Patients with benign 
colorectal polyps 
(n = 8 659) 
Patients with CRC 
(n = 111 047) 
P 
Readmission 
 Colon 
 Rectum 
772 (8.9%) 
580 / 6 635 (8.7%) 
192 / 2 024 (9.5%) 
9 592 (8.6%) 
3 918 / 54 086 (7.2%)* 
5 674 / 56 961 (10.0%) 
0.372 
 
 
Mortality 
 Colon 
 Rectum 
159 (1.8%) 
114 / 6 635 (1.7%) 
45 / 2 024 (2.2%) 
4 196 (3.8%) 
2 160 / 54 086 (4.0%)* 
2 036 / 56 961 (3.6%)* 
<0.001 
 
 
Mean (SD) LOS, days≠ 
 Colon 
 Rectum 
10.5 (1.9) (0 - 279) 
10.1 (1.9) (0 - 231) 
12.2 (1.8) (0 - 279) 
12.7 (1.8) (1 - 468) 
11.7 (1.7) (0 - 313)* 
13.9 (1.8) (0 - 468)* 
<0.001¥ 
 
(*) The difference detected between the groups was significant 
(≠) Derived from exponential logarithmic transformation 
(¥) Independent t test 
 
Following case-mix adjustment for age, sex, social deprivation, co-morbidity, lesion location 
and cancer diagnosis, advanced age, complications and social deprivation scores were 
found to be associated with an independent increase in 30-day mortality risk (OR 14.84, 
95% CI 10.94 – 20.14; p <0.001, OR 2.84, 95% CI 2.66 – 3.03; p <0.001 and OR 1.39, 95% 
CI 1.25 - 1.54; p <0.001 respectively) (Table 4.5). The additional mortality risk posed by a 
diagnosis of malignancy was not significant in the multifactorial logistical regression.  
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Figure 4.3 Cumulative mortality by surgical procedure  
 
 
Table 4.5 Multiple regression analysis 
Outcome Univariable analysis Multivariable analysis 
OR (95% CI) P OR (95% CI) P 
Sex 0.68 (0.63, 0.72) <0.001 0.65 (0.60, 0.68) <0.001 
Age (years) 
 >50 
 51 – 60 
 61 - 70 
 71 – 80 
 >81 
 
1.00 
1.38 (0.98, 1.95) 
3.42 (2.51, 4.66) 
8.21 (6.07, 11.12) 
15.92 (11.75, 21.58) 
<0.001 
 
0.064 
<0.001 
<0.001 
<0.001 
 
1.00 
1.31 (0.93, 1.84) 
3.90 (2.27, 4.21 
7.33 (5.41, 9.93) 
14.84 (10.94, 20.14) 
<0.001 
 
0.129 
<0.001 
<0.001 
<0.001 
Carstairs score 
 1 (least deprived) 
 2 
 3 
 4 
 5 
 6 (most deprived)* 
 
1.00 
1.10 (0.99, 1.21) 
1.26 (1.14, 1.38) 
1.32 (1.19, 1.46) 
1.49 (1.35, 1.67) 
0.00 
<0.001 
 
0.062 
<0.001 
<0.001 
<0.001 
0.997 
 
1.00 
1.04 (0.94, 1.15) 
1.16 (1.05, 1.28) 
1.21 1.09, 1.28) 
1.39 (1.25, 1.54) 
0.00 (0.00) 
<0.001 
 
0.411 
0.003 
<0.001 
<0.001 
0.996 
Charlson score 3.12 (2.94, 3.33) <0.001 2.84 (2.66, 3.03) <0.001 
Rectal 0.94 (0.89, 0.99) 0.045 1.06 (0.99, 1.13) 0.056 
Malignant 0.47 (0.41, 0.56) <0.001 0.97 (0.83, 1.15) 0.754 
(*) Sample size too small to perform formal analysis  
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4.4 Discussion  
Our review of 30-day outcomes following surgery for benign colorectal polyps from all 
English NHS hospitals is the largest series of this kind described to date. The results of this 
study support our findings presented in Chapter 3. Although the observed 30-day in-hospital 
mortality for the benign cohort was 50% lower when compared to that of patients undergoing 
cancer resections, at approximately 2% it remains considerable, with advanced age rather 
than diagnosis being an independent risk factor. The risk of mortality following surgery for 
patients with benign colorectal polyps aged 71 – 80 and >80 (3.0% and 4.9% respectively) 
reiterates the need for a careful balance of the risks associated with surgery and other 
treatment options. In addition, LOS in excess of 10 days and 28-day readmission rates 
approaching 9% are substantial, despite this cohort being younger with a lower co-morbidity 
score. Slight increase in hospital stay following colonic resections for benign polyps 
described in Chapter 3 (median 5.5, IQR 4, 8 vs. 5, IQR 3, 6) was not observed in this 
national cohort (median 10.5, IQR 7, 17 vs. 12.7, IQR 8, 14). The difference in the LOS 
between the two studies is likely to be due to the different data collection period and the fact 
that the majority of the procedures presented in Chapter 3 were performed laparoscopically 
within ERAS protocol.  
Patient demographics suggest that rectal surgery was avoided when possible in the benign 
cohort, with significantly fewer patients undergoing rectal excision compared to the cancer 
group (23.4% vs. 51.3%). This could be explained by the increasing utilisation of advanced 
endoluminal therapies such as EMR, ESD and TEMS, as discussed in Chapter 1. However, 
due to the lack of a localised excision technique for colonic lesions equivalent to TEMS 
procedure, a significant proportion of patients diagnosed with colonic lesions are directly 
referred for surgery. More than a third of all resections in the benign cohort were performed 
for right sided lesions. Although the risk of complications associated with advanced 
polypectomy techniques is higher in the right colon181, some studies suggest that a 
significant proportion of such patients can be managed by well-trained endoscopists194-197. 
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Brooker et al.196 compared the outcomes of large sessile polyps (>2cm) treated by specialist 
and non-specialist endoscopists in a single unit, reporting that specialists more frequently 
attempted endoscopic resection of polyps thought to be benign (93% vs. 75%), with 42% of 
the lesions located proximal to the splenic flexure. In this retrospective study, surgery was 
avoided in 76% of cases treated by specialists, compared to 40% treated by non-specialists. 
Similar findings were reported in a prospective series form Australia197 in which 174 patients 
were referred to a specialist tertiary referral service. Over a 21 month period, surgery was 
avoided in 90% of the cases with only few complications which included post-polypectomy 
syndrome (6.4%) and significant delayed bleeding (3.7%). In addition, following an economic 
analysis comparing tertiary referral service and surgical intervention, the authors estimated a 
mean cost-saving of $6 900 and a reduction in the LOS of 6.7 days per patient.  
Unfortunately, many patients referred for surgery do not get the benefit of an expert 
endoscopist performing their colonoscopy. Widespread introduction of CRC screening is 
likely to lead to an increase in the number of patients diagnosed with benign colorectal 
polyps123, 124 and therefore it is not unreasonable to suggest that those with complex lesions 
warrant referral to a tertiary centre for management. Centres with high volume of difficult 
cases and expertise to offer advanced endoluminal therapies and TEMS service are likely to 
achieve results similar to those reported by Brooker et al.196 and Swan et al.197. In addition, 
taking into account that approximately 18% of the polyps harbour a malignant focus183, a 
careful pathological assessment is essential. Experienced and meticulous pathological 
examination of the specimen is essential when determining the adequacy of local excision 
and the risk of nodal involvement, as it will influence the need for definitive surgery.  
This study has several shortcomings that should be noted. Data for patients undergoing 
surgery for benign colorectal polyps were only available for a period from April 2000 to 
March 2007. Introduction of the Laparoscopic National Training Programme96, 97 has had a 
significant effect on elective colorectal surgery over the past five years as demonstrated in 
Chapter 3. The proportion of laparoscopic resections in this study was very small (4.43% in 
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the benign and 5.23% in CRC cohort) and therefore the impact of minimally invasive surgery 
on patient outcome cannot be assessed. Due to the nature of HES database, it is impossible 
to ascertain the reasons for surgery and a proportion of the patients may have been deemed 
unsuitable for endoscopic treatment by expert endoscopist. In addition, a specific OPCS 
code for TEMS procedure was not available during this period and therefore a proportion of 
the patients classed as having surgery for both benign and malignant rectal lesions may 
have indeed had a TEMS procedure.  
4.5 Conclusion 
This is the largest series to date reporting short-term outcomes of patients undergoing 
surgery for treatment of benign colorectal polyps using historical data. High post-operative 
morbidity, mortality and prolonged in-hospital stay emphasise the need to improve the way 
that these patients are managed. In addition, patients with advanced age diagnosed with 
complex colorectal polyps might benefit from a referral to a tertiary centre offering advanced 
endoluminal therapies and TEMS in order to minimise the risk of complications.  
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Chapter 5 Functional outcomes and related quality of 
life after hemicolectomy: prospective case-
controlled study  
5.1 Introduction 
The introduction of screening, earlier diagnosis of the disease and advances in surgical and 
adjuvant treatments are likely to improve the overall survival of patients with CRC. In 
addition to disease free survival and traditional clinical outcome measures such as morbidity 
and mortality, quality of life is an important outcome of CRC treatment198, 199. Although 
several studies have reported bowel, urinary and sexual dysfunction after rectal cancer 
treatment200-202, the relationship between bowel function and QOL after colonic resection is 
scarcely reported in the literature. Most healthy individuals average one bowel movement 
per day203 and the events that occur within the colon providing this regularity include 
absorption of water and electrolytes, coordinated propulsion of faecal mass from the right 
colon to the rectum, storage, and ultimately, expulsion204. Therefore, the unavoidable 
distortion of bowel anatomy after colonic resection may lead to a number of functional 
disturbances which may be of long-term importance to the patient.  
Few studies published to date have focused on the outcomes following left sided resection 
(sigmoid and anterior resection) for the treatment of CRC205-208 and diverticular disease209, 
210, suggesting that after surgery patients have an increase in stool frequency206, 208. These 
studies have made limited use of validated questionnaires designed to assess bowel 
function and related QOL. Instead, bowel function is usually reported as numeric data from 
self-constructed questionnaire surveys205-208. This makes it challenging to translate the 
scanty data that are available into clinically meaningful information for patients. To address 
the gap in our knowledge, we designed a prospective study to assess ‘early’ (≤12 months 
after surgery) and ‘intermediate’ (two to four years after surgery) bowel function in patients 
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undergoing hemicolectomy with en bloc mesenteric resection (open/laparoscopic) and its 
effect on the patients’ QOL when compared to healthy controls. Our proposed hypothesis 
was that potentially curative hemicolectomy for invasive and non-invasive colonic neoplasia 
adversely affects patients’ bowel function and QOL.  
5.2 Methods 
5.2.1 Recruitment process 
5.2.1.1 Pre-operative patient group recruited for assessment of ‘early’ bowel 
function  
Patients diagnosed with colonic neoplasia were identified during the weekly colorectal 
cancer MDT meetings in four centres (St. Mark’s Hospital, London; Oxford Radcliffe 
Hospitals, Oxford; St. Mary’s Hospital, London and The London Clinic, London). A research 
fellow (A.B., N.R.A.S.) or research assistant (S.S.) approached patients in the clinic to 
discuss the study in detail. A patient information sheet (PIS) was provided for patients to 
take away and consider whether they wished to participate. Potential participants were 
approached again during their pre-operative assessment or after surgery, and provided that 
they fulfilled study inclusion criteria (Table 5.1), their consent to participate was obtained.  
5.2.1.2 Post-operative patient group recruited for assessment of ‘intermediate’ 
bowel function  
Eligible patients who had colonic neoplasia resected two to four years previously were 
identified from prospectively maintained colorectal cancer databases in two teaching 
hospitals (St. Mark’s Hospital, London and John Radcliffe Hospitals, Oxford) using criteria 
presented in (Table 5.1). Initially, a letter of invitation to participate in the study was posted to 
patients two weeks prior to their regular appointment. Patients were then approached in the 
clinic by the research fellow (A.B.) or research assistant (S.S.) to discuss the study further 
and answer questions. Consent was obtained from those willing to participate and study 
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questionnaires completed. Due to the slow recruitment observed during the first three 
months of the study, the protocol was amended to enable postal recruitment. An invitation 
letter and a reply slip were posted to potentially eligible patients with no follow-up 
appointment pending. Implied consent to take part in the study was assumed if the patients 
returned the reply slip agreeing to a telephone interview during which study questionnaires 
were completed and relevant sociodemographic data collected. All non-responders were 
contacted within two weeks after the invitation was mailed to ensure that the information was 
received and to encourage response. 
5.2.1.3 Controls 
The control group consisted of siblings, partners and spouses of patients diagnosed with 
colonic neoplasia who were approached to take part in the study for evaluation of ‘early’ 
bowel function. More than one member of each family was approached to compensate for 
subjects with no controls. Control subjects were recruited into the study at the same time as 
the patients, using the criteria presented in Table 5.2.  
5.2.2 Data collection  
Sociodemographic (sex, age, ethnicity, BMI, employment status, marital status) and clinical 
data including past medical, surgical and drug history were recorded for both patient groups. 
Particular care was taken to record the use of laxatives, analgesia (opiate based) or 
antibiotics within 4 weeks of recruitment, at 6 and 12 months after surgery for patients who 
had been recruited pre-operatively. The caecum, ascending and transverse colon were 
defined as the ‘right’ and descending and sigmoid colon as the ‘left’ colon. Clinical notes and 
pathology reports were reviewed to record the level of concomitant co-morbidity (ASA 
grade), intra- and post-operative data, stage of the disease and adjuvant treatment. The 
length of all resected colonic specimens was recorded after fixation. Post-operative 
complications with a potential to have an adverse effect on post-operative bowel function 
including anastomotic leakage, intra-abdominal abscess formation and further abdominal 
surgery were recorded.   
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Table 5.1 Inclusion and exclusion criteria for patients 
Inclusion criteria Exclusion criteria 
 Male or female aged 18 and above 
 Able and willing to comply with study 
requirements 
 For assessment of ‘early’ bowel function 
patients with a diagnosis of invasive or non-
invasive neoplasm suitable for curative colonic 
resection (open/laparoscopic) 
 For assessment of ‘intermediate’ bowel function 
patients who underwent curative colonic 
resection (open/laparoscopic) for treatment of 
invasive or non-invasive neoplasm 
 Surgical procedures: right hemicolectomy, 
transverse colectomy, left hemicolectomy, 
sigmoid colectomy/high anterior resection*  
 ASA grade I, II or III** 
 IUCC stage I to III 
 Poor cognitive ability or the inability to provide 
fully informed consent or complete study 
questionnaires 
 Diagnosis of Crohn’s disease, ulcerative colitis 
or coeliac disease 
 Rectal neoplasm  
 Previous pelvic radiation 
 Previous bowel resection (colon, stomach or 
small bowel), bypass surgery or vagotomy 
 Emergency colonic resection 
 Previous stoma 
 Localised recurrence of the disease during the 
study period 
 Diagnosis of anal incontinence prior to surgery 
(*) For lesions located above 15cm from the anal verge 
(**) For ‘intermediate’ bowel function group, ASA grade at the time of surgery was recorded 
 
Table 5.2 Inclusion and exclusion criteria for controls 
Inclusion criteria Exclusion criteria 
 Siblings, partners or spouses of patients 
recruited for assessment of ‘early’ bowel 
function 
 Male or female aged 18 and above 
 Able and willing to comply with study 
requirements 
 
 Poor cognitive ability or the inability to provide 
fully informed consent or complete study 
questionnaires 
 Diagnosis of Crohn’s disease, ulcerative colitis 
or coeliac disease 
 Previous pelvic radiation 
 Previous bowel resection (colon, stomach or 
small bowel), bypass surgery or vagotomy 
 Diagnosis of anal incontinence  
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5.2.3 Study questionnaires 
5.2.3.1 Memorial Sloan-Kettering Cancer Centre (MSKCC) bowel function 
questionnaire 
Study participants were provided with the Memorial Sloan-Kettering Cancer Centre 
(MSKCC) bowel function questionnaire designed to evaluate bowel function following rectal 
resection211. Despite extensive literature review, we were unable to identify a validated 
questionnaire developed specifically to evaluate bowel function following colonic resection. 
The questionnaires that have been rigorously developed are those to assess continence212-
214 and were therefore deemed not suitable for this study. The MSKCC questionnaire was 
designed to measure bowel function rather than quality of life211, 215 and has been validated 
against the more established Faecal Incontinence Quality of Life Scale (FIQL) and the 
European Organisation of Research and Treatment of Cancer Quality of Life (EORTC) 
questionnaires: QLQ-C30 (core cancer module) and QLC-38 (colorectal cancer specific 
module)211.  
The questionnaire consists of 18 items (Table 5.3) that are grouped into three subscales: 
frequency, diet and urgency/soilage. In addition, four individual questions (Q) of clinical 
significance are also included: incomplete emptying after a bowel movement [Q4], having a 
second bowel movement within 15 minutes [Q6], knowing the difference between gas and 
bowel movement [Q7] and the ability to control the passage of wind [Q12]. The frequency 
subscale includes 6 questions (Q1, Q5, Q8, Q9, Q10, Q11) regarding the number of bowel 
movements per 24 hours (divided into quintiles), stool consistency and the ability to get to 
the toilet on time. Four questions (Q2, Q3, Q13, Q14) relating to the impact of certain 
food/drink items on bowel movements and avoidance of those items are included in the 
dietary subscale. The urgency/soilage subscale consists of four questions (Q15, Q16, Q17, 
Q18) concerning faecal leakage (day or night and use of pads) and the impact of bowel 
function on social activities. The responses are given on a 5-point Likert scale for all items 
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apart from the item asking for the number of bowel movement per 24 hours (categorised into 
quintiles).  
Table 5.3 The MSKCC questionnaire 
1 
Over the last 4 weeks, how many bowel 
movements do you generally have in 24 
hours? (please write down the number) 
_______ bowel movements/24 hours 
 Over the last 4 weeks ……. (please tick most appropriate answer) Always  
Most of 
the time Sometimes Rarely Never 
2 Do certain solid foods increase the number of bowel movements in a day? 1 2 3 4 5 
3 Do certain liquids that you drink increase the number of bowel movements in a day? 1 2 3 4 5 
4 Do you feel like you have totally emptied your bowels after a bowel movement? 5 4 3 2 1 
5 Do you get to the toilet on time? 5 4 3 2 1 
6 Do you have another bowel movement within 15 minutes of your last bowel movement? 1 2 3 4 5 
7 
Do you know the difference between having 
to pass gas (air) and needing to have a bowel 
movement? 
5 4 3 2 1 
8 
Have you used medicines to decrease the 
number of bowel movements (drugs like 
Imodium®, Lomotil®)? 
1 2 3 4 5 
9 Have you had diarrhea (no form, watery stool)? 1 2 3 4 5 
10 Have you had loose stool (slight form, but mushy)? 1 2 3 4 5 
11 
Have you been able to wait 15 minutes to get 
to the toilet when you feel like you are going 
to have a bowel movement? 
5 4 3 2 1 
12 Have you been able to control the passage of gas (air)? 5 4 3 2 1 
13 Have you limited the types of solid foods you eat to control your bowel movements? 1 2 3 4 5 
14 Have you limited the types of liquids you drink to control you bowel movements? 1 2 3 4 5 
15 Have you had soilage (leakage of stool) of your undergarments during the day? 1 2 3 4 5 
16 
Have you used a tissue, napkin, and/or pad in 
your undergarments during the day in case of 
stool leakage? 
1 2 3 4 5 
17 Have you had soilage (leakage of stool) of your undergarments when you go to bed? 1 2 3 4 5 
18 Have you had to alter your activities because of your bowel function? 1 2 3 4 5 
Temple et al.211   
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Within the three subscales, scores for diet and urgency/soilage range from 4 to 20 and 
frequency from 6 to 30. One total score is obtained by summing all 18 items ranging 
between 18 and 90. Higher scores indicate better function. 
5.2.3.2 EQ-5D Quality of Life questionnaire 
To evaluate participants’ QOL, we chose the EuroQol EQ-5D questionnaire which consists 
of the index score representing the societal value of health state and has a scale ranging 
from 0 (no quality of life) to 100 (optimal quality of life). This is a descriptive system that 
measures health-related QOL on five dimensions (mobility, self-care, usual activities, 
pain/discomfort, and anxiety/depression). It also contains a visual analogue scale, the EQ-
VAS, representing the patient perspective. This scale also ranges from 0 (no quality of life) 
to 100 (optimal quality of life). This is a simple questionnaire and was deliberately chosen to 
optimise compliance with study requirements.  
5.2.4 Assessment and follow-up 
Patients recruited for assessment of ‘early’ bowel function were asked to complete 
questionnaires at three points during the study – at recruitment, and at 6 and 12 months 
after surgery. Patients who described a change in bowel habit prior to diagnosis of colonic 
neoplasm were provided with two sets of study questionnaires – one for documentation of 
their bowel habit and QOL at the time of recruitment and the second recording their bowel 
habit preceding the onset of bowel symptoms (historic data). Comparison of questionnaire 
variables between patients and controls was made at baseline, and then and 6 and 12 
months follow-up. For the subgroup of patients who reported a change in bowel habit, the 
'historic’ data were used as the baseline values rather than the values obtained immediately 
prior to surgery.  
In the assessment of ‘intermediate’ bowel function we assumed that a one-off measurement 
of bowel function and QOL was representative of patients’ regular bowel habit at two to four 
years after surgery and study questionnaires were completed during the interview. Control 
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subjects were also required to complete one set of questionnaires and for the purposes of 
analysis, the 6 and 12 month values were assumed to be the same as those at the baseline. 
5.2.5 Ethical approval  
Ethical approval to conduct the study was obtained from the National Research Ethics 
Service (NRES) Committee London – Stanmore in May 2011 with a substantial amendment 
to allow postal recruitment (‘intermediate’ bowel function group) and postal follow-up (‘early’ 
bowel function group) in September 2011 (REC reference 11/LO/0294). 
5.2.6 Power calculation  
The MSKCC questionnaire was validated in 2005 and to date has been utilised in several 
small clinical studies198, 216, 217. To obtain meaningful results for patients undergoing 
segmental colectomy, we based our power calculation on the preliminary results from an on-
going study conducted by the authors who developed the questionnaire. The study was 
designed to measure functional outcomes and QOL in patients undergoing surgery for rectal 
cancer218 and preliminary data collected at six months after surgery suggest that bowel 
function was clinically worse when a drop of 5 points in the median total score was 
observed218.  
Extrapolating this data, we calculated that a sample size of 85 participants in each group 
would give 90% power to demonstrate a difference in the median total score of 5 between 
the patients and controls, assuming the α value of 0.05. To allow for a 10 to 15% loss of 
patients due to withdrawal from the study (5%), local (anastomotic/peritoneal) disease 
recurrence (5%) or death (1 - 2%), we aimed to recruit 98 patients in the ‘early’ bowel 
function group.  
5.2.7 Statistical methods 
Categorical variables were compared between the groups using the Fisher’s exact test and 
normally distributed continuous variables using the unpaired t test. Continuous data with 
skewed distribution were examined using the Mann-Whitney test. Linear regression was 
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used to perform further analyses allowing adjustment for the differences in demographics 
between the two groups. Log transformation was performed for positively skewed data using 
linear regression, whereas bootstrapping methods alongside the regression methods were 
used to analyse negatively skewed outcomes. The results are presented as regression 
coefficients, which is the mean difference in the outcome between the groups reported as 
the value for the patient group minus the value for the control group. Therefore, a positive 
value suggests higher scores and better function for the patient group. The exception is the 
number of bowel movements per 24 hours which is reported as the ratio of the number of 
bowel movements in the patient group compared to that observed in the control group. The 
Spearman’s rank correlation was performed to evaluate the relationship between the bowel 
function and QOL as well as the MSKCC items and the bowel length excised.  
5.3 Results 
5.3.1 Demographic data  
For assessment of ‘early’ bowel function a total of 121 patients were recruited prior to 
surgery and data for 91 patients were included in the final analysis. In addition, 85 controls 
agreed to take part in the study. The majority of the patients were recruited from St. Mark’s 
Hospital, London (n = 42) and Oxford Radcliffe Hospitals, Oxford (n = 57). Reasons for 
exclusion from the final analysis were: loss to follow-up (n = 15), stoma formation (n = 8), 
death during the study period (n = 5), emergency surgery (n = 1) and rectal cancer (n = 1). 
Although this data were not collected, we estimate that approximately 10 – 20% of patients 
approached in the clinic declined to take part.  
A total of 106 patients who underwent surgery two to four years previously in two teaching 
hospitals (St. Mark’s Hospital London; Oxford Radcliffe Hospitals, Oxford) were invited to 
take part, of which 85 agreed to participate. All patients approached in the clinics (n = 48) 
agreed to take part in the study with the exception of one. Fifty eight invitation letters and 
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reply slips were posted, of which 41 patients returned the reply slip (71% response rate) and 
40 agreed to participate. Two of these patients however could not then be contacted and 
were not included. Six non-responders declined to take part and 11 could not be contacted.  
Table 5.4 Baseline demographics 
 Control group 
(n = 85) 
‘Early’ bowel function 
group 
‘Intermediate’ bowel 
function group 
(n = 91) P (n = 85) P 
M:F 34:51 43:47 0.36 49:36 0.03 
Mean (SD) age 58.2 (13.4) 71.2 (10.5) <0.001* 69.0 (11.2) <0.001* 
Ethnicity 
 White  
 Other 
 
77 (92%) 
7 (8%) 
 
79 (87%) 
11 (13%) 
0.34 
 
68 (81%) 
16 (19%) 
0.07 
Marital status 
 Single 
 Married 
 Living with partner 
 Widowed 
 
11 (13%) 
66 (78%) 
7 (8%) 
1 (1%) 
 
5 (5%) 
64 (70%) 
6 (7%) 
16 (18%) 
0.001 
 
13 (16%) 
52 (63%) 
6 (7%) 
12 (14%) 
0.007 
Employment 
 Retired 
 Unemployed 
 Working 
 
37 (44%) 
5 (6%) 
50 (51%) 
 
70 (77%) 
8 (9%) 
13 (14%) 
<0.001 
 
63 (75%) 
5 (6%) 
16 (19%) 
<0.001 
Laxatives 
 Baseline 
 6-months 
 12 months 
 
1 (1%) 
1 (1%) 
1 (1%) 
 
8 (9%) 
12 (14%) 
5 (6%) 
 
0.02 
0.002 
0.21 
 
9 (11%) 
 
0.02 
Antibiotics 1 (1%) 0 (0%) 0.48 5 (6%) 0.21 
Anti-diarrhoeal medication
 Baseline 
 6-months 
 12 months 
 
1 (1%) 
1 (1%) 
1 (1%) 
 
0 (0%) 
11 (13%) 
5 (6%) 
 
0.48 
0.005 
0.21 
 
5 (6%) 
 
 
0.21 
Opiates 
 Baseline 
 6-months 
 12 months 
 
5 (6%) 
5 (6%) 
5 (6%) 
 
2 (2%) 
6 (7%) 
1 (1%) 
 
0.27 
0.06 
0.11 
 
4 (5%) 
 
1.00 
Diabetes 1 (1%) 10 (11%) 0.01 11 (13%) 0.005 
BMI 27.2 (4.8) 26.1 (5.6) 0.18* 
27.3 
(25.0, 31.4) 
0.22** 
(*) Unpaired t-test, data presented as mean (SD) 
(**) Mann-Whitney test, data presented as median (IQR)  
82 
 
Group comparison of demographic data is presented in Table 5.4 where several differences 
were observed: the control group were found to be younger, more likely to be married and to 
be working at recruitment compared to both patient groups. Patients were more likely to use 
laxatives and anti-diarrhoeal agents six months after surgery although this difference was 
not observed at 12 months. General demographics of patients recruited for assessment of 
‘intermediate’ bowel function were similar to that of the patients recruited prior to surgery. 
This group were also more likely to use laxatives.  
 
5.3.2 MSKCC questionnaire 
For the purposes of this study we present the number of bowel movements per 24 hours 
independently and include the values in the MSKCC frequency score as instructed by the 
authors of the questionnaire (personal communication). The first analysis demonstrated a 
higher dietary score for patients at each time point, indicating better function when compared 
to controls (Table 5.5). Patients however appear to experience a significantly higher number 
of bowel movements per 24 hours (Figure 5.1 and Table 5.5). At 6 and 12 months after 
surgery approximately a third of patients experienced more than three motions per day, with 
an additional 20 to 30% experiencing two. Although the number of patients reporting three or 
more motions per day decreased to 20% in the intermediate group, the number is still 
significantly higher than the 10% of controls.  
Lower scores, indicating worse function, were reported for the urgency item (p 0.008) and 
knowing the difference between gas and bowel movement [Q7] at 6 and 12 months after 
surgery (p 0.05 and <0.001 respectively). This appeared to persist at two to four years after 
surgery and the ‘intermediate’ bowel function group also reported difficulty in controlling the 
passage of wind [Q12] (Table 5.6). After adjusting for the differences in demographics, 
however, statistically significant differences remained for several items only. This includes: 
increase in the number of bowel movements at each time point [ratio 1.59, (95% CI 1.31, 
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Table 5.5 MSKCC questionnaire 
 Median (IQR) 
score for patient 
group 
Median (IQR) 
score for control 
group 
P* 
Baseline ‘early’ bowel function group [n = 91] 
 Bowel movements per 24 
 hours 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
1.0 (1.0, 2.0) 
ccccccccccccc 
26 (22, 28) 
19 (16, 20) 
20 (20, 20) 
4 (3, 5) 
5 (4, 5) 
5 (4, 5) 
4 (4, 5) 
80 (76, 85) 
 
1.0 (1.0, 2.0) 
cccccccccccc 
26 (23, 27) 
16 (14, 18) 
20 (20, 20) 
4 (4, 4) 
4 (4, 5) 
5 (5, 5) 
4 (4, 5) 
79 (74, 83) 
 
0.40 
cccccccccccccccc 
0.45 
<0.001 
0.87 
0.90 
0.09 
0.16 
0.93 
0.09 
‘Early’ bowel function group at 6 months 
 Bowel movements per 24 
 hours 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
2.0 (1.0, 3.0) 
ccccccccccccc 
25 (22, 26) 
18 (15, 20) 
20 (18, 20) 
4 (3, 4) 
4 (3, 5) 
5 (4, 5) 
4 (4, 5) 
78 (72, 82) 
 
1.0 (1.0, 2.0) 
cccccccccccc 
26 (23, 27) 
16 (14, 18) 
20 (20, 20) 
4 (4, 4) 
4 (4, 5) 
5 (5, 5) 
4 (4, 5) 
79 (74, 83) 
 
<0.001 
ccccccccccc 
0.06 
0.01 
0.008 
0.12 
1.00 
0.05 
0.27 
0.32 
‘Early’ bowel function group at 12 months 
 Bowel movements per 24 
 hours 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
2.0 (1.0, 2.5) 
cccccccccc 
24 (22, 27) 
18 (16, 20) 
20 (18, 20) 
4 (3, 4) 
4 (3, 5) 
5 (4, 5) 
4 (4, 5) 
79 (70, 84) 
 
1.0 (1.0, 2.0) 
cccccccccccc 
26 (23, 27) 
16 (14, 18) 
20 (20, 20) 
4 (4, 4) 
4 (4, 5) 
5 (5, 5) 
4 (4, 5) 
79 (74, 83) 
 
<0.001 
ccccccccccc 
0.07 
0.005 
0.004 
0.65 
0.67 
<0.001 
0.43 
0.33 
‘Intermediate’ bowel function group [n = 85] 
 Bowel movements per 24 
 hours 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
2.0 (1.0, 3.0) 
cccccccccccc 
24 (21, 26) 
18 (16, 20) 
20 (19, 20) 
4 (3, 5) 
4 (3, 5) 
5 (4, 5) 
4 (3, 4) 
81 (73, 84) 
 
1.0 (1.0, 2.0) 
ccccccccccccc 
26 (23, 27) 
16 (14, 18) 
20 (20, 20) 
4 (4, 4) 
4 (4, 5) 
5 (5, 5) 
4 (4, 5) 
79 (74, 83) 
 
<0.001 
ccccccccccc 
0.03 
0.009 
0.04 
0.10 
0.95 
0.002 
<0.001 
0.08 
(*) Mann-Whitney test       
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Table 5.6 MSKCC questionnaire linear regression analysis for ‘early’ bowel 
function group 
 Mean (95% CI) 
group difference§ 
P 
Baseline ‘early’ bowel function group [n = 91] 
 Bowel movements per 24 
 hours¥ 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
0.95 (0.78, 1.16) 
ccccccccccccccccccccccc 
0.1 (-1.2, 1.4) 
1.1 (0.2, 2.1) 
0.3 (-0.3, 1.0) 
0.1 (-0.3, 0.5) 
0.2 (-0.1, 0.6) 
0.0 (-0.3, 0.2) 
-0.1 (-0.4, 0.2) 
1.8 (-1.2, 4.2) 
 
0.61 
ccccccccccccccccccccccc 
0.92 
0.02 
0.39 
0.75 
0.26 
0.75 
0.72 
0.19 
‘Early’ bowel function group at 6 months** 
 Bowel movements per 24 
 hours¥ 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
1.59 (1.31, 1.92) 
ccccccccccccccccccccccc 
-0.3 (-1.6, 0.9) 
0.1 (-0.9, 1.2) 
-0.6 (-1.5, 0.2) 
-0.1 (-0.5, 0.3) 
-0.1 (-0.6, 0.3) 
-0.1 (-0.4, 0.2) 
-0.1 (-0.4, 0.2) 
-1.1 (-4.1, 2.1) 
 
<0.001 
ccccccccccccccccccccccc 
0.61 
0.90 
0.15 
0.52 
0.48 
0.31 
0.55 
0.51 
‘Early’ bowel function group at 12 months*** 
 Bowel movements per 24 
 hours¥ 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
1.45 (1.21, 1.75) 
ccccccccccccccccccccccc 
-1.2 (-2.7, 0.1) 
0.7 (-0.3, 1.6) 
-0.5 (-1.4, 0.3) 
0.1 (-0.3, 0.4) 
-0.1 (-0.6, 0.3) 
-0.4 (-0.7, -0.1) 
-0.4 (-0.8, 0.0) 
-1.5 (-4.6, 1.6) 
 
<0.001 
ccccccccccccccccccccccc 
0.07 
0.16 
0.24 
0.72 
0.54 
0.01 
0.06 
0.36 
(§) Regression coefficient where a higher value indicates higher score and therefore better function for patients 
(*) Adjusted for age, marital status, employment, laxatives at baseline, diabetes  
(¥) Due to log transformation results are reported as the ratio of number of movements in the patient group 
(**) Adjusted for age, marital status, employment, diabetes, laxatives & anti-diarrhoeal medication 
(***) Adjusted for age, marital status, employment, diabetes 
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Table 5.7 MSKCC questionnaire linear regression analysis for ‘intermediate’ bowel 
function group 
 Mean (95% CI) 
group difference§ 
P 
‘Intermediate’ bowel function group  
[n = 85]≠ 
 Bowel movements per 24 
 hours¥ 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
 
1.44 (1.20, 1.73) 
ccccccccccccccccccccccc 
-1.5 (-3.0, 0.0) 
0.6 (-0.4, 1.6) 
-0.6 (-1.5, 0.3) 
-0.1 (-0.5, 0.3) 
-0.1 (-0.5, 0.3) 
-0.2 (-0.5, 0.1) 
-0.6 (-1.0, -0.3) 
-2.7 (-36.0, 0.7) 
 
 
<0.001 
cccccccccccccccccccccccc 
0.03 
0.23 
0.20 
0.47 
0.54 
0.12 
<0.001 
0.11 
(§) Regression coefficient where a higher value indicates higher score and therefore better function for patients 
(≠) Adjusted for age, sex, marital status, employment, laxative use and diabetes 
(¥) Due to log transformation results are reported as the ratio of number of movements in the patient group 
 
Table 5.8 MSKCC values for patients presenting with symptoms of change in 
bowel habit 
 Median (IQR) 
historical 
score, 
[n = 35] 
Immediate pre-
operative values 
6 month 
follow-up 
12 month  
follow-up 
Median 
(IQR) P 
Median 
(IQR) P 
Median 
(IQR) P 
Bowel movements  
per 24 hours 
1.0 
(1.0, 2.0) 
2.0 
(1.0, 5.0) 
0.001 
2.0 
(1.0, 3.0) 
<0.001 
 
2.0 
(1, 2.1) 
<0.001 
Frequency score 
27 
(24, 29) 
22 
(19, 26) 
<0.001 
24 
(21, 26) 
0.004 
24 
(21, 28) 
0.003 
Dietary score 
20 
(18, 20) 
18 
(14, 20) 
0.001 
18 
(15, 20) 
0.05 
 
18 
(15, 20) 
0.02 
Urgency score 
20 
(19, 20) 
19 
(16, 20) 
0.001 
20 
(18, 20) 
0.01 
 
20 
(18, 20) 
0.02 
MSKCC Q4 4 (4, 5) 3 (2, 4) 0.002 3 (3, 4) 0.008 4 (3, 5) 0.16 
MSKCC Q6 4 (4, 5) 3 (3, 5) 0.03 5 (3, 5) 0.62 4 (3, 5) 0.27 
MSKCC Q7 5 (5, 5) 4 (3, 5) <0.001 5 (4, 5) 0.07 4 (4, 5) 0.03 
MSKCC Q12 4 (4, 5) 4 (3, 4) 0.03 4 (4, 5) 0.82 4 (4, 5) 0.84 
Total score 
82 
(78, 87) 
74 
(61, 80) 
<0.001 
79 
(68, 82) 
0.001 
80 
(70, 84) 
0.005 
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5.3.3 EQ-5D questionnaire 
No difference in the QOL between patients and controls was observed at any time point 
(Table 5.9). A weak positive correlation was observed between the EQ-VAS score and the 
ability to control the passage of wind [Q12] (rs 0.30, p 0.005), urgency score (rs 0.29, p 
0.007) and the total MSKCC score (rs 0.31, p 0.006) at six months after surgery, indicating 
that patients able to control wind, those without symptoms of urgency and higher total 
MSKCC score have better QOL. A similar relationship between the EQ-VAS and the ability 
to fully evacuate bowels [Q4] was seen at 12 months (rs 0.34, p 0.01). In the ‘intermediate’ 
bowel function group, complete evacuation [Q4] was positively correlated with both EQ-5D 
variables (rs 0.29, p 0.007 and rs 0.25, p 0.02 respectively) whereas knowing the difference 
between gas and bowel movement [Q7] with EQ-5D-QOL only (p 0.02). The results indicate 
that for patients in the ‘intermediate’ bowel function group, full evacuation and the ability to 
differentiate between wind and solid stool were associated with a better QOL.  
Table 5.9 EQ-5D questionnaire linear regression analysis 
 Mean (95% CI) 
group difference§ 
P 
Baseline ‘early’ bowel function group [n = 91]*  
 EQ-5D-QOL 
 EQ-VAS 
 
-0.01 (-0.07, 0.05) 
-2.5 (-9.3, -3.9) 
 
0.78 
0.45 
‘Early’ bowel function group at 6 months** 
 EQ-5D-QOL 
 EQ-VAS 
 
-0.02 (-0.08, 0.04) 
-3.9 (-9.6, 1.8) 
 
0.52 
0.18 
‘Early’ bowel function group at 12 months*** 
 EQ-5D-QOL 
 EQ-VAS 
 
0.00 (-0.06, 0.06) 
-0.3 (-5.9, 6.1) 
 
0.95 
0.93 
‘Intermediate’ bowel function group [n = 85]≠ 
 EQ-5D-QOL 
 EQ-VAS 
 
-0.04 (-0.11, 0.04) 
-2.1 (-7.8, 3.6) 
 
0.31 
0.47 
(§) Regression coefficient where a higher value indicates higher score and therefore better function for patients 
(*) Adjusted for age, marital status, employment, diabetes and laxatives 
(**) Adjusted for age, marital status, employment, diabetes, laxatives and anti-diarrhoeal medication  
(***) Adjusted for age, marital status, employment, diabetes 
(≠) Adjusted for age, sex, marital status, employment, laxative use, diabetes 
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5.3.4 Right sided versus left sided resections  
Both patient cohorts undergoing right- or left-sided resections had similar demographic 
details and post-operative outcomes (Table 5.10 and Table 5.11). Principles of ERAS were 
followed for post-operative care of all patients and over 80% of procedures were 
laparoscopic. Anastomotic leakage occurred only in two patients following left-sided 
resections recruited for assessment of ‘early’ bowel function. Both were successfully treated 
with antibiotics only (International Classification grade A)180.  
No difference in QOL between the groups was observed at any time point after surgery. At 
six and 12 months follow-up, patients who underwent left-sided resections experienced a 
higher number of bowel movements [2.0 (1.5, 3.3) vs. 1.5 (1.0, 2.5), p 0.04 and 2.0 (1.5, 3.0) 
vs. 1.5 (1.0, 2.0), p 0.002 respectively] and slightly lower scores for Q6 (having a second 
bowel movement within 15 minutes) [4 (3, 5) vs. 5 (4, 5) at both time points, p 0.001 and 
0.01 respectively]. Results from the intermediate group suggest that few years after surgery 
this appears to resolve, although this group of patients had a lower frequency score following 
right-sided resections, indicating worse function (Table 5.12).  
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Table 5.10 Demographics details right- vs. left-sided colonic resections for patients 
recruited for assessment of ‘early’ bowel function 
 Right-sided resection 
(n = 47) 
Left sided-resection 
(n = 44) 
P 
 
M:F 22 (47%) : 25 (53%) 21 (49%) : 22 (51%) 1.00 
ASA grade 
 I  
 II 
 III 
 
7 (18%) 
20 (51%) 
12 (31%) 
 
9 (26%) 
21 (60%) 
5 (14%) 
0.22 
Type of surgery 
 Laparoscopic 
 Open 
 Converted 
 
41 (87%) 
5 (11%) 
1 (2%) 
 
37 (86%) 
1 (2%) 
5 (12%) 
0.09 
Median (IQR) LOS, days* 6 (4, 10) 5 (4, 7) 0.29 
30-day complications  14 (30%) 13 (30%) 1.00 
30-day readmission 0 (0%) 5 (12%) 0.02 
30-day reoperation 0 (0%) 0 (0%) - 
Mean (SD) size of the excised 
specimen, cm** 29.4 (12.8) 27.2 (9.1) 0.36 
IUCC stage 
 I  
 II 
 III  
 benign 
 
9 (20%) 
18 (41%) 
17 (39%) 
0 (0%) 
 
11 (26%) 
14 (33%) 
14 (33%) 
4   (9%) 
0.19 
Distant recurrence at 6 
months 2 (5%) 0 (0%) 0.50 
Distant recurrence at 12 
months 2 (4%) 1 (2%) 1.00 
Chemotherapy 19 (40%) 16 (34%) <0.0001 
(*) Mann-Whitney test  
(**) Unpaired t-test 
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Table 5.11 Demographic details right- vs. left-sided colonic resections for patients 
recruited for assessment of ‘intermediate’ bowel function 
 Right-sided resections 
(n = 48) 
Left-sided resections 
(n = 37) 
P 
M:F 26 (54%) : 22 (46%) 10 (27%) : 27 (73%) 0.015 
ASA grade 
 I  
 II 
 III 
 not available 
 
7 (15%) 
33 (68%) 
7 (15%) 
1 (2%) 
 
8 (22%) 
26 (70%) 
1 (3%) 
2 (5%) 
0.22 
Type of surgery 
 Laparoscopic 
 Open 
 Converted 
 
38 (79%) 
8 (16%) 
2 (5%) 
 
32 (87%) 
3 (8%) 
2 (5%) 
0.25 
Median (IQR) LOS, days* 4 (3, 6) 5 (4, 6) 0.15 
30-day complications 14 (29%) 6 (16%) 0.02 
30-day readmission 4 (8%) 1 (3%) 0.30 
30-day reoperation 1 (2%) 1 (3%) 0.68 
Mean (SD) size of the excised 
specimen, cm** 
29.4 (12.8) 27.2 (9.1) 0.36 
IUCC stage 
 I  
 II 
 III 
 
6 (12%) 
23 (48%) 
19 (40%) 
 
10 (27%) 
12 (32%) 
15 (41%) 
0.19 
Distant recurrence 1 (2%) 2 (5%) 0.50 
(*) Mann-Whitney test 
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Table 5.12 MSKCC outcomes right- vs. left-sided colonic resections 
 Median (IQR) 
score for right-
sided resections 
Median (IQR)  
score for left-
sided resections 
P 
Baseline ‘early’ bowel function group [n = 91] 
 Bowel movements per 24 
 hours 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
1.0 (1.0, 1.5) 
ccccccccccccc 
26 (22, 28) 
18 (16, 20) 
20 (20, 20) 
4 (3, 5) 
5 (4, 5) 
5 (4, 5) 
4 (4, 5) 
80 (75, 84) 
 
1.0 (1.0, 2.0) 
cccccccccccc 
27 (23, 28) 
19 (17, 20) 
20 (20, 20) 
4 (3, 5) 
4 (4, 5) 
5 (4, 5) 
4 (4, 5) 
81 (77, 86) 
 
0.68 
cccccccccccccccc 
0.72 
0.71 
0.88 
0.53 
0.15 
0.77 
0.50 
0.56 
‘Early’ bowel function group at 6 months
 Bowel movements per 24 
 hours 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
1.5 (1.0, 2.5) 
ccccccccccccc 
25 (22, 28) 
18 (15, 20) 
20 (19, 20) 
4 (3, 4) 
5 (4, 5) 
5 (4, 5) 
4 (4, 5) 
80 (73, 84) 
 
2.0 (1.5, 3.3) 
cccccccccccc 
25 (22, 26) 
18 (15, 20) 
20 (18, 20) 
4 (3, 4) 
4 (3, 5) 
5 (4, 5) 
4 (4, 5) 
77 (71, 81) 
 
0.04 
ccccccccccccc 
0.27 
0.73 
0.96 
0.29 
0.001 
0.98 
0.43 
0.20 
‘Early’ bowel function group at 12 month
 Bowel movements per 24 
 hours 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
1.5 (1.0, 2.0) 
cccccccccc 
25 (22, 27) 
18 (15, 20) 
20 (18, 20) 
4 (3, 4) 
5 (4, 5) 
5 (4, 5) 
4 (4, 5) 
79 (70, 84) 
 
2.0 (1.5, 3.0) 
cccccccccccc 
23 (21, 27) 
18 (16, 20) 
20 (18, 20) 
4 (3, 5) 
4 (3, 5) 
4 (4, 5) 
4 (3, 5) 
77 (70, 81) 
 
0.002 
cccccccccccc 
0.17 
0.62 
0.88 
0.73 
0.01 
0.50 
0.23 
0.27 
‘Intermediate’ bowel function group [n = 85] 
 Bowel movements per 24 
 hours 
 Frequency score 
 Dietary score 
 Urgency score 
 MSKCC Q4 
 MSKCC Q6 
 MSKCC Q7 
 MSKCC Q12 
 Total score 
 
2.0 (1.0, 2.5) 
cccccccccccc 
24 (21, 26) 
18 (15, 20) 
20 (18, 20) 
4 (3, 4.5) 
4 (3, 5) 
4.5 (4, 5) 
4 (2.5, 4) 
78 (71, 82) 
 
2.0 (1.0, 2.5) 
ccccccccccccc 
25 (23, 27) 
18 (16, 20) 
20 (19, 20) 
3 (3, 5) 
5 (3, 5) 
5 (4, 5) 
4 (3, 4) 
79 (74, 83) 
 
0.87 
ccccccccccccc 
0.03 
0.31 
0.17 
0.81 
0.86 
0.12 
0.67 
0.27 
 
92 
 
5.4 Discussion  
Almost 50% of patients undergoing surgery for colonic neoplasia have concerns about post-
operative bowel function219. The colon plays a key physiological role in defecation and fluid 
balance and understandably patients seek counselling preoperatively. This study was 
motivated by the need to generate an estimate of bowel dysfunction after hemicolectomy 
and its effect on QOL as the literature on this subject is scarce. Assuming that the overall 
bowel function is represented by the total MSKCC score, the results of our study suggest 
that bowel function of patients undergoing hemicolectomy for neoplasia, as well as their 
QOL, are comparable to that of healthy controls as early as six months after surgery. 
However, we also observed that certain elements of the MSKCC questionnaire remain 
altered one to four years after surgery. At 12 months follow-up patients reported having 
difficulty discriminating between wind and solid stool whereas those recruited for 
assessment of ‘intermediate’ bowel function reported having difficulty controlling the passage 
of wind. In addition, both of our patient cohorts reported an increased number of bowel 
movements at each follow-up time point, with one in five patients having more than three 
motions per day two years after surgery. Although this was significantly higher than the 
values reported by our controls or previous reports220, 221, patients do not seem to perceive 
this as an issue when assessed using the EQ-5D QOL and EQ-VAS scores. However, weak 
correlation between several items of the MSKCC and their QOL was observed. Patients with 
higher total MSKCC scores, no symptoms of urgency and those able to control win appear to 
have a better QOL during the first year after surgery. For patients in the ‘intermediate’ bowel 
function group, the ability to fully evacuate their bowel and differentiate between wind and 
solid stool, was also associated with a better QOL. 
Although the number of studies reporting on this subject is small, similar findings have been 
published previously. Graf et al.222 reported functional outcomes of patients who underwent 
anterior resection at least three years previously (n = 70) , comparing them to patients who 
had undergone hemicolectomy during the same period (n = 40). Although patients reported 
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a higher number of bowel movements following rectal surgery (16% vs. 8% respectively 
reporting >4 motions per day, p <0.001), no difference was observed between the groups for 
gas-stool discrimination and emptying difficulties. The majority (88%) of hemicolectomy 
patients in this cohort described their bowel function as excellent or good. Adachi et al.208 
compared late functional outcomes of patients who underwent anterior vs. sigmoid resection 
using a self-constructed questionnaire, and found that an increased length of resected 
specimen was associated with worse functional outcomes following sigmoid colectomy (p 
<0.05). The number of patients reporting poor bowel function however was relatively small (n 
= 16) which could explain why in our study we found no correlation between the length of the 
resected specimen and any of the MSKCC items and EQ5D in either patient group.  
Although we found a weak correlation between several MSKCC items and the EQ-5D QOL 
and EQ-VAS scores, the overall QOL of patients in our study was comparable to that of 
slightly younger control group. Theodoropoulus et al.221 recently reported the use of SF-36, 
EORTC QLQ-C30, QLQ-CR29 and GIQLI questionnaires to evaluate patients’ QOL at one, 
six and 12 months after laparoscopic colectomy. These authors reported that at six and 12 
months after surgery, almost all QOL scores were better than baseline and were comparable 
to the general population values. In addition, Ramsey et al.202 reviewed QOL of long-term 
CRC survivors more than five years after their initial treatment and found that patients had a 
relatively high perceived QOL compared to age-matched, population based controls. 
Therefore, although we utilised a very simple QOL instrument, our findings are in keeping 
with the previously published studies.  
The observed increase in bowel frequency however is not easy to explain taking into 
account that we found no association between the length of the bowel excised and any of 
the MSKCC items. In both groups of patients, the pelvic autonomic nerves were preserved. 
Sarli et al.220, 223 have suggested that high ligation of inferior mesenteric artery (IMA) during 
left hemicolectomy can lead to damage of the lower mesenteric ganglion219, the origin of 
thoracolumbar sympathetic nerves224. This damage, associated with the preservation of the 
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parasympathetic pelvic nerves, could be responsible for the increased motility of the residual 
colon and rectum and altered functioning of the internal anal sphincter as sphincter 
innervation by the thoracolumbar sympathetic nerves has been demonstrated225, 226. In 
addition, animal studies have shown that resection of the ganglion and plexus around the 
IMA causes contractile abnormalities in the distal colon with an increased number of bowel 
movements and diarrhoea227. Dobrowski et al.228 recently published a study aimed to 
investigate functional results after sigmoid resection following ligation or preservation of the 
IMA origin. The authors reported that at 12 months after surgery increased bowel frequency 
and incomplete evacuation were more common after IMA ligation with an adverse effect on 
patients’ QOL. However with a total of 43 patients recruited in the study, it is difficult to draw 
conclusions that are clinically relevant.  
Wilson et al.229 however reported increased incidence of diarrhoea during the early post-
operative period following right hemicolectomy. This might be expected as resection of the 
ileo-caecal valve can result in bile acid malabsorption230. Failure of absorption of bile acids in 
the distal ileum results in bile acid overload in the colon leading to loose stools by various 
mechanisms including increased colonic motility, mucus secretion and stimulation of 
defecation231. In addition, the colon as an organ demonstrates regional differences. The 
proximal and distal segments have different embryological origins, and different function. 
The ascending colon demonstrates the greatest absorptive capability and the chime resides 
within this segment the longest, maximising its contact with mucosa. As a result the salvage 
of water and electrolytes is primarily accorded to the proximal colon232, 233. The absorption of 
water primarily follows a para-cellular pathway, although trans-cellular route via protein 
channels is also available for larger molecules234. In the event that a large amount of watery 
chime is delivered to the colon, the distal colon and rectum contribute to this task, although 
to a lesser extent233. As a result, diarrhoea is more likely to ensue after right, as opposed to 
a left hemicolectomy.  
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Despite the prospective nature of this adequately powered case-controlled study, utilising 
validated questionnaires, there are several potential limitations that may affect the 
generalizability of our conclusions to patients undergoing colonic surgery. A selection bias 
exists as only patients and controls willing and able to take part in the study were recruited. 
These patients and controls are potentially at a higher level of functioning than the average 
patient population. Recall bias is common in self-reported surveys and a large proportion of 
our patients presented with a change in bowel habit which may have had an effect on the 
baseline values for both questionnaires. Although loss to follow-up was relatively low (12%), 
these patients may have been embarrassed to talk about their bowel function after surgery 
due to the severity of their symptoms. In addition, having survived cancer may strengthen 
positive health perceptions in this relatively older patient population if they compare their 
present health to that at the time of cancer diagnosis. Although the reported QOL is very 
similar between patients and controls using a very simple QOL questionnaire, one could 
argue that similar results are likely to be obtained using more elaborate questionnaires such 
as those described by Theodoropoulus et al.221 and Ramsey et al.202.  
The results of this study suggest that certain aspects of bowel function after hemicolectomy 
remain altered years after surgery and should be evaluated further. A study of a similar 
design presented in this chapter using the MSKCC questionnaire and perhaps more detailed 
QOL questionnaire could be conducted using our results for power calculation to estimate a 
more appropriate sample size. Longer follow up would clarify the discrepancy observed 
between the ‘early’ and ‘intermediate’ bowel function following different resections. In 
addition, semi-structured interviews may help identify issues that are specific for this patient 
group and could be used to design a questionnaire for assessment of bowel function 
following hemicolectomy.  
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5.5 Conclusion 
Guided by the results of this study, we can draw several conclusions. These that can be 
used during pre-operative consultation of patients with colonic neoplasia scheduled to 
undergo elective hemicolectomy: 1) their overall bowel function and QOL are likely to be 
similar to that of general population as early as six months after surgery; 2) their bowel 
function is unlikely to be affected by certain food or drink items any more that it was before 
surgery or when compared to healthy population; 3) even few years after surgery one in five 
patients are likely to experience more than three bowel movements per day although this will 
not affect their QOL; 4) patients undergoing left-sided resections are more likely to 
experience an increased number of bowel movements during the first 12 months after 
surgery whereas two to four years after surgery, patients who underwent right sided 
resections are more likely to be affected; 5) despite the increase in the number of bowel 
movements per day, the patients should be able to ‘hold on’ for a reasonable length of time 
without having an accident or adverse effect on their social activities; 6) at times, they may 
find it difficult to differentiate between wind and solid stool. 
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Chapter 6 Current status of endoscopic full thickness 
resection of colonic lesions: systematic 
review 
6.1 Introduction 
The literature published to date supports utilisation of TEMS as an alternative to radical 
surgery for treatment of a select group of patients with benign rectal polyps and early 
cancers78, 79, 137, 235. The procedure enables preservation of the rectum and results in a full 
thickness excision of the lesion with an adequate margin of healthy tissue. Interest in 
developing similar endoscopic full thickness resection techniques (EFTR) for colonic and 
gastric lesions has increased over the past decade as recently summarised by Kopelman et 
al236. If available, EFTR would obviate the need for radical surgery in a significant proportion 
of these patients and even replace piecemeal EMR as a procedure of preference. The 
procedure could minimise the risk of residual intramural disease and recurrence, enabling a 
more accurate assessment of resection margins and depth of invasion in the full thickness 
specimen. Several research groups have described surgical procedures as potential 
alternatives to hemicolectomy both in clinical and preclinical models142-144, 237, 238.  
In addition, a description of a hybrid technique called the Full thickness Laparo-endoscopic 
EXcision (FLEX) recently technique173 published from our institution. Although the procedure 
was successfully performed in both acute and survival animal models, technical issues 
encountered have prevented the development of a translational study. These are discussed 
in detail in Chapter 7. Prior to attempting to modify the original FLEX technique, we 
conducted a systematic review of the studies describing colonic EFTR, focusing on clinical 
outcomes and technical aspects, to assess the feasibility and safety of this approach.  
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6.2 Methods  
6.2.1 Study selection  
The published literature was searched using OVID SP for MEDLINE, EMBASE and 
PsychINFO databases for studies reporting EFTR of colonic lesions published between 
January 1990 and June 2012. Both animal and human studies were included. The search 
strategy is presented in Figure 6.1. Duplicate records were excluded and two reviewers (A.B. 
and N.R.A.S) independently screened titles and abstracts of the remaining citations in order 
to obtain full text articles of the potentially eligible studies. Reference lists of these articles 
were also searched for additional relevant publications.  
Figure 6.1 Literature search  
 
6.2.2 Study eligibility  
All studies describing full thickness colonic resection and defect closure were eligible for 
inclusion in the review. Conference proceedings, abstracts and case reports were excluded 
as they lacked sufficient detail. Only articles published in English were included. Any 
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disagreement about eligibility was resolved by discussion with the third assessor (S.K.C.). 
Two authors (A.B. and N.R.A.S) extracted the data from included papers using a predefined 
protocol. 
6.2.3 End points 
The primary end point was successful in vivo completion of an endoscopic or a laparo-
endoscopic full thickness colonic resection and subsequent closure of the resulting defect. 
Secondary end points were intraoperative complications, anastomotic bursting pressures, 
procedure duration, size and quality of the excised specimen, post-operative complications 
and post-mortem findings.   
6.3 Results 
6.3.1 Published studies 
A total of seven publications173, 237-242 published by five research groups were retrieved by 
the search strategy. These publications included 10 studies describing full thickness colonic 
resection and closure of the defect using acute and survival porcine models. The adult pig is 
accepted as a suitable model for studying gastrointestinal tract interventions due to the 
similarities to the human in anatomy, vascular supply of the rectum and sigmoid segment as 
well as the thickness of colonic wall237. Von Renteln et al. reported two different closure 
methods238, 242 whereas Schurr et al.237 described three separate studies in a single 
publication. For the purpose of this review, these are referred to as independent studies. 
Experimental work in human cadavers, an ex-vivo porcine model and an acute animal study 
were described by Rieder et al.241, but EFTR procedure was performed in its entirety only in 
the latter study. Therefore, only the results of this complete procedure were included in the 
review (Table 6.1).  
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Table 6.1 Summary of procedural methods  
Study authors Procedure Approach 
Study 
type 
No. of 
animals 
Schurr et al.,  
2001237 
EFTR performed by conventional 
circular stapler 
Laparotomy with 
endoscopic resection 
(pre-RCM) 
A & S 10 & 5 
 EFTR performed by endoscopic FTRD 
Endoscopic only 
(pre-RCM) 
S 5 
 EFTR performed by endoscopic FTRD 
Laparoscopically 
monitored endoscopic 
resection 
(pre-RCM) 
A 10 & 10 
Rajan et al.,  
2002239   
EFTR performed by endoscopic 
FTRD 
Endoscopic only 
(pre-RCM) 
S 8 
Raju et al.,  
2009240 
EFTR performed using endoscopic 
knife/snare and interrupted TAS for 
defect closure 
Endoscopic only 
(post-RCM) 
S 20 
Von Renteln et al.,  
2010238 
Snare resection of the lesion 
followed by OTSC application using  
twin-grasper to approximate 
colotomy edges  
Endoscopic only 
(post-RCM) 
A 10 
 
Endoloop applied to the base 
of the pseudopolyp prior to snare 
resection; closure reinforced by 
application of OTSC over the 
endoloop 
Endoscopic only 
(pre-RCM) 
A 4 
Rieder et al.,  
2010241 
Tissue manipulated into an OTSC 
using TAS where the clip was 
applied prior to snare resection 
Laparoscopically 
monitored endoscopic 
resection 
(pre-RCM) 
A 2 
Von Renteln et al.,  
2011242  
Tissue manipulated into an OTSC 
using a grasper followed by snare 
resection above the clip 
Endoscopic only 
(pre-RCM) 
S 8 
Kennedy et al.,  
2011173 
Inversion of the bowel segment 
achieved using laparoscopic BBs 
placed on either side of the polyp; 
the inverted area is over-sewn 
laparoscopically and pseudopolyp 
resected endoscopically 
Laparoscopically      
assisted endoscopic 
resection (pre-RCM) 
A & S 3 & 4 
Total Row    99 
Abbreviations: EFTR = endoscopic full thickness resection; FTRD = full thickness resection device; pre-RCM = 
pre-resection closure method; post-RCM = post-resection closure method; A = acute study; S = survival study; 
OTSC = Over-The-(endo)Scope Clip; TAS = tissue apposition system; BB = brace bars 
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Six out of seven publications173, 238-242 reported details of ethical approval to conduct the 
research. There was a significant variation in weights of animals utilised in these studies, 
ranging from 20kg to 74.9kg. Details of pre-operative starvation protocols were described in 
three studies173, 239, 240. The distal colon was prepared using pre-operative oral bowel 
preparation239, intraoperative colonic lavage173, 238, 241, 242 or a combination of both240. 
Isoflurane was the most commonly used anaesthetic agent (5/9). A total of 113 procedures 
were performed in 99 animals, 50 of which were enrolled in survival studies.  
6.3.2 Procedural methods 
Studies included used either a ‘pre-resection’ closure method, in which the colonic wall was 
plicated and anastomosed prior to resection, or a ‘post-resection’ closure, where specimen 
resection preceded defect closure. Combined stapling/cutting devices were considered as 
pre-resection closure methods as the abdominal cavity was not exposed to endoluminal 
contents. The resection techniques and closure methods employed varied significantly 
between the studies and a brief summary is presented in Table 6.1. 
6.3.2.1 Full thickness resection device (FTRD)  
Schurr et al.237 and Rajan et al.239 described the use of a Full Thickness Resection Device 
(FTRD) consisting of a hollow flexible shaft with a resection head (Figure 6.2). An 
endoscope with an outer diameter of 9.8mm was introduced into the central channel 
alongside tissue manipulators in order to manoeuvre colonic tissue under direct endoscopic 
vision. The head of the device contained a resection chamber surrounded by a semi-circular 
stapler and a cutting blade. The device was available in a rectal (25cm) or colonic (50cm) 
version. In the first study reported by Schurr et al.237 the FTRD was still under development 
and a conventional surgical stapler was used as a predicate device to imitate the procedure. 
In this study, following a midline laparotomy and mobilisation of the sigmoid colon, the 
circular stapler was inserted transanally. Both colon and its accompanying mesentery were 
manoeuvred into one side of the stapler and a semi-circular resection and anastomosis were 
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performed. The procedure was undertaken in 10 acute and five survival animals. Two 
studies reported in the same paper and an additional study published by Rajan et al.239 were 
performed using the FTRD with the aim of assessing the feasibility and safety of EFTR. Both 
authors described placing coagulation marks on the colonic mucosa to simulate a target 
lesion of approximately 3cm in diameter. Following transanal insertion of FTRD, the lesion 
was manoeuvred into the resection chamber using either traction or suction. The device was 
deployed creating a stapled full thickness resection.  
Figure 6.2 Tissue manipulation into the head of the FTRD under endoscopic vision  
 
 
 
6.3.2.2 Post-resection closure method using Tissue Apposition System (TAS)  
In the paper published by Raju et al.240, EFTR was performed on the mesenteric (n = 10) 
and anti-mesenteric (n = 10) side of the colon. The authors created a colotomy using an 
insulated needle-knife and a snare for excision. The resulting defect was closed with a series 
of Tissue Apposition Systems (TAS) (Ethicon, Endo-Surgery Inc., Cincinnati, Ohio) (Figure 
6.3). This was a single application system and it was reloaded as many times as necessary 
to close the defect. 
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Figure 6.3 Step-by-step closure of the colonic wall defect using T-tags 
 
6.3.2.3 Pre- and post-resection closure using Over-The-(endo)Scope-Clip 
device 
Several variations of a grasp and snare technique were described by Von Renteln et al.238, 
242 and Rieder et al.241. An Over-The-(endo)Scope-Clip (OTSC) (Ovesco Endoscopy, 
Tubingen Germany (Figure 6.4) was used for both pre- and post-resection closure methods 
described in the first paper published by Von Renteln et al.238. A tissue anchor (Ovesco 
Endoscopy, Tubingen, Germany), introduced through a double channel gastroscope (2T160, 
Olympus, Hamburg, Germany), deployed three needles at its tip in order to grasp the bowel 
wall creating a colonic fold. Eight procedures were performed in four animals in which the 
base of the colonic fold was ligated with an endoloop (HX-400U-30, Olympus) prior to snare 
resection (2.5cm snare, SD-990, Olympus). An OTSC was then loaded onto a transparent 
14mm cap at the end of the endoscope and applied at the base of the endoloop. This group 
is referred to as the pre-resection closure group. A further 20 procedures were performed in 
10 animals with defect closure subsequent to the resection (post-resection closure method). 
The edges of the resulting colotomy were manipulated into the cap using a twin grasper 
(Ovesco, Endoscopy) and one or more OTSCs were applied to close the defect. 
In the subsequent paper published by the same research group242, a modified pre-resection 
closure method was described. Following colonic lavage, mucosal diathermy marks were 
placed to simulate a 2cm polyp. In this series a single channel endoscope (EG-2940, 
Pentax, Hamburg, Germany) was fitted with a transparent cap preloaded with an OTSC and 
a snare. The delineated area of the colonic wall was manipulated is into the cap using 
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forceps (FG-42-L, Olympus, Hamburg, Germany) and OTSC deployed at the base inverting 
a full thickness of colonic wall. The specimen was resected with a snare taking the tissue 
superficial to the clip.  
Figure 6.4 Schematic illustration of the clip closure device described.  
 
 
A. Over-The-(endo) Scope Clip (OTSC); B. OTSC loaded onto a cap 
 
A pre-resection closure method using the same closure system (OTSC, Ovesco Endoscopy, 
Tubingen, Germany) mounted on a dual channel gastroscope (GIF-2T-160, Olympus) was 
also described by Rieder et al.241. In an attempt to improve excision accuracy, anchoring 
TAS were placed at a predetermined distance from a simulated lesion to draw colonic wall 
into the cap with the aid of suction. Subsequent to this, the OTSC was deployed at the base 
of the inverted fold and a standard snare (Boston, Scientific) was used to resect the tissue 
superficial to the clip. This procedure was performed with laparoscopic overview. 
6.3.2.4 Full thickness Laparo-endoscopic EXcision (FLEX) technique 
The technique developed in our institution173 was also identified during the literature search. 
This hybrid laparo-endoscopic approach requires two operators (a surgeon and an 
A B 
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endoscopist), two working endoscopes (R-scope, Olympus, Keymed and GIF-Q240, 
Olympus Keymed) and a prototype double lumen anal sealing device. A simulated polyp was 
created by submucosal injection of black ink (Spot®) and circumferential argon plasma 
coagulator (APC) marks were placed 1cm away from the edge of the polyp. A laparoscopic 
bowel clamp was placed proximally to prevent proximal bowel insufflation. Three pairs of the 
prototype BraceBarsTM (BBs) (Olympus Medical Systems, Olympus) were placed 1cm away 
from the mucosal APC marks, in order to invert the area of the colon bearing the polyp. The 
BraceBarsTM system consisted of a bifurcating nylon thread with a small tag at each end and 
a tag-tightener (Figure 6.5). Each pair was preloaded into a needle catheter used to 
perforate the serosal surface of the colon laparoscopically (from the outside in).  
Figure 6.5 BraceBarsTM System 
 
A. The thread that connects two BBs is secured in the needle; B. BBs preloaded into the needle catheter before 
the needle is retracted into the catheter with the tightener 
 
To ensure the correct placement of BBs, diathermy marks were placed on the serosal 
surface 1cm away from the endoluminal APC marks for guidance. This was achieved by 
endoscopic assistance by applying pressure to the colonic wall (from the inside out) using 
grasping forceps. Once the tags were deployed and approximated using the tightener, the 
excess suture was cut and the process repeated. The inversion site (approximately 6cm in 
length) was over-sewn laparoscopically in two layers. The endoluminal fold of the colon 
created during the inversion process was resected endoscopically using a hook or triangle 
A B 
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knife (Olympus, Keymed). One endoscope was used as a working platform for cutting (R-
scope, Olympus, Keymed) while the second endoscope provided traction (GIF-Q240, 
Olympus Keymed). Mucosal APC marks and BBs visible endoluminally provided guidance 
during the resection process to ensure that adequate margin of clearance was achieved. 
Procedural steps of the technique are presented in the Figure 6.6. 
6.3.3 Feasibility 
6.3.3.1 Complete resection and defect closure 
From the studies included in this review, the overall EFTR completion rate was 89% with a 
mortality rate of 4% (Table 6.2). Although excision of the lesion was achieved in all 
procedures regardless of the resection method, failure to close the defect in studies 
describing a post-resection closure method was a common problem238, 240, 242. Raju et al.240 
reported snapping of TAS sutures in 1/20 (5%) animals leaving a 3 to 4cm colonic wall 
defect. Post-resection defect closure using the OTSC system with the aid of twin graspers 
was successful in only 9/20 (45%) cases 238. Von Rentlen et al.238 however reported failure 
to close the defect in 11/20 (55%) animals, mainly in those with defects exceeding 2.9cm in 
diameter.  
6.3.4 Safety  
6.3.4.1 Intraoperative complications 
In animals where EFTR was successfully completed, the overall procedural complication 
rate was 22%, ranging from 0% to 67% (Table 6.2). These complications included both 
clinical problems and equipment related issues. Rajan et al.239 used 10 FTRD devices for 
eight procedures as failure to staple occurred in two animals due to the engagement of a 
safety ‘lock-out’ mechanism. Failed devices were replaced and procedures were completed 
successfully. Incomplete cutting of the tissue occurred in another animal leaving a narrow 
tag of tissue attached at the end of the resection line that was cut with electrosurgical snare. 
Rajan et al.239 also reported transient bleeding at the resection site in one animal, in keeping 
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with findings reported by Schurr et al.237 who observed small haematomas (range 2 – 20mm 
in diameter) close to the staple line in five acute animals treated with the FTRD.  
 
Figure 6.6 Schematic illustration of the FLEX technique as described originally  
  
  
  
  
A. Placement of endoluminal APC and serosal diathermy markings; B. Circumferential APC marks visible 
endoluminally delineate lateral clearance margin whereas serosal diathermy markings (A, B and C) indicate 
position of BBs; C & D. Laparoscopic placement of BBs including side-view of the colonic fold inverted into the 
lumen (clear resection line is visible between BBs and APC marks); E & F. Inversion site is over-sewn 
laparoscopically; G & H. Pseudopolyp is retracted and excised 
 
B
 
 A 
C 
A 
D 
F
 
 A 
G 
E 
H 
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Von Renteln et al.238 reported complications in 6/9 (67%) animals associated with the post-
resection closure method using the OTSC system. In one case, the anchor pins were placed 
through the colonic wall into the adjacent small bowel wall resulting in small bowel 
perforation. Defect closure using OTSCs resulted in luminal obstruction at the site of 
anastomosis in three animals. In addition, OTSC closure was associated with incorporation 
of a loop of small bowel into the clip, resulting in bowel obstruction in two animals. Fewer 
complications (2/8 animals) were observed in the pre-resection closure arm of this study 
including lumen obstruction following OTSC application (n = 1) and cutting of the endoloop 
during snare resection (n = 1). The resulting defect was successfully closed with application 
of an OTSC. The same research group subsequently described a modified method of pre-
resection closure in eight animals and concluded that this approach was more successful 
with complications occurring in only two animals242. The OTSC failed to deploy in one case 
leaving a large colonic defect. Although the defect was successfully closed with application 
of two clips this resulted in lumen obstruction and the animal was euthanized immediately. 
Incomplete closure was observed in one additional case that was rectified by the application 
of two clips, resulting in closure and a patent lumen. 
Schurr et al.237 described manipulating tissue into the FTRD using either suction or tissue 
graspers. Small bowel entrapment into the closure device occurred when suction was 
applied to aid tissue manipulation into the device. Similar findings were reported by another 
group investigating closure of colonic perforation using OTSC243. Accidental incorporation of 
adjacent organs was greatly reduced by the use of traction to manipulate colonic wall, rather 
than suction in both studies. 
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Table 6.2  Intraoperative outcome measures 
Study authors Study 
type 
Procedure 
method 
Procedure 
completed 
Intraoperative 
complications 
Procedure duration, min Median (range) size of 
the excised specimen, 
cm 
Schurr et al., 2001237 
A 
S 
S 
A 
Circular stapler 
Circular stapler 
Traction into the FTRD 
Suction (S) or traction (T) 
10/10 (100%) 
5/5 (100%) 
5/5 (100%) 
20/20 (100%) 
 
5/10 (50%) 
0/5 (0%) 
0/5 (0%) 
(S) 3/10 (30%) 
(T) 0/10 (0%) 
- 
- 
- 
- 
- 
- 
Over 3 
- 
Rajan et al., 2002239 S Traction into the FTRD 8/8 (100%) 4/8 (50%) Mean 30.2 Mean 3.6 (1.5 – 5.2) 
Raju et al., 2009240 
S 
 
Post-RCM using TAS 19/20 (95%) 0/19 (0%) 
Marking: median 3 (1 – 7) 
Resection: median 6 (2.5 – 35) 
Closure: median 41 (21 – 125) 
Overall: median 50 (24.5 – 167) 
Median 1.7 (1 – 2.5) 
Von Renteln et al., 2010238 
A 
 
 
A 
Post-RCM using OTSC 
 
 
Pre-RCM using endoloop 
9/20 (45%) 
 
 
8/8 (100%) 
6/9 (67%) 
 
 
2/8 (25%) 
Resection: mean 4 (2 – 10) 
Closure: mean 10.8 (5 – 26) 
Overall: mean 14.8 (7 – 36) 
 
Resection: mean 27.9 (19 –36) 
Closure: mean 3.6 (2 – 6) 
Overall: mean 31.5 (21 – 42) 
Mean 3.3 (2.4 – 5.5) 
 
 
Mean 1.8 (1.2 – 2.2) 
Rieder et al., 2010241 A Pre-RCM using OTSC 2/2 (100%) 0/2 (0%) Mean 33 +/- 4 Mean 2.2 (0.1) 
Von Renteln et al., 2011242 S Pre-RCM using OTSC 8/8 (88%) 2/8 (25%) Median 3 (2 – 12) 7.6cm2 (5.4 – 11cm2) 
Kennedy et al., 2011173 
A 
S 
Laparo-endoscopic 
Laparo-endoscopic 
3/3 (100%) 
4/4 (100%) 
0/3 (0%) 
0/4 (0%) 
- 
Median 233 (201 – 245) 
Median 2.5 (2 – 3) 
Median 3.5 (3.5 – 4) 
Total   101/113 (89%) 22/101 (22%)   
Abbreviations: A = acute study; S = survival study;FTRD = full thickness resection device; post-RCM = post-resection closure method; pre-RCM = pre-resection closure 
method; TAS = tissue apposition system; OTSC = Over-The-(endo)Scope Clip 
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6.3.4.2 Bursting pressures 
Five studies173, 237, 238, 240 reported examining anastomotic integrity (Table 6.3). Raju et al.240 
used methylene blue dye only to detect a leak in the acute study. Two studies reported 
bursting pressures following acute237, 238 and one after survival experiments173. Although 
Schurr et al.237 reported pressures of >38mmHg for FTRD stapled anastomosis, values 
presented by von Renteln et al.238 differed significantly between pre- and post-resection 
closure. The combination of an endoloop with the OTSC produced a higher mean pressure 
(Table 6.3). Kennedy et al.173 were the only group to report bursting pressures following a 
survival study with a median pressure of 245mmHg following a laparoscopic hand-sewn, 
partial-circumferential anastomosis. 
Table 6.3 Colonic anastomosis bursting pressure 
Study authors Study 
type 
Closure method Testing method Mean (SD) bursting 
pressure, mmHg 
Schurr et al., 2001237 A FTRD Not clear >38 
Raju et al., 2009240 S Post-RCM using TAS Blue dye - 
Von Renteln et al., 
2010238 
A 
 
A 
Post-RCM using OTSC 
 
Pre-RCM using endoloop 
Inflation using 
sphygmomanometer 
under immersion 
Inflation using 
sphygmomanometer 
under immersion 
29.2 (29.92) 
 
76.6 (31) 
Kennedy et al., 2011173 S Laparo-endoscopic 
Inflation using 
sphygmomanometer 
under immersion 
Median 245 
[240 – 260] 
Abbreviations: A = acute study; S = survival study; FTRD = full thickness resection device; pre-RCM = pre-
resection closure method; post-RCM = post-resection closure method; TAS = tissue apposition system, OTSC = 
Over-The-(endo)Scope Clip 
 
6.3.4.3 Duration of the procedure, size and quality of the excised specimen 
Data on procedure duration was recorded in six studies173, 238-242, however, significant 
heterogeneity in reporting was observed. Procedure duration ranged from 2 to 245 minutes 
with the mean or median ranging from 3 to 233 minutes (Table 6.2). Variation in the size of 
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the excised specimen was also observed with a mean or median diameter between 1.7cm 
and 3.6cm in diameter173, 237-242.  
Six studies173, 237, 239-242 reported placing mucosal markings (diathermy or India ink) to serve 
as a simulated lesion and the quality of the excised specimen was assessed in five 
studies173, 237, 239, 241, 242. Only two research groups173, 241 reported a well-defined clearance 
margin. Rieder et al.241 placed T-tags in each quadrant surrounding the lesion in order to 
draw the delineated area into the OTSC cap and four sutures were present in all resected 
specimens. During the FLEX procedure173 circumferential APC marks were placed 1cm 
away from the edge of the lesion with the excision line being between the APC marks and 
BBs visible endoluminally. Adequate clearance margin was achieved in all cases. 
Unfortunately, the authors were unable to maintain adequate endoscopic traction during 
resection. Consequently, the excision was tangential to the inverted bowel with the diameter 
of the excised mucosa being larger than that of the serosa. Similar findings were reported by 
Rajan et al.239 who used tissue manipulators to pull the delineated area of the colon into the 
head of the FTRD. Although diathermy markings representing a simulated lesions were 
evident in all specimens, the mucosal surface was wider [mean 3.8 (SD 0.9) cm] than the 
serosal surface [mean 2.41 (SD 0.6) cm]. Rajan et al.239 did not comment on adequacy of 
the lateral clearance margin. Schurr et al.237 and Von Renteln et al.242 reported that the 
diathermy markings used to simulate the lesion were visible in all resection specimens but 
again did not comment on the lateral clearance margin.  
6.3.4.4 Post-operative complications and post-mortem examination 
Post-operative complications were observed in 4/48 (8%) of the survival cases173, 239, 240 
(Table 6.4). Rajan et al.239 described two complications occurring in two animals (transient 
hind leg weakness post-procedure and an oedematous anal skin tag), both of which 
resolved spontaneously. Failure to thrive was observed by Raju et al.240 in 1/19 cases. 
Following the FLEX procedure173 re-suturing of a laparoscopic port site was required in one 
animal.  
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Post-mortem examination was performed by all research groups but abnormal findings were 
only observed by two239, 240. Rajan et al.239 reported ulceration at the stapled resection line in 
three out of four animals terminated at 14 days, but normal anastomoses in animals 
terminated at 28 days. They also noted adhesions between the resection margin and 
adjacent small bowel in one animal. Raju et al.240 were the only research group to describe 
post-resection closure method in survival experiments, reporting a high incidence of 
abnormal findings on post-mortem (84%).  
Table 6.4 Post-operative complications and post-mortem examination findings 
Study authors Survival Post-operative 
complications 
Abnormal findings on post-
mortem examination 
Schurr et al., 2001237 
5/5 (100%) 
5/5 (100%) 
0/5 (0%) 
0/5 (0%) 
0/5 (0%) 
0/5 (0%) 
Rajan et al., 2009239 8/8 (100%) 2/8 (25%) 4/8 (50%) 
Raju et al., 2009240 19/20 (95%) 1/19 (5%) 16/19 (84%) 
Von Renteln et al., 2011242 7/8 (88%) 0/7 (0%) 0/7 (0%) 
Kennedy et al., 2011173 4/4 (100%) 1/4 (25%) 0/4 (0%) 
Total  48/50 (96%) 4/48 (8%) 20/48 (42%) 
 
These included mild fibrinous peritoneal deposits (n = 1), local (n = 6) adhesions, small 
abscesses (<5mm) at the closure site (n = 2), away from the closure site (n = 3) as well as 
distant abscess (n = 1). A small anastomotic leak was demonstrated using methylene blue in 
one animal which failed to thrive during the recovery period. The authors also reported that 
two of the total 132 TAS used, were inserted into the adjacent viscera.  
6.4 Discussion 
This is the first systematic review that summarizes clinical outcomes following colonic EFTR 
as well as description of complete procedures published to date. Current experience is 
limited to pre-clinical studies only and although the concept appears to be feasible, further 
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advances in technology are necessary before this research can be translated into clinical 
practice. To date, EFTR has only been successfully performed in 89% of animal experiments 
presented in this review, with an overall survival rate of 96%.  
Although several EFTR procedures have been described, problems exist with every 
approach. Full thickness resection of the colonic wall was successfully performed using all 
techniques but secure closure appears to be a major obstacle. Post-resection closure with 
systematic application of TAS was reported to be effective in 95% of cases240. The post-
mortem findings in this study however suggest that the risk of peritoneal contamination with 
this method of colotomy closure is high. Many colonic polyps managed surgically carry a risk 
of containing a focus of malignancy183 and therefore during this procedure potentially 
malignant cells could seed into the peritoneal cavity. Pre-resection closure methods such as 
those described by Von Renteln et al.238, 242, Rider et al.241 and Kennedy et al.173 are clearly 
preferable as they minimise the risk of peritoneal contamination. Although several pre-
clinical and clinical studies evaluating effectiveness of Natural Orifice Transluminal 
Endoscopic Surgery have suggested that the risk of intra-abdominal sepsis following trans-
gastric or trans-vaginal approach is low244-247, in the context of EFTR for complex colonic 
polyps this should be avoided in the view of their malignant potential.  
It is difficult to consistently provide large colonic specimens with adequate lateral clearance 
margins using the grasp-and-snare techniques described to date. Additional risks with this 
approach include damage to the specimen with malignant potential and bowel perforation. 
The authors of the FLEX technique173 successfully addressed these issues by defining the 
resection line to be between the APC marks and BBs and performing the procedure with 
laparoscopic assistance. The resulting specimens had adequate mucosal clearance but due 
to tangential resection, a significantly smaller serosal surface area was observed. Similar 
findings were reported by Rieder et al.241 using the grasp-and-snare pre-resection closure 
method. This limitation may only be rectified by development of an endoscope with 
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additional, independent retracting arms and better endoluminal or extraluminal retraction as 
demonstrated by Kennedy at al173.  
The method of closure needs to be carefully considered. Anastomotic leakage is a major 
problem following colorectal surgery, increasing morbidity and occasionally resulting in 
death. Automatic stapling devices are the most frequently utilised technique of colorectal 
anastomosis and for this reason, the cutting and stapling device (FTRD) described by Schurr 
et al.237 and Rajan et al.239 was initially met with enthusiasm. The lack of further development 
of this device presumably reflects dissatisfaction with its performance. Two research 
groups238, 241, 242 have demonstrated that pre-resection compression closure with OTSCs 
although feasible, can lead to luminal obstruction and/or damage of surrounding 
structures237, 238, 240 following application of one or more clips. It is possible that the risk of 
luminal obstruction secondary to OTSC application would be lower when applied in human 
colon as the pigs used in these studies were relatively small (range 20 – 58kg). In addition, 
traction of the polyp rather than suction resulted in less collateral damage, although safety 
during closure could potentially be further enhanced with laparoscopic overview or 
assistance173, 241. More importantly however, the risk of anastomotic dehiscence following a 
partial circumferential anastomosis remains. Prior to translating this research into clinical 
studies, the safety of the chosen anastomotic closure technique should be formally tested 
using anastomotic bursting pressure analysis. At present, it is difficult to formulate a 
conclusion on anastomotic quality following OTSC compression closure based on the 
bursting pressures reported in a single acute study238. If compression closure devices are to 
be considered as an alternative to other closure methods, further survival studies are 
necessary to demonstrate their safety.  
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6.5 Conclusion 
Current experience with colonic EFTR is limited to porcine models only. Findings presented 
in this review suggest that the concept is feasible however none of the techniques described 
to date are suitable for translational studies. The review however does highlight several 
challenges that need to be addressed in future studies. Oncological principles must be 
followed and therefore minimal handling of the lesion and precision during resection are 
required in order to provide a full thickness specimen with adequate clearance margin. 
Luminal obstruction and peritoneal contamination with endoluminal content must also be 
avoided. A purely endoscopic full thickness resection technique is unlikely to be successful 
with the currently available technology, and development of a hybrid procedure with 
laparoscopic overview or assistance may minimise the risk of collateral damage. 
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Chapter 7 Ex vivo evaluation of the FLEX technique 
7.1 Introduction 
The original FLEX technique was successfully performed in three acute and four survival 
animals. Following interrogation of the literature published to date, it is evident that very few 
documented EFTR techniques follow oncological principles. Only the authors of the FLEX 
technique173 and Rieder et al.241 clearly defined a clearance margin before applying a pre-
resection closure method with laparoscopic overview. Although no major intra- or post-
operative complications were encountered, four main issues precluded its application in a 
clinical setting: 1) maintenance of the airtight seal was difficult despite using a prototype anal 
sealing device to maintain pneumocolon following insertion of two separate endoscopes; 2) 
the inability to maintain adequate traction by the retracting endoscope led to tangential 
excision of the specimen with the diameter of the excised mucosa being larger than that of 
the serosa; 3) the median size of the excised specimen was 2.5cm (range 2 to 3cm) and if 
the technique is to be applied in patients with large, complex colonic polyps, the ability to 
reliably deliver specimens exceeding 3cm in diameter is necessary; 4) lastly, the procedure 
itself was lengthy with a median duration of 233 minutes (range 201 to 245 minutes).  
In this chapter, experiments to address the aforementioned limitations of the FLEX technique 
are described. These aimed to increase the size of the excised specimen whilst avoiding 
tangential excision and reducing procedure time in an ex vivo setting.  
7.2 Detailed evaluation of the FLEX technique 
7.2.1 Introduction 
In vivo modifications of the originally described FLEX technique could not be justified. In 
order to avoid unnecessary sacrifice of animals, a major component of the experiments 
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presented in this chapter was development of an appropriate ex vivo model in which step-
wise improvements to the FLEX technique could be assessed.  
7.2.2 Materials and methods  
7.2.2.1 Modification of the anal sealing device 
The original anal sealing device was made using two pieces of corrugated anaesthetic 
tubing (length 60mm, internal diameter 20mm). The fingers of a surgical glove (size 8) were 
cut off and a 6mm skin biopsy cutter was used to make a hole at the fingertip. A glove finger 
was placed tightly over each end of the tube, stretching the hole to accommodate 
endoscopes exceeding 9.8mm in diameter. The tubes were joined using thread and secured 
with silicone (standard bathroom sealant) (Figure 7.1). Silicone ridges were created at each 
end so once inserted into the anus, the sphincters lay between the two ridges to increase the 
quality of the seal and to assist in retaining the position of the device.  
Figure 7.1 The original anal sealing device 
 
 
Although the endoscopes were easily inserted into the colon, movement in any direction 
other than back and forth led to air leakage through the glove finger holes, compromising 
insufflation.  
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To improve the seal and enable the use of endoscopes of different external diameters, two 
separate glove fingers (one inside the other) were loosely placed on the end of each tube to 
avoid stretching of holes, allowing gripping of the endoscopes at two different points at each 
end of the anal sealing device. In addition, different diameter holes (range 3 to 8mm) were 
made depending on the combination of endoscopes planned for experimental work. The 
device was assembled as described previously (Figure 7.2).  
Figure 7.2 Assembly of a modified double lumen anal sealing device 
 
A. Anaesthetic corrugated tubing; B. Two layers of pierced glove fingers placed over each end of the tube. The 
tubes are stabilised by thread; C. Configuration is further reinforced using silicone sealant used to make ridges at 
each end 
 
7.2.2.2 Specimen preparation  
Cadaver bowel specimens were collected from pigs euthanized during unrelated 
experiments. The distal colon up to the spiral segment (approximate length 50cm), anus, 
bladder and an area of perianal skin were excised en bloc. All specimens were washed and 
stored at -20ºC. Short segments of sheep bowel were harvested and stored in the same 
way, in case no porcine terminations were scheduled. Specimens were defrosted 12 hours 
prior to each experiment. The anal sealing device was inserted with a colonoscope in situ 
and a crushing bowel clamp was placed at the proximal end of the colon to allow colonic 
insufflation. Due to the shortage of the prototype BraceBarTM system, dyed 3.0 Vicryl suture 
(Ethicon, Endo-Surgery) was used instead, so that stitches could be identified endoluminally. 
A B C 
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A 6cm segment of the colon was measured longitudinally and transversely on the anti-
mesenteric border (Figure 7.3, A & B) and three pairs of stitches were placed (positions A, B 
and C as described in Chapter 6) to invert the segment (Figure 7.3, C). The inversion area 
on the serosal surface was over-sewn using undyed 3.0 Vicryl suture (Ethicon, Endo-
Surgery) as described previously (Figure 7.3, D).  
Figure 7.3 Inversion of the pseudopolyp in a cadaver bowel specimen 
 
A & B. Serosal diathermy marks (A, B and C) are used to guide placement of sutures; C. Inverting sutures visible 
on the serosal surface; D. Inversion area is over-sewn (arrows) 
 
7.2.2.3 Development of a purpose built jig 
The ex vivo set up evolved over several experiments. The jig designed for the first 
experiment was a two-part structure including a V-shaped glass gutter filled with water and a 
separate perspex plate (Figure 7.4). A hole, 7cm in diameter, was created in the perspex 
plate and a colostomy bag baseplate was placed over it. The hole in the silicone baseplate 
A 
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was expanded sufficiently to allow passage of the bowel into the jig and stabilise the anus 
with the anal sealing device in situ. The perspex plate was then secured to the jig using 
clamps and the colon was suspended in the water (Figure 7.4, C).To prevent the specimen 
from floating to the surface when insufflated, several interrupted loose stitches were placed 
on the mesentery starting 10cm away from the anal verge (Figure 7.4, A). A metal rod was 
inserted through the loops and placed at the bottom of the jig, suspending the bowel. A 
diathermy plate was placed over the perianal skin covered with gauze soaked with 0.9% 
sodium chloride (NaCl) to improve conduction.  
Although this jig was successfully used, the arrangement was simplified in following 
experiments. A shallow cardboard box lined with a plastic bag was used instead as it 
allowed horizontal placement of the colon (Figure 7.5). A window was cut in the anterior wall 
to allow placement of the perspex segment as described above. The floor and the anterior 
wall of the jig were reinforced using wide strips of cardboard and the perspex segment 
stabilised using clamps (Figure 7.5). Excess perianal skin and/or bladder (required for 
current conduction) were secured to a corkboard with pins and a diathermy plate applied 
over it as before. The bowel was sprayed with water or 0.9% NaCl throughout the 
experiment to prevent drying. 
  
121 
Figure 7.4 Specimen with anal sealing device in situ suspended in the water jig 
 
 
A. Bowel specimen with a metal rod passed through a series loose mesenteric stitches; B. The perspex plate 
secured to the anterior wall of the glass gutter with clamps. The anus is stabilised with application of a stoma 
silicone baseplate onto the perspex plate. C. Side view of the specimen sumberged under the water and held 
down with a metal rod 
Figure 7.5 Horizontal placement of the porcine colon in a cardboard jig  
  
A & B. Horizontal placement of the colon enables more than one procedure to be performed on the same 
specimen 
A B 
C 
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An additional jig was developed to establish the relationship of endoscopes during retraction 
and examine the efficacy of a single working endoscope with a fixed retracting endoscope 
(Section 7.2.2.4). The body of a plastic bottle (with the bottleneck cut off) was secured on a 
cutting board using tape with a pen placed on either side to stabilise it. A 1 to 4cm incision 
was made circumferentially in the bottle wall between the 10 and 2 o’clock positions to allow 
insertion of an artificial colonic fold created after transverse closure (using sutures) of a 6cm 
longitudinal segment of the bowel (Figure 7.6). Diathermy or a permanent marker pen was 
used to delineate mucosal markings simulating the APC marks described in the original 
paper. The diathermy pad was applied to the excess perianal skin as described above. 
Figure 7.6 Plastic jig developed to assess the working relationship between the 
cutting and retracting endoscope 
 
A & B. Colonic fold inserted into a transparent plastic bottle enabling visualisation of both endoscopes during 
resection  
 
7.2.2.4 Development of a single working endoscope with an fixed retracting 
arm 
The original set of experiments was performed using two independently operated 
endoscopes. We decided to compare the efficacy of this 2-scope approach with the concept 
of a single working endoscope incorporating a retracting endoscope. In order to achieve this 
several combinations of different endoscopes were evaluated. The GIF-Q20 (Olympus, 
Keymed) gastroscope that was used in our original study was damaged and therefore 
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unavailable. Instead, a single channel prototype GIF-2TQ-260M (working length 1030mm, 
channel size 3.2mm) (Olympus Keymed) and a PCF-240S (working length 950mm, channel 
size 3.2mm) (Olympus Keymed) were used as two choices of working endoscope. 
The XST-28CH-M (Olympus Keymed) is a prototype blind probe similar to an endoscope but 
devoid of endoscopic functions such as optics, insufflation, suction and light source248. It is a 
1000mm long flexible tube, with an external diameter of 6mm and a working channel of 
2.8mm. Its multi-bending tip is the main feature of this scope, allowing retroflexion of up to 
250º which may be useful in areas difficult to access. The tip has two bending sections, 
which are both steerable in up/down direction only. Left/right movement is obtained by 
applying rotational torque to the shaft of the scope. This scope was utilised as the retracting 
arm either attached to one of our chosen working endoscopes (‘single working endoscopic 
configuration with a retracting arm’) or separate to it, as described in the original study. 
Positioning of the retracting endoscope had to be performed under direct vision of the 
working endoscope.  
Figure 7.7 Single working endoscope configuration 
   
A. GIF-2TQ-260M & XST-28CH-M arrangement allowing movement of the XST-28CH-M in one direction only; B. 
PCF-240S & XST-28CH-M arrangement stabilised with plastic fasteners to allow independent (back and forth) 
movement of the XST-28CH-M but fixing it in relationship to the working endoscope 
 
For experiments aiming to assess the efficacy of a single working endoscope with a 
retracting endoscope configuration, the XST-28CH-M was aligned with the working 
A B 
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endoscope (PCF-240S or GIF-2TQ-260M) and secured with tape proximal to the first 
articulating joint of the XST-28CH-M. This was repeated at regular intervals for 
approximately 20cm to further stabilise the arrangement. This set up allowed movement of 
the tip of the retracting endoscope in one direction only (90º tip down), perpendicular to the 
cutting endoscope. This single working endoscope configuration was introduced into the 
bowel through a single channel anal sealing device. The combination and relationship of 
endoscopes utilised in these experiments is presented in Table 7.1.  
Table 7.1 Combination of endoscopes utilised in experimental work 
PCF-240S GIF-2TQ-260M XST-28CH-M Arrangement 
 W R Independent 
W R  Independent 
W  R Independent 
 W R Single endoscope 
W  R Single endoscope 
 
 
7.2.3 Results 
7.2.3.1 Optimisation of the ex vivo set up 
Although the glass jig was found to be ‘fit for purpose’, the cardboard jig was preferred as 
inadvertent bowel perforation during resection would cause water leakage into the colon. It 
also enabled us to perform more than one resection on the same specimen. In addition 
when suspended in the glass jig, due to the distance from the perspex plate, a 15 to 20cm 
segment of the bowel was left above the water and could not be utilised (Figure 18C). Since 
the length and diameter of the bowel harvested varied significantly with the weight of animals 
at termination, with the shortest segments being approximately 40cm long, this also became 
a limiting factor.  
Pneumocolon was easily maintained in all experiments using the modified anal sealing 
device which permitted movement of endoscopes in all planes without air leakage. At times 
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however, insertion of the device into the anus was difficult due to the diameter created by 
silicone ridges (>6cm). Freezing of the specimens adversely affected the quality of defrosted 
tissue and it was difficult to create a simulated lesion with submucosal injection of ink as 
described in the original study. On all occasions, a 4 to 6cm segment of the bowel was 
successfully inverted by placement of dyed sutures at positions A, B and C. Although the 
midline stitch (position C) was easily identified, endoluminal visualisation of the stitches 
placed at position A and/or B was more challenging. In addition, the absence of a simulated 
lesion made it difficult to maintain an accurate transverse resection line due to the lack of 
reference points. We attempted to address this in the bottle jig but preliminary testing 
showed that mucosal diathermy markings placed on a segment of sheep bowel quickly 
disappeared and marker pen used on mucosa of porcine bowel was wiped off during 
frequent repositioning of grasping forceps. Preliminary tests also showed that sheep bowel 
was too thin and friable to withstand traction during the resection process and therefore was 
not used in formal experiments. 
7.2.3.2 Ideal endoscopic combination 
The results of five different combinations of endoscopes are presented in Table 7.2. The 
most effective combination of 2 endoscopes used independently was the GIF-2TQ-260M for 
grasping and retraction and the PCF-240S as a working endoscope. Time taken to excise 
the specimen from first incision was 45min. Although GIF-2TQ-260M was rigid enough to 
apply good traction to the colonic fold, tangential excision could not be avoided. When 
traction was applied by the assisting endoscope, as well as being pulled perpendicular to the 
bowel wall, the fold was simultaneously pulled distally (towards the anus), away from the 
midline and forming an arc. This was easily visible on the screen and in an attempt to correct 
for the inadvertent traction towards the anus the retracting endoscope was pushed forward 
(away from the anus). It was extremely difficult to maintain adequate traction perpendicular 
to the bowel wall in isolation and during the excision both endoscopes and the colonic fold 
were pushed forward (away from the anus). This resulted in tangential excision with the   
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Table 7.2 Results 
PCF-240S GIF-2TQ-260M 
XST-28CH-
M Arrangement 
Procedures 
performed Jig 
Inversion area, 
cm 
Procedure time, 
min 
Size of the excised 
specimen, cm 
 W R Independent 1 Glass 6 82 5.1 
W R  Independent 2 Cardboard 4 
45 
- 
4.0 
procedure abandoned 
W  R Independent 1 Cardboard 4 - procedure abandoned 
 W R Single endoscope 2 
Cardboard 
Bottle 
6 
6 
72 
57 
2.8 
5.6 
W  R Single endoscope 1 Bottle 4 63 3.8 
W-working endoscope, R-retracting endoscope  
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serosal surface of the excised specimen being slightly smaller than that of the mucosa 
(3.8cm vs. 4.0cm) (Figure 7.8, C & D). We were unable to reproduce these results as the 
colonic lumen used in the subsequent experiment was too narrow to accommodate two 
endoscopes with an external diameter exceeding 9.8mm.  
When the XST-28CH-M was used for retraction alongside the GIF-2TQ-260M as the working 
endoscope, it was found to lack the rigidity necessary to apply effective traction to an 
inverted area of area 6cm. During this experiment, the inversion stitches placed at positions 
A and B were not visible endoluminally and contact between the diathermy plate and 
perianal skin was lost intermittently. When contact between the plate and the tissue was 
established, only the coagulation setting was found to be working, creating a lot of smoke 
during the excision and obscuring the view. As the XST-28CH-M allows movement in one 
direction only, combined with a lack of imaging capability and a tip position located distal to 
the tip of the working endoscope, controlling the direction of tip flexion and therefore 
retraction of the inverted bowel proved too difficult. This resulted in a poor quality specimen 
(Figure 7.8, A) and due to technical difficulties with orientation and retraction the subsequent 
experiment with the PCF-240S as a working endoscope was abandoned altogether.  
The internal diameter of the corrugated tubing used to make the anal sealing device did not 
permit evaluation of the GIF-2TQ-260M and PCF-240S as a single endoscopic configuration. 
Instead, both endoscopes were assessed as working endoscopes using XST-28CH-M as a 
fixed retracting endoscope. This arrangement was first assessed in the cardboard jig 
resulting in a 2.8cm specimen despite inverting a colonic fold of 6cm in diameter (Table 7.2). 
In this experiment the endoscopes were secured with tape placed at 2cm intervals. Although 
we hoped that fixation of the retracting endoscope would improve retraction of the inverted 
bowel perpendicular to the long axis of the bowel, the arrangement was very unstable with 
the tip of the retracting endoscope slipping around the working endoscope as the strips of 
the tape became wet. 
128 
Figure 7.8 Specimens achieved with independent combination of endoscopes 
 
   
A & B. Poor orientation and retraction in the experiment assessing the efficacy of the XST-28CH-M and GIF-
2TQ-260M as two independent endoscopes resulted in an irregular specimen with the edges burnt with the 
coagulation diathermy. Colonic lumen post resection was patent; C & D. Although the quality of the specimen is 
far superior with the GIF-2TQ-260M utilized as the independent retracting endoscope and the PCF-240S as a 
working endoscope, a 2mm discrepancy in the diameter of the mucosa and serosa is visible. In addition, mucosal 
surface is damaged by grasping forceps  
 
In order to examine the relationship between two endoscopes in a greater detail, the 
arrangement was assessed in the bottle jig. In subsequent experiments the tape was applied 
continuously along both endoscopes for approximately 40cm to further stabilise the 
arrangement. Although this made the handling of the two endoscopes somewhat easier, it 
became apparent that when traction was applied by the retracting endoscope, the movement 
still occurred in both vertical and horizontal planes (away from the midline), but to a lesser 
degree. As both endoscopes were fixed, we were unable to correct the horizontal movement 
of the colonic fold by forward movement of the retracting endoscope and a discrepancy 
A B 
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between the serosal and mucosal diameter was observed again. In addition, due to 
resistance encountered during tissue retraction, the retracting endoscope would push the 
working endoscope upwards, against the roof of the jig. This made it difficult to perform an 
accurate resection, resulting in an irregular specimen and on one occasion, perforation of 
the colonic segment (Figure 7.9, C).  
Figure 7.9 Excised specimens following utilisation of a single endoscope 
configuration 
  
  
A & B. Combination of GIF-2TQ-260M and XST-28CH-M as a single working endoscope configuration in a paper 
and a bottle jig respectively; C. Single working endoscopic configuration PCF-240S (working) and the XST-28CH-
M (retracting) in a bottle resulted in colonic perforation; D. Specimen and colonic defect following assessment of 
the PCF-240S and XST-28CH-M as two independent endoscopes 
 
In order to allow independent back and forth movement of the retracting endoscope and the 
ability to adjust for horizontal movement during retraction, the endoscopic arrangement was 
further modified. In the last experiment, loops made out of plastic fasteners were created 
and secured at 2cm intervals along the shaft of the PCF-240S (Figure 7.7). This stabilised 
the XST-28CH-M alongside the working endoscope while independent forward and 
A B 
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backward movement as well as torque were retained. This arrangement was more stable 
when compared to the same combination of endoscopes when not attached to each other. 
Upward movement of the working endoscope when retraction was applied however could 
not be avoided, resulting in a disruptive effect on the resection process. In addition, frequent 
repositioning of the grasping forceps caused mucosal injury.  
7.3 Discussion 
The experimental work presented in this chapter ultimately led to the development of an 
optimal ex vivo arrangement for the evaluation of colonic EFTR. Full thickness excision was 
successfully performed in all jigs presented in this chapter, with the cardboard jig being the 
most practical. Pneumocolon was successfully maintained with the modified anal sealing 
device that could be used for a single or double endoscope procedure. This set-up is cheap, 
easily reproducible and suitable for ex-vivo assessment and development of EFTR 
techniques for colon and potentially stomach. In addition, it could also be used as a training 
tool for advanced endoscopic techniques provided that freshly harvested specimens are 
available.  
The FLEX technique described in the original paper allowed inversion of a colonic fold with 
formation of a simulated lesion (polyp) with margins delineated by BBs and mucosal APC 
markings. For the procedure to be applicable in a clinical setting, the ability to consistently 
provide a high quality specimen is paramount. One of the key lessons in training for 
laparoscopic surgery is that counter-traction applied to the target tissue is a fundamental 
principle for accurate resection248. Several authors have described techniques to help lift the 
lesion away from the submucosa during the gastrointestinal ESD procedure utilizing clips249, 
magnetic anchor system250, O-rings251, spring devices252 or even using double-endoscope 
approach253, however many of them are time consuming with limited effectiveness and 
mostly applied for gastric lesions. Effective traction using a double endoscope approach was 
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difficult to achieve in the original study173 and discrepancy in the serosal and mucosal 
diameter was observed in the excised specimens.  
We attempted to improve retraction during resection using either an independent (as part of 
a two endoscope procedure) or a fixed retraction endoscope (attached in some form to a 
working endoscope) but with no success. The best quality specimen achieved in this series 
of experiments was excised using an independent combination of the GIF-2TQ-260M 
(retracting) and PCF-240S (working) endoscopes, similar to that described in the original 
paper. The prototype XST-28CH-M utilised either independently or as part of a single 
endoscopic configuration lacked the rigidity to apply effective traction, with disruptive effects 
on the working endoscope during cutting. Although attaching the XST-28CH-M to the 
working endoscope did enable more controlled traction, it was evident that independent 
movement of the retracting endoscope (forward and back) as part of a single endoscopic 
configuration is necessary to allow correction for traction in the horizontal plane. This was 
only feasible when we combined the PCF-240S and XST-28CH-M together using plastic 
fasteners however it was not possible to evaluate this set-up in vivo. The inability to correct 
the issues with retraction resulted in small, poor quality specimens. In addition, the time 
taken to excise the specimens was in excess of 60 minutes meaning that it was unlikely that 
the overall procedure time could be reduced significantly. 
7.4 Conclusion 
Combined experience from the original study and findings of experimental work presented in 
this chapter indicated that the inversion, two-endoscope technique was unlikely to progress 
to a clinical study/ Major technical developments in both the endoscopes and other 
equipment used is likely to be required. The technique could also be further developed if a 
stable endoscopic working platform was available in order to avoid tangential specimen 
excision.   
132 
Chapter 8 Eversion FLEX technique: proof of principle 
ex vivo experimental work  
8.1 Introduction 
The results of the experimental work outlined in Chapter 7 demonstrated that further 
development of the originally described inversion FLEX technique is limited by the 
equipment currently available. In this chapter, four sets of experiments are presented 
describing development of the eversion FLEX (eFLEX) technique in an ex vivo setting. The 
aim was to assess the feasibility of everting a fold of colonic segment into the peritoneal 
cavity using BBs, followed by laparoscopic excision of the specimen. In the original 
technique, mucosal APC markings and BBs clearly delineated the resection margin and 
therefore, for the eversion method to be effective, the surgeon must have the equivalent 
landmarks on the serosal surface. In addition, the resulting specimen and the excision site 
on the colon should be closed, at least temporarily, to avoid peritoneal contamination. This 
would allow a controlled extraction of the specimen and perhaps laparoscopic over-sewing 
of the temporary partial circumferential anastomosis.  
These experiments aimed to define procedural steps of the eFLEX technique whilst 
examining whether the quality of the excised specimen could be improved and procedure 
time reduced.  
8.2 Proof of principle experiment: eversion of the colonic fold 
8.2.1 Introduction 
The aim of this experiment was to create a simulated mucosal lesion with well-defined 
clearance margins on the serosal surface of the bowel, evert a colonic fold containing the 
simulated polyp and excise the specimen using bipolar diathermy.  
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8.2.2 Materials and methods  
The cardboard jig described in section 7.2.2.3 (Page 120) was replaced with a plastic box 
with a circular defect created in the anterior wall to accommodate the perspex piece with the 
specimen in situ. Defrosted porcine colon was placed in the jig as described before. A single 
lumen anal sealing device was inserted into the anus to maintain pneumocolon. The PCF-
240S was used as a working endoscope and a simulated 2cm polyp was created on the anti-
mesenteric side by submucosal injection of water. Although we initially planned to place 
diathermy marks on the serosa 1cm away from the edge of the lesion guided by the 
endoscopist, the diathermy machine was not available for this experiment. Instead, serosal 
circumferential marks (equivalent to the endoluminal APC marks described in the original 
technique)173 were placed on the serosal surface using a permanent marker pen (Figure 8.1, 
B). To ensure accurate placement, the endoscopist used biopsy forceps to apply pressure 
on the bowel wall indicating a 1cm margin around the simulated polyp. Three pairs of BBs 
were placed endoluminally and laparoscopic graspers were used to apply pressure over the 
distended colon, approximately 1cm away from the serosal marks, indicating A, B and C 
position for BBs (Figure 8.1, B). Once all three pairs of BBs were tightened (Figure 8.1, C), 
the everted colonic fold was retracted using laparoscopic graspers and the specimen 
excised with bipolar diathermy and cut using serosal markings and BBs for guidance. 
8.2.3 Results 
The colonic fold was successfully everted by endoscopic placement of BBs. Blue serosal 
markings and BBs were clearly visible on the serosa, demarcating the resection line (Figure 
8.1, C). Following excision, all three pairs of BBs remained within the resection line in the 
colon, as described in the original procedure, but neither the specimen nor the colotomy site 
were sealed temporarily. Mucosal and serosal diameter of the excised specimen was 3.5cm 
(Figure 8.1, E & F). 
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Figure 8.1 Procedural steps for proof of principle eversion experiment 
  
  
  
A. Colonic segment placed into a re-usable plastic jig equivalent to the cardboard jig; B. Serosal markings 
demarcating circumferential margin (marker pen marks) and laparoscopic grasper indicating position of BB; C & 
D. Endoluminal and serosal view following endoscopic deployment of BBs; E & F. Mucosal and serosal surface 
of the specimen, with serosal permanent pen markings delineating the clearance margin 
 
A B 
C D 
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8.2.4 Discussion 
This proof-of concept experiment demonstrated the feasibility of everting a colonic segment 
containing a simulated lesion by endoscopic placement of BBs. The serosal circumferential 
marks and BBs clearly defined the resection margin (Figure 8.1, D). Using laparoscopic 
graspers to apply adequate traction perpendicular to the bowel wall prevents tangential 
excision, improving the quality of the excised specimen as demonstrated by equal diameters 
of the mucosa and serosa. As expected however, standard bipolar diathermy did not provide 
even a temporary seal of the excised specimen or the excision site, an issue that needed to 
be addressed in further experiments. In addition, excess thread from BBs present 
endoluminally (Figure 8.1, C) interfered with placement of the subsequent BBs and therefore 
needed to be removed in the next experiment.  
8.3 Proof of principle experiment: stapled vs. Enseal® excision 
8.3.1 Introduction  
Anastomotic leakage is a major cause of morbidity and mortality following colorectal surgery. 
Stapling devices have been refined over the years and reproducibility of the results have 
made them most frequently utilised technique of colorectal anastomosis. The standard width 
of the currently available laparoscopic stapling devices however is 1cm and if applied in the 
eFLEX procedure, the distance between the serosal circumferential markings and BBs 
needed to be increased in order to avoid misfiring of the staples if BBs were accidentally 
included in the staple line.  
The ENSEAL® (Ethicon, Endo-Surgery) is a device designed for bipolar coagulation and 
transection of tissue during laparoscopic and open surgery254. It uses a patented 
temperature-controlled bipolar energy delivery system with a unique cutting mechanism 
known as the I-BLADETM that delivers high compression uniformly across the sealing area 
whilst minimising thermal spread to the surrounding tissues255. The device can be used to 
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cut and seal vessels up to 7mm diameter. Having tested the device on a freshly harvested 
segment of the bowel (Figure 8.2), we formed a hypothesis that this energy device could be 
used to provide a closed excision specimen and a temporary colonic anastomosis that could 
be subsequently over-sewn laparoscopically.  
Figure 8.2 Wedge excision using the ENSEAL® device 
  
A. Sealed colotomy site following wedge excision in a freshly harvested porcine cadaver bowel; B. 
Closed wedge excision specimen 
 
The aim of this experiment was to assess the effectiveness of two excision methods, stapled 
vs. ENSEAL® during the eFLEX procedure.  
8.3.2 Methods 
The experiment was performed on an animal (approximate weight 55kg) terminated 
following an unrelated experiment. Three hours after termination, the animal was placed in a 
supine position and three laparoscopic ports were inserted into the abdomen. Colonic lavage 
was performed using the CF-Q240ZL (Olympus, Keymed). After detailed planning, the 
procedure involved the following steps:  
1. Creation of two simulated 2cm sigmoid polyps at 30cm and 45cm from the anal 
verge, by submucosal injection of Spot® (GI Supply) 
A B 
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2. Laparoscopic placement of circumferential diathermy marks on the serosal surface 
1cm away from the edge of the polyp guided by the endoscopist by application of 
pressure at predetermined site endoluminally using biopsy forceps 
3. Placement of additional serosal diathermy marks 1cm away from circumferential 
markings to demarcate positions for BBs 
4. Endoscopic placement of BBs (A, B and C positions) with laparoscopic guidance and 
overview to ensure correct deployment 
5. Tightening of the BBs to evert the colonic segment into the abdominal cavity and 
cutting off the excess nylon thread using endoscopic scissors (Prototype Endoscopic 
Scissors, Ethicon Endosurgery) and removing it through the endoscopic channel 
using grasping forceps (Boston Scientific) 
6. Laparoscopic excision of the specimen with either laparoscopic stapler (ETS-45, 
Ethicon Endo-Surgery) or the Enseal® bipolar diathermy device (Ethicon, Endo-
Surgery), using BBs and serosal diathermy marks for guidance 
Following completion of both procedures, the abdominal cavity was filled with water and 
colon insufflated whilst observing resection sites for air bubbles. Duration of the procedure 
was defined from the placement of initial diathermy marks to specimen excision.  
8.3.3 Results 
Initial laparoscopic examination of the abdomen revealed distended loops of colon and 
despite increasing the intra-abdominal pressure, the laparoscopic view was limited. Animals 
undergoing terminal anaesthesia are not starved prior to the procedure and therefore the 
gastrointestinal tract contained large amounts of semi-solid fermenting material. In addition, 
the procedure was commenced three hours after termination. Midline laparotomy was 
performed in order to mobilise the distended loops of spiral colon and procedural steps 
described above were performed on the exposed sigmoid colon (Figure 8.3). Due to 
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progressive distension and thinning of the colonic wall, only one simulated polyp was 
created by submucosal injection of Spot®. Instead, a permanent pen was used to simulate 
the second polyp.  
A satisfactory eversion fold (4cm maximum diameter) along with a full thickness local 
excision of the simulated polyp was achieved during both procedures. Some difficulties were 
encountered during application of BBs in both experiments, including failure to deploy 
requiring withdrawal of the endoscope from the colon, and partial deployment. With partial 
deployment the plunger that forces the BB out of the needle slid past it, releasing only one of 
the two metal BBs. The BB was released with extraluminal assistance by using forceps to 
pull the nylon thread. Although the resection line between serosal diathermy marks and BBs 
was visible, the distance of >1cm was not uniform throughout, therefore, some of the 
diathermy marks were included in the staple line potentially compromising the predetermined 
clearance margin.  
Stapling excision required three reloads with the overall procedure time of 42 minutes. 
Procedure duration with the Enseal® device was slightly shorter at 37 minutes and the 
resulting specimens had maximum diameters of 3.7cm and 1.8cm respectively (Figure 8.3, 
G). Macroscopic examination of sigmoid colon revealed closure of both anastomoses with 
BBs in situ and colonoscopy revealed patent colonic lumen. Following immersion of the 
bowel and colonic insufflation, the Enseal® resection line failed almost immediately whereas 
the staple line held as expected (Figure 8.3, E & F).  
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Figure 8.3 Procedural steps Enseal® vs. stapled excision 
  
   
  
  
A & B. Sigmoid colon with a simulated lesion exposed; C & D. Endoluminal and serosal view following eversion 
of the colonic fold; E & F. Stapled and Enseal® excision sites with BBs in situ (respectively); G & H. Excised 
specimens stapled vs. Enseal® excision and endoluminal view of the stapled anastomosis 
A B 
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E F 
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8.3.4 Discussion  
Although conversion to open procedure occurred during the early stages of the experiment 
due to poor visualisation secondary to bowel distension, it was possible to draw several 
conclusions. Our hypothesis that the Enseal® device would create a temporary partial 
circumferential anastomosis and allow laparoscopic over-sewing was rejected, as the 
resulting anastomosis was too weak to withstand even minimal manipulation of the colon, 
thereby exposing the abdominal cavity to colonic content. In addition, the thermal nature of 
the device caused contraction of the specimen, which was significantly smaller than that 
produced by stapling resection (1.8cm vs. 3.7cm). This would have an adverse effect on the 
quality of the excised specimen and the subsequent histological assessment. The quality of 
the specimen following stapling excision was far superior although some of the 
circumferential marks were included in the staple line indicating that if the same procedural 
steps were to be followed, the distance between BBs and circumferential marks needs to be 
increased further to ensure adequate clearance margins. Although we anticipated that the 
linear nature of a laparoscopic stapling device was likely to cause extensive narrowing of the 
colonic lumen; endoscopic findings suggested otherwise (Figure 8.3, H). All BB systems 
utilised in this experiment were pre-loaded a week prior to the procedure. Nylon thread has a 
great deal of memory when deformed for a prolonged period of time and this is likely to have 
contributed to the problems during BB deployment. The results of this experiment however 
suggested that this modified single endoscope eFLEX procedure utilising laparoscopic 
stapling excision of the specimen is a feasible and quicker alternative to the original 
inversion technique.  
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8.4 Modification of the stapled eFLEX technique 
8.4.1 Introduction 
Our previous in vivo experiment performed on a terminated animal demonstrated the 
feasibility of linear stapling for excision of the everted bowel segment in a timely manner. To 
simplify the steps of the procedure and possibly reduce the inflammatory reaction by 
decreasing the amount of the foreign material remaining at the anastomotic site, two 
separate ex-vivo experiments were performed in which the BBs were removed with the 
excised specimens. The aim of these experiments was to simplify and standardise operative 
steps of the eFLEX procedure and establish the feasibility of using BBs to delineate polyp 
clearance margins.  
8.4.2 Methods 
The previously described experimental jig containing a defrosted specimen was placed into 
a neoprene cylinder to simulate a laparoscopic training box (Figure 8.4, A). Three 
laparoscopic ports were inserted into the simulated abdominal wall and the insufflated colon 
was visualised inside the box. Two simulated polyps, approximately 2cm in diameter, were 
created as described previously and the operative steps included the following:  
1. Placement of endoluminal circumferential diathermy marks 1cm away from the edge 
of the simulated polyp 
2. Endoscopic placement of BBs at A, B and C positions just lateral to circumferential 
markings with laparoscopic overview 
3. Tightening of the BBs everting the colonic segment into the laparoscopic box and 
cutting off the excess nylon thread  
4. Laparoscopic excision of the specimen using a linear laparoscopic stapler below BBs 
visible on the serosal surface so that they are included in the excised specimen 
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The duration of the procedure was defined from placement of initial diathermy marks to 
complete excision of the specimen. The resulting anastomoses were assessed at the end of 
each experiment by colonic insufflation under water.  
8.4.3 Results 
The first two procedures were performed with only three members of the team. Despite a 
seemingly good contact between the diathermy plate and perianal skin, diathermy was not 
effective. This is likely to be due to the defrosted nature of the specimen. We were therefore 
unable to place circumferential endoluminal marks (Step 1). Instead, a permanent pen was 
used to place serosal circumferential clearance marks with endoscopic assistance. The 
colon was very mobile in the laparoscopic box and due to the lack of manpower to provide 
the necessary counter traction on either side of the specimen BB placement was inaccurate. 
As a result, the everted colonic fold was tangential to the bowel axis. Only four stapling 
reloads were available for this experiment, and therefore due to limited resources, the 
decision was made to abandon the procedure for the first polyp.  
Prior to creating the second polyp, several drawing board pins were used to stabilise the 
specimen by placing them through the remnants of the colonic mesentery and fixing it to the 
floor of the box. The second polyp was created on the anti-mesenteric border 30cm from the 
anal verge, with permanent marker pen markings delineating the serosal clearance margin. 
The same procedural steps were followed as described above. On this occasion, handling of 
the bowel was more controlled due to the anchor point and therefore placement of the BBs 
was more accurate. Although the resection line was still to some extent tangential, a 4cm 
specimen containing three pairs of BBs was successfully excised with three stapler firings 
(Figure 8.4, E).  
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Figure 8.4 Modification of the stapled eFLEX procedure  
   
   
   
A, B & C. Colonic segment with simulated lesions placed in a hand-made laparoscopic training box; D. Stapled 
anastomoses; E & F. Closed excised specimens  
 
A week later, two additional procedures were performed with five members of the team 
ensuring that both the surgeon and the endoscopist had an assistant. The specimen was 
stabilised again by placement of drawing pins through the remaining mesentery. The same 
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issue with the diathermy was encountered and serosal circumferential clearance markings 
were placed with a permanent pen. Thereafter, both procedures were performed 
satisfactorily without further deviation from the protocol. A full thickness local excision of the 
colonic wall was performed with each specimen containing three pairs of BBs. Procedure 
duration and size of the excised specimens are presented in Table 8.1. 
Table 8.1 Procedural details 
 Procedure duration, min 
(range) 
Size of the excised specimen, 
cm 
Procedure 1 abandoned* - 
Procedure 2 62 4 
Procedure 3 49 5 
Procedure 4 34 6 
Median (range) 48.3 (34 – 62) 5 (4 – 6) 
(*) Eversion occurred tangential to the colonic wall axis and due to limited availability of staple reloads, the 
procedure was abandoned 
 
8.4.4 Discussion 
This simplified protocol provided an effective way for excising full thickness colonic 
specimens with a median diameter of 5cm (range 4cm - 6cm) using a single endoscope. 
Procedure duration decreased significantly with each successive experiment with the 
median procedure time of 48.3 minutes (range 34 – 64 minutes). The efficacy and safety of 
the stapling devices are well documented and this pre-resection closure method would 
minimise the risk of peritoneal contamination. BBs defining the lateral clearance margins 
were easily visible on the serosa during laparoscopic retraction of the colonic fold and their 
inclusion in the excision specimen is likely to reduce the risk of micro-abscess formation at 
the anastomotic site. In addition, the resulting specimen was sealed, further minimising the 
risk of peritoneal contamination.  
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8.5 Conclusion 
This simplified, single endoscope eversion FLEX procedure can be performed in a timely 
manner. The procedure in the jig described required a team of at least five members but the 
results of these experiments suggest that this modified technique could be tested in vivo.   
 
  
146 
Chapter 9 eFLEX technique: a survival porcine study 
9.1 Introduction 
The results of experiments presented in the previous chapter summarise the development of 
a single-endoscope eFLEX technique. In this chapter, we describe a survival porcine study 
designed to assess safety and efficacy of the eFLEX procedure in a pre-clinical setting.  
The aim of this set of in vivo experiments was to perform a full thickness, R0 resection of 
colon defined as a specimen that contained three pairs of BBs delineating the clearance 
margin with a secure, partial circumferential colonic anastomosis. Secondary outcomes were 
duration of the procedure, related intra- and post-operative complications and histological 
assessment of the anastomotic line.  
9.2 Methods 
9.2.1 Animals and pre-operative preparation 
Procedural steps were standardised in a series of experiments described in Chapter 8. The 
study was approved by the Northwick Park Institute for Medical Research ethics review 
process. All procedures were performed on Large White Landrace-Crossbreed pigs in 
compliance with the UK Home Office regulations (license number PPL 80/2297) and in line 
with the ARRIVE guidelines256. The median weight of animals included in this study was 
70kg with the aim to simulate the dimensions of human colon. In order to demonstrate the 
safety of the procedure, an acute study involving one animal was performed first. Following 
this, further four pigs underwent surgery and were terminated eight days later.  
All animals were habituated for a week prior to the procedure as per departmental policy. 
Four days prior to the procedure oral intake of grower nuts was reduced to half and two days 
prior to surgery, standard feed was replaced with liquid diet (Complan®). Pens were lined 
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with rubber mats instead of straw during this period. Animals were fasted overnight before 
surgery but water was allowed ad libitum throughout. Pre-anaesthesia was administered 
using ketamine and xylazine. General anaesthesia was induced and maintained using 
isoflurane with oxygen and nitrous oxide delivered via endotracheal tube. A saline drip was 
established via an ear vein and skin preparation was performed using alcoholic 
chlorhexidine. 
9.2.2 Equipment  
Standard laparoscopic instruments were used including atraumatic laparoscopic graspers, 
conventional suture holders and camera (Olympus Keymed). Colonic lavage was performed 
using a CF-Q240ZL colonoscope whereas PCF-240S was used as a working endoscope. 
The prototype endoscopic BraceBarTM system was used for endoscopic eversion of the 
colonic fold containing a simulated mucosal lesion as described previously. The colonic fold 
was excised using a laparoscopic linear stapler. Additional accessories included injection 
needle, Gelofusine® solution (B. Braun Medical, Ltd.), Spot®, APC, prototype endoscopic 
scissors and endoscopic biopsy forceps. The equipment used in this study was kindly 
provided by Olympus Keymed and Ethicon Endo-Surgery.  
9.2.3 Operative technique 
The anaesthetised animal was placed in the supine position and four laparoscopic ports 
were inserted into the abdomen. A soft bowel clamp was placed laparoscopically at 
approximately 45cm from the anal verge to prevent proximal inflation. Distal colon was 
inspected and colonic lavage using warm water performed when necessary. A simulated 
sigmoid polyp of approximately 3cm diameter was created endoscopically by submucosal 
injection of a mixture of Spot® and Gelofusine®. All polyps were created on the anti-
mesenteric border at between 25cm and 35cm from the anal verge. Procedural steps are 
illustrated and presented in Figure 9.1 and Figure 9.2. As described previously, 
circumferential APC marks were placed endoscopically 1cm away from the edge of the 
lesion. In order to maintain orientation of the endoscopic view, additional mucosal marks 
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were placed as the experiments progressed. Three and two APC marks were placed outside 
the existing circumferential to define the proximal and distal edge of the polyp respectively 
(position C), and single marks were also placed at positions A and B (Figure 9.1). Using the 
APC marks for orientation, three pairs of BBs were placed endoscopically at positions A, B 
and C, at predetermined sites. All BBs were deployed under direct laparoscopic vision to 
prevent damage to the surrounding structures. After tightening the thread and approximating 
the BBs, excess monofilament thread was cut and removed using biopsy forceps. An 
atraumatic laparoscopic grasper was used to retract the everted colonic fold and manipulate 
it into the laparoscopic stapler ensuring that the stapler was placed below the three pairs of 
BBs visible on the serosal surface. The excised specimen was removed through a 
laparoscopic port incision with the BBs in situ. The abdominal cavity was inspected to ensure 
haemostasis prior to closure of laparoscopic port sites using 2.0 Vicryl suture (Ethicon, 
Endo-Surgery). 
9.2.4 Post-operative care and assessment 
The animal used in the acute study was euthanised under general anaesthesia immediately 
after the procedure. The subsequent four animals were recovered successfully following 
administration of appropriate analgesia and a single dose of Cefuroxime. Regular feeding 
was recommenced immediately after the procedure and animals were euthanised after eight 
days. 
All animals were terminated under general anaesthesia and a post-mortem examination was 
performed in every case. Midline laparotomy allowed full inspection of the peritoneal cavity 
for procedure related complications and close examination of the sigmoid colon. Endoscopic 
examination was performed in two animals under terminal anaesthesia in order to assess 
the colonic lumen. Bursting pressures of stapled anastomoses are well documented in the 
literature and although the eFLEX technique results in partial circumferential anastomosis, 
additional bursting pressure analysis was deemed unnecessary257, 258. 
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Figure 9.2 In-vivo eFLEX procedure 
  
   
A. Position of laparoscopic ports; B. Endoluminal view of the simulated polyp (yellow line) with BB tighteners 
visible in A and B positions (3 and 9 o’clock); C. Approximation of BBs placed in position C; D. Endoluminal view 
post-resection  
 
9.2.4.1 Tissue preparation 
A 10cm segment of the sigmoid colon including the anastomotic line was excised from the 
four surviving animals and macroscopic examination of the serosal and mucosal surfaces 
performed. To prevent tissue drying and desiccation, all specimens was rinsed, placed on a 
corkboard and immersed in 10% neutral buffered formal saline (10% NBF) (Genta Medical) 
for a minimum of 48 hours for fixation. Following fixation, sections of the bowel 
approximately 1cm wide were taken perpendicular to the anastomotic line (one in the 
midline, and one or two on either side of the midline). Staples were carefully removed and 
tissue samples were placed into labelled processing cassettes. These were processed in the 
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Tissue Tek-VIP processor to allow dehydration and clearing of tissue samples, which were 
then embedded in paraffin using the Tissue-Tek III embedding centre.  
9.2.4.2 Slide preparation and staining  
Sectioning of the blocks was performed using a Shandon microtome producing sections of 
5µmthickness. Sections were mounted onto labelled slides which were then placed on a 
hotplate at 60ºC overnight. The sections were immersed in two consecutive xylene baths for 
5min to remove the wax. For haematoxylin and eosin (H&E) staining all slides were de-
waxed in xylene (Genta Medical), rehydrated in descending grades (100%, 95% and 70%) of 
Industrial Methylated Spirit (IMS) (Genta Medical) and washed in tap water. Slides were then 
placed in Gill’s III Haematoxylin (Leica Microsystems, UK Ltd.) for 90 seconds, washed in 
tap water, differentiated in acid alcohol (1% hydrochloric acid in 70% IMS) and washed again 
in tap water before being placed in 0.5% aqueous eosin (Pioneer Research Chemicals) for 5 
minutes. After staining was complete, the sections were again washed in tap water and 
dehydrated in ascending grades of industrial methylated spirits (IMS) (70%, 95%, and 100%) 
and finally cleared by treating with xylene before being cover-slipped. Cells were 
differentially stained; nuclei appearing a dark purple/blue, the cytoplasm-stained pink, 
muscle fibres and elastic fibres stained deep pink and collagen stained light pink.  
For staining with the Picro Sirius Red (BDH) in combination with the Miller’s elastic stain 
(Leica Microsystems, UK Ltd.), de-waxed and rehydrated slides were placed in 0.5% acid 
potassium permanganate (Sigma). After rinsing in de-ionised water, the slides were placed 
in 1% oxalic acid (Sigma). They were rinsed again in de-ionised water followed by 95% IMS 
before being placed in Miller’s stain for 1 hour. After this, the slides were rinsed in 95% IMS 
followed by tap water and placed in Weigert’s haematoxylin (Pioneer Research Chemicals) 
for 10 minutes. After this, the slides were rinsed in tap water, differentiated in acid alcohol 
and rinsed again before being placed in Picro Sirius Red solution 45min. Once the staining 
process was complete, the sections were again washed in de-ionised water and dehydrated 
by treating with serial alcohol washes (ascending grades) and finally cleared in xylene before 
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application of a cover slip. When assessed in the white light microscopy the collagen is red 
on a pale yellow background with black/brown nuclei. When examined in polarised light 
however, the large, mature collagen fibres are bright yellow/orange with thin, new collagen 
fibres being green.  
9.3 Results 
9.3.1 eFLEX procedures and survival  
Full thickness resection of colonic lesions was successfully performed in all cases. The 
median time taken to perform the eFLEX elements of the procedure, defined from placement 
of mucosal APC marks to excision of the specimen was only 26 minutes (range 20 - 31 
minutes) (Table 9.1). All five specimens included APC markings and BBs, which was 
considered the equivalent of full thickness R0 resection. The median diameter of the 
specimen was 5.1cm (range 4.5 - 6.3cm) (Figure 9.3).  
Technical difficulties encountered during the procedure were mostly related to the 
equipment. On four occasions the second metal tag of the BB pair was jammed in the 
needle and failed to deploy. This was rectified with laparoscopic assistance and BBs were 
successfully released. In one case, the deployed BB remained in a vertical position in line 
with the needle and was pulled back into the colon through the puncture site. Unfortunately, 
the BBs are too wide to be withdrawn through the endoscopic channel and the pair was 
released from the needle into the colonic lumen. New BraceBarTM system was used and 
original BBs withdrawn with the endoscope at the end of the procedure.  
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Figure 9.3 eFLEX specimens 
  
  
A & B. Tangential excision of the specimen in Animal 3 resulting in additional 2cm of tissue excised; C & D. 
Open and closed specimen Animal 4 
 
Mucosal APC marks placed at position B were not clearly visible in one animal and the BBs 
were deployed at approximately the 7 o’clock position instead of 9 o’clock, further away from 
the edge of the polyp than anticipated. The everted fold was rotated anti-clockwise resulting 
in tangential excision of the specimen. An additional 2cm of healthy tissue was included in 
the specimen (Figure 9.3, A & B) and the resection line extended to the mesentery where it 
bled. The bleeding point was easily controlled by placement of laparoscopic sutures. Minimal 
bleeding at the staple line was also observed in one additional animal, requiring laparoscopic 
over-sewing. Anastomotic line was inspected endoscopically following resection and patent 
lumen was visualised in all animals (Figure 9.4).  
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The survival period was uneventful. All animals tolerated normal diet immediately after the 
procedure and thrived during the post-operative period. Median time to first bowel movement 
was 3 days (range 2 – 4 days) with the median weight of animals at termination of 66kg.  
Table 9.1 Procedural duration 
Table 1  Animal 1, 
(min) 
Animal 2, 
(min) 
Animal 3, 
(min) 
Animal 4, 
(min) 
Animal 5, 
(min) 
Median, 
(min) 
Laparoscopy and bowel 
lavage 41 29 27 30 26 29 
Polyp creation 8 6 7 4 2 6 
APC marking 3 4 3 6 3 3 
BB pair 1   7* 6 5 4 4 5 
BB pair 2 6   8*   5* 3 5 5 
BB pair 3   7*¥ 4 5 3 3 4 
Polyp excision 8 9 6 10 5 8 
Skin closure N/A 15 17  30≠  14≠ 16 
Total procedural steps time 80 81 75 90 62 80 
eFLEX time 31 31 24 26 20 26 
(*) Second BB jammed in the needle 
(¥) BB retracted into the colon through the puncture site 
(≠) Resection line extended to the mesentery resulting in mesenteric bleeding  
 
9.3.2 Post-mortem examination and histological examination 
Endoscopic examination of the resection site at 8 days revealed no evidence of luminal 
obstruction with fully healed mucosa (Figure 9.4). In one animal, the anastomosis was only 
identified endoscopically following laparotomy and placing pressure on distended colon from 
the outside. Examination of peritoneal cavity at laparotomy was normal in all animals with no 
evidence of local or distant abscesses. Small serosal haematomas were observed in two 
animals proximal to the anastomosis at the position of the bowel clamp (Figure 9.4, E). 
Macroscopic examination revealed healed anastomotic line on both serosal and mucosal 
surface (Figure 9.4, E & F).   
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Figure 9.4 Post-mortem examination  
  
  
   
A & B. Endoscopic evaluation of the anastomoses in Animals 4 and 5; C & D. Serosal examination of 
anastomoses Animal 2 (tangential excision) and Animal 4; E & F. Serosal and mucosal view of the anastomosis 
Animal 4 
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Figure 9.5 Histological examination of anastomosis, Animal 2 
  
  
  
A. H&E stain of representative strip taken perpendicularly across the anastomosis demonstrating regeneration 
and continuity of both subumosa and serosa. White arrows indicate tissue loss during specimen preparation and 
black arrows indicate tissue defects created by staples; B & C. Non-polarized and polarized view following Picro-
Sirius red staining demonstrate maturing and new collagen formation across the anastomosis; D & E. H&E and 
Picro-Sirius staining of the serosa demonstrate normal inflammatory cells and collagen; F. New collagen 
formation at the subserosa and serosa  
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Figure 9.6 Histological examination of anastomosis, Animal 4 
  
  
  
A. H&E stain of the healed anastomotic site. Black arrows indicate tissue loss following removal of staples. Good 
repair and continuation of the mucosa (with formation of neomucosa)a and submucosa as well as serosa is 
evident; B & C. Non-polarized and polarized view following Picro-Sirius red staining demonstrate maturing and 
new collagen formation across the anastomosis; D & E. H&E and Picro-Sirius staining of the mucosal surface 
and submucosa demonstrate normal inflammatory cells and collagen; F. New collagen formation in the 
submucosal layer  
 
Histological assessment showed good abuttal of neomucosa and serosa. Regeneration and 
restoration of continuity of the submucosal layer was clearly visible with good apposition of 
muscularis mucosae containing inflammatory cells as expected (Figure 9.5 and Figure 9.6). 
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Picro-sirius red staining showed that collagen was continuous beneath the neomucosa, with 
neo-collagen formation at the junction of submucosa and muscularis mucosae. This confirms 
complete and maturing closure at the full thickness resection site without micro-abscess 
formation.  
9.4 Discussion  
The results of this survival porcine study demonstrate the feasibility and safety of localised 
full thickness resection of colonic lesions in adherence with the established oncological 
principles. With application of a modified, single-endoscope eFLEX technique, we 
successfully achieved R0 excision of colonic specimens with the largest median diameter 
reported to date in a pre-clinical study. The overall duration of the procedure was 
significantly reduced when compared to the original technique (median 80 vs. 233 minutes 
respectively), with the duration of the procedure performed later in the series being reduced 
with experience. More importantly, the median time taken to delineate circumferential 
margins of the lesion, evert the colonic fold and excise the specimen resulting in a stapled, 
partial circumferential anastomosis was 26 minutes (range 20 – 31 minutes). 
At a median diameter of 5.1cm, the size of the specimen resected is larger than previously 
achieved by hybrid or EFTR techniques. In addition, all specimens contained three pairs of 
BBs defining the circumferential margin. The literature suggests that an inadequate resection 
margin (<2 mm) is a poor prognostic factor and an indicator of increased risk of local 
recurrence and/or nodal disease26 and therefore to ensure completeness of resection, all 
BBs were placed 1cm away from the edge of the polyp (in excess of the required 2mm 
reported in the literature). This approach allows the excision to be sufficiently accurate to 
ensure the precise removal of target lesions.  
This modified, single endoscope eFLEX technique is likely to overcome the issues reported 
in the literature describing ‘rendezvous’ laparo-endoscopic techniques in human as well as 
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those encountered in preclinical studies evaluating effectiveness of colonic EFTR. As 
discussed previously, clinical application of the laparo-endoscopic procedures is limited with 
experience restricted to few centres. All endoscopically or laparoscopically assisted full 
thickness resection techniques evaluated in pre-clinical model for colonic lesions presented 
in Chapter 6 have limitations regarding safety, reproducibility and secure wall closure. The 
eFLEX procedure is an accurate excisional technique that removes only a portion of 
circumference of the bowel and should impair blood supply less than conventional 
colectomy, potentially reducing the risk of anastomotic leakage and ileus leading to a faster 
recovery. Pre-resection closure of the colonic wall results in a stapled anastomosis, with a 
well-documented safety profile and a closed specimen which prevents spillage of 
endoluminal contents or potentially malignant cells into peritoneal cavity. Laparoscopic 
overview and assistance minimises the risk of inadvertent damage of the surrounding organs 
during application of BBs.  
This proof-of-concept survival study has several limitations. Further animal work is unlikely to 
progress the technique as porcine models are limited by their differences from human 
anatomy, particularly with regard to the vasculature and retroperitoneal portions of human 
colon. Presence of spiral colon limits the evaluation of the technique in this pre-clinical model 
to the long sigmoid colon only, although we anticipate that application of this single-
endoscope technique for right sided colonic lesions should not be technically challenging. 
Colonic mobilisation would be required for lesions located at flexures or retroperitoneum in 
order to optimise endoluminal exposure of the lesion as described by Franklin et al.143 and 
Wilhelm et al.144. This, however, is difficult to assess in a straight segment of the porcine 
sigmoid colon. In addition, the porcine mesentery is very short and all procedures presented 
in this chapter were performed for lesions located on the anti-mesenteric side. Therefore 
there will be issues to overcome regarding the mesentery and marginal vessels potentially 
impeding the procedure in humans and eFLEX procedure may not be appropriate for such 
lesions. Utilisation of pre-operative imaging such as CT colonography to ascertain location of 
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the lesion in relation to the mesentery and retroperitoneum would facilitate pre-operative 
planning and avoid unnecessary conversion to laparoscopic hemicolectomy.   
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Chapter 10 Conclusion 
10.1 Summary 
Over thousand patients undergo hemicolectomy with en bloc mesenteric excision for the 
treatment of complex benign colonic polyps in England each year. Such patients are at risk 
of major morbidity, mortality and long-term functional problems associated with this 
procedure. This thesis presents evidence regarding short-term morbidity and long-term 
functional problems after colectomy for benign polyps. It also details the development of a 
precisely targeted full thickness excision technique suitable for translational work in the 
human.  
10.2 Short-term outcomes following hemicolectomy for treatment 
of benign colonic polyps: local and national data 
The study presented in Chapter 3 describes outcome data following surgery for benign 
colonic polyps, comparing results to those after equivalent resection for colonic cancer. Both 
hospitals included in this study were tertiary referral centres for endoscopy with expertise 
available in complex EMR and ESD procedures. Data from this study suggest that the size 
of the lesion is the commonest indication for surgery in this patient cohort, followed by 
difficult endoscopic access and suspicious morphological/histological features. Over 60% of 
patients underwent right hemicolectomy, confirming that right sided lesions represent a 
challenge even for experienced endoscopists. Although the majority of the patients 
underwent laparoscopic surgery within an enhanced recovery programme, post-operative 
complications, re-operation and re-admission rates were similar to the cancer group. The 
results of this study suggest that benign diagnosis does not reduce the risk of post-operative 
morbidity.  
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The sample size in this study, however, was small and it may affect the generalizability of 
our conclusions. In order to find more meaningful differences between the two cohorts and 
establish the true risk of morbidity, we conducted a second study analyzing national data 
from the HES database. Data for all elective colorectal resections performed between 2000 
and 2007 were available, enabling us to evaluate post-operative outcomes of 8 659 patients 
who underwent colorectal resection for the treatment of benign colorectal polyps and 111 
047 for CRC. The results of this study confirmed that over 60% of colonic resections were 
performed for right sided polyps and no difference in re-admission rates was observed 
between benign and malignant groups. Post-operative morbidity was lower in the benign 
cohort, most probably because patients undergoing surgery for colonic polyps are younger, 
with less co-morbidity, when compared to the cancer cohort. Multiple regression analysis 
demonstrated that male sex, advanced age, high comorbidity and social deprivation were all 
independently associated with an increase in 30-day mortality. The histological diagnosis of 
the lesion had no effect on mortality.  
In conclusion, both studies analysing outcomes after colectomy for benign colonic polyps 
show that the morbidity is similar to that following resection for colonic cancer. This provides 
impetus to development of new treatments that will improve outcomes by reducing post-
operative morbidity.  
10.3 Functional outcomes and QOL following hemicolectomy  
The results of the study presented in Chapter 5 suggest that although patients seem to have 
a total MSKCC score that is comparable to healthy controls as early as six months after 
surgery, certain elements of bowel function remain altered several years after 
hemicolectomy. At 12 months follow-up patients reported having difficulty with gas-stool 
discrimination and at two to four years, difficulty controlling the passage of wind. In addition, 
patients reported a significantly higher number of bowel movements when compared to 
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healthy controls, but with no adverse effect on their QOL. At six and 12 month follow-up 
however, patients with low total MSKCC score, symptoms of urgency and those reporting 
incomplete bowel emptying had worse QOL. Similarly, those recruited for assessment of the 
‘intermediate’ bowel function reported worse QOL if they were unable to differentiate 
between wind and solid stool or completely empty their bowels.  
Although the MSKCC questionnaire has only been validated in patients undergoing rectal 
surgery, the results of this study suggest that hemicolectomy for the treatment of invasive or 
non-invasive neoplasia may have an adverse effect on patients’ bowel function even few 
years after surgery. Although these findings are yet to be confirmed in a larger, prospective 
study, bowel dysfunction following hemicolectomy could potentially be avoided if targeted, 
localised excision could be offered as an alternative definitive treatment.  
10.4 Development of a localised full thickness colonic excision 
technique  
Chapter 6 is the first systematic review published to date that summarises the outcomes 
following colonic EFTR techniques, with the current experience being limited to pre-clinical 
models only. The results suggest that pre-resection closure is preferable as it is associated 
with fewer intra- and post-operative complications. It minimises the risk of peritoneal 
contamination with endoluminal content and potentially malignant cells. In addition, traction 
of the colonic wall rather than suction seems likely to result in less collateral damage and 
laparoscopic overview or assistance improves the safety of the procedure.  
The review also highlights the importance of safety and reliability of the anastomotic closure 
method. Colotomy closure using endoscopically placed Tissue Apposition System was time 
consuming and post-mortem findings from the survival study suggested that the risk of 
peritoneal contamination was high. It is difficult to formulate any conclusions regarding 
anastomotic quality following pre-resection Over-The-(endo)Scope-Clip (OTSC) 
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compression closure. In fact, bursting pressures analysis following a survival study has only 
been reported by one research group and further studies are necessary to demonstrate their 
safety.  
Ex vivo experimental work designed to assess limitations of the originally described FLEX 
technique resulted in the development of a cheap, practical jig and a modified anal sealing 
device that maintained a pneumocolon for all procedures. Despite utilising several 
endoscopic combinations, we were unable to maintain effective traction on the inverted 
colonic fold during resection. As a result, the quality and diameter of the excised specimens 
were inconsistent. Although the inversion FLEX procedure could potentially be applied for 
lesions located in any part of the colonic circumference, further advances in technology such 
as the development of a stable endoscopic platform during retraction, and an endoscopic 
cutting and sealing device to shorten the procedure time, are necessary.  
Anastomotic leakage following colorectal surgery is a major cause of morbidity and, at times, 
mortality. Stapling devices have been refined over the years and the speed of application 
and reproducibility of the results has made them the most frequently utilised technique for 
colorectal anastomosis259. The results of the systematic review presented in Chapter 6 and 
experimental work in Chapter 7 have led to the development of the single-endoscope 
eversion FLEX (eFLEX) technique. This simplified procedural protocol provided an effective 
way of excising a full thickness colonic specimens in excess of 5cm in diameter in an ex vivo 
model. We were able to perform the procedure in less than 30 minutes resulting in a stapled, 
partial circumferential anastomosis, and a closed specimen. Safety and efficacy of the 
eFLEX procedure was subsequently demonstrated in a survival animal model with no intra- 
or post-operative complications. The study suggested that colonic eFLEX can be performed 
in such way that oncological principles are respected for lesions located on the anti-
mesenteric side throughout the colon.  
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Chapter 11 Future work 
11.1 Full-thickness laparo-endoscopic excision for benign colonic 
polyps in human 
Pre-clinical bench and survival animal studies presented in this thesis have demonstrated 
the likely feasibility and safety of the eFLEX procedure for colonic lesions located on the 
anti-mesenteric border. Data analysis from two teaching hospitals presented in Chapter 3 
suggests that approximately 50% of patients referred for hemicolectomy have polyps <5cm 
in diameter and as such are potentially suitable for the eFLEX procedure. A study protocol is 
currently in development to translate the eFLEX technique into clinical practice in a 
representative sample of patients with complex benign colonic polyps. A protocol for a 
descriptive cohort study is currently under development in line with the IDEAL (Idea, 
Development, Exploration, Assessment, Long-term follow-up) guidelines260. Specific 
objectives of the study are likely to include the completion of the eFLEX procedure 
(completeness of excision and the proportion in whom it is suitable), conversion rates to 
hemicolectomy with lymphadenectomy, and details of post-operative morbidity and mortality. 
The study will also enable standardization of the technique, as due to the differences 
between porcine and human anatomy certain elements of the procedure could not be 
assessed in a pre-clinical study. There will be issues to overcome regarding the mesentery 
and marginal vessels potentially impeding the procedure in a proportion of these patients 
when lesions lie on the mesenteric border. Retroperitoneal location of the lesion is likely to 
require colonic mobilization to allow access and pre-operative utilisation of computed 
tomography may clarify polyp location in relation to the mesentery and retroperitoneum, 
facilitating surgical planning.  
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11.2 Feasibility and diagnostic yield of EUS as an assessment tool 
of early colonic neoplasia 
Studies reporting outcomes of surgically treated colonic polyps thought to be benign pre-
operatively show that the incidence of unexpected invasive malignancy can be as high as 
20%183, 261, suggesting that such lesions should be treated with caution. Provided that the 
safety and efficacy of the eFLEX procedure is demonstrated in the aforementioned clinical 
study, this novel technique could potentially be offered as a definitive treatment for a 
proportion of this patient cohort. Careful preoperative selection of patients least likely to have 
a malignant polyp may be appropriate.  
EUS is used routinely in the preoperative staging of neoplasms of upper gastrointestinal and 
rectal neoplasms. In contrast, it has not gained widespread use for the staging of colonic 
lesions because, until recently, such accurate preoperative local staging information had no 
relevant therapeutic consequences. However, with advances in endoscopic techniques, 
growing interest in minimally invasive surgery and the success of screening programmes, 
accurate staging of colonic lesions has become more relevant. Several authors have 
reported some experience with endoscopic radial scanning probes of differing frequencies in 
early stage colonic tumours54, 262. Technical difficulties encountered include limited depth of 
tissue penetration, unsatisfactory water immersion coupling for lesions located at flexures 
and, more importantly, operator experience. Application of a curved linear array endoscope 
for assessment of the right sided lesions has been recently reported as safe and feasible263. 
This novel front-view 14.2 mm endoscope (125-cm insertion length) with a 3.7-mm working 
channel provides a forward-arrayed EUS images which may overcome some of the issues 
encountered using mini-probes and thus improve the pre-operative selection process of 
patients potentially suitable for eFLEX procedure.  
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11.3 A study to assess NIR laparoscopy with ICG for intra-
operative SLN mapping in early colon cancer 
Application of the eFLEX procedure for the treatment of localised colonic carcinoma is an 
attractive clinical possibility. T1 malignant lesions that are less than 3.5cm in diameter have 
been shown by Cahill and colleagues 150 to be associated with positive lymph nodes in only 
5% of cases. In patients confirmed to have a T1 tumour on colonic EUS, those at high risk of 
postoperative morbidity, or those who elect to pursue a potentially safer postoperative 
course, eFLEX may be a preferable treatment option, even if oncological clearance 
equivalent to conventional resection cannot be guaranteed. Alternatively, the combination of 
eFLEX with laparoscopic SLN biopsy using NIR immunofluorescence identification is a 
possible solution for determining which patients require hemicolectomy to clear the nodal 
basin. A post hoc analysis of the two largest SLN biopsy databases150 reported a sensitivity 
of 89% and a negative predictive value of 97% when SLN mapping was performed by 
experienced surgeons patients with selected T1 and T2 lesions. In the cohort of 186 
patients, the authors reported a false positive rate in 7.5% (12) of patients whereas under-
staging would have occurred in only three patients (false negative rate 1.6%).  
The ability to identify accurately the exact lymphatic drainage pattern of the primary tumor in 
real time and to ascertain lymph node involvement before definitive resection could allow 
decisions regarding a tailored operative approach to be made intra-operatively. While 
previous attempts have been made to use SLN mapping in colon cancer, these studies and 
their accuracy have often been compromised by the inclusion of advanced stage cancers155. 
The appropriate Medicines Health Regulatory Agency and National Research Ethics Service 
(12/LO/1406) approvals are currently in place to conduct a pilot trial of NIR ICG laparoscopy 
for SLN mapping in patients with colonic cancer at St. Mark’s Hospital. The primary objective 
of the trial is to establish whether it is possible to identify the first order draining mesocolic 
lymph nodes (SLNs) in patients with suspected T1 and T2 colonic cancer, using ICG and a 
laparoscopic NIR system. In addition, the extent to which the tumour-bearing status of 
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SLN(s) corresponds with lymph node status of the entire basin will be assessed using 
standard pathological examination (H&E) of excised nodes with additional 
immunohistochemistry of negative SLN(s).  
11.4 Conclusion 
Much remains to be done before a full thickness, localised excision technique can be offered 
as an alternative to hemicolectomy to patients with complex, benign colonic polyps. Studies 
presented in this thesis demonstrate high post-operative morbidity, mortality and prolonged 
in-hospital stay associated with the current treatment and emphasise the need to improve 
the way that these patients are managed. In the meantime, these patients might benefit from 
a referral to tertiary centres offering advanced endoluminal therapies in order to minimise the 
risk of complications.  
  
169 
Chapter 12 References 
1. Cancer Research UK;  Bowel Cancer Incidence Statistics, 2010. 
http://www.cancerresearchuk.org/cancer-info/cancerstats/types/bowel/incidence/uk-bowel-
cancer-incidence-statistics (Last accessed November 2012). 
2. Cunningham D, Atkin W, Lenz H-J, et al. Colorectal cancer. The Lancet 2010;375:1030-1047. 
3. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic Alterations during Colorectal-Tumor 
Development. New England Journal of Medicine 1988;319:525-532. 
4. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal 
tumorigenesis. Nature 1992;359:235-7. 
5. Scott N, Bell SM, Sagar P, et al. p53 expression and K-ras mutation in colorectal adenomas. 
Gut 1993;34:621-4. 
6. Kikuchi-Yanoshita R, Konishi M, Ito S, et al. Genetic changes of both p53 alleles associated 
with the conversion from colorectal adenoma to early carcinoma in familial adenomatous 
polyposis and non-familial adenomatous polyposis patients. Cancer Research 1992;52:3965-
71. 
7. Noffsinger AE. Serrated polyps and colorectal cancer: new pathway to malignancy. Annual 
Review of Pathology 2009;4:343-64. 
8. A companion to specialist surgical practice: Colorectal Surgery. S. K. Clark Inherited bowel 
cancer. 4th Edition 2009, Saunders Elsevier: Saunders Elsevier 
9. Iino H, Simms L, Young J, et al. DNA microsatellite instability and mismatch repair protein 
loss in adenomas presenting in hereditary non-polyposis colorectal cancer. Gut 2000;47:37-
42. 
10. Cunningham JM, Christensen ER, Tester DJ, et al. Hypermethylation of the hMLH1 promoter 
in colon cancer with microsatellite instability. Cancer Research 1998;58:3455-60. 
11. Jass JR, Whitehall VL, Young J, et al. Emerging concepts in colorectal neoplasia. 
Gastroenterology 2002;123:862-76. 
12. Foss FA, West KP, McGregor AH. Pathology of polyps detected in the bowel cancer 
screening programme. Diagnostic Histopathology 2011;17:495-504. 
13. Bettington M, Walker N, Clouston A, et al. The serrated pathway to colorectal carcinoma: 
current concepts and challenges. Histopathology 2013;62:367-86. 
14. Makinen MJ, George SM, Jernvall P, et al. Colorectal carcinoma associated with serrated 
adenoma--prevalence, histological features, and prognosis. Journal of Pathology 
2001;193:286-94. 
15. Makinen MJ. Colorectal serrated adenocarcinoma. Histopathology 2007;50:131-50. 
16. Winawer S, Zauber A, Ho M, et al. Prevention of colorectal cancer by colonoscopic 
polypectomy. The National Polyp Study Workgroup. New England Journal of Medicine 
1993;329:1977 - 1981. 
17. Koenig M, Schofield JB. The pathology of colorectal polyps and cancers. Surgery (Medicine 
Publishing) 2011;29:11-14. 
18. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 
1975;36:2251-70. 
19. Hassan C, Pickhardt PJ, Kim DH, et al. Systematic review: distribution of advanced neoplasia 
according to polyp size at screening colonoscopy. Aliment Pharmacology & Therapeutics 
2010;31:210-7. 
20. Lieberman D, Moravec M, Holub J, et al. Polyp size and advanced histology in patients 
undergoing colonoscopy screening: implications for CT colonography. Gastroenterology 
2008;135:1100-5. 
21. Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and 
recommendations from an expert panel. American Journal of Gastroenterology 
2012;107:1315-29. 
170 
22. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal 
epithelial neoplasia. Gut 2000;47:251-255. 
23. Haggitt RC, Glotzbach RE, Soffer EE, et al. Prognostic factors in colorectal carcinomas 
arising in adenomas: implications for lesions removed by endoscopic polypectomy. 
Gastroenterology 1985;89:328-36. 
24. Kikuchi R, Takano M, Takagi K, et al. Management of early invasive colorectal cancer. 
Diseases of the Colon & Rectum 1995;38:1286-1295. 
25. Nascimbeni R, Burgart L, Nivatvongs S, et al. Risk of lymph node metastasis in T1 carcinoma 
of the colon and rectum. Diseases of the Colon & Rectum 2002;45:200 - 206. 
26. Hassan C, Zullo A, Risio M, et al. Histologic risk factors and clinical outcome in colorectal 
malignant polyp: A pooled-data analysis. Diseases of the Colon & Rectum 2005;48:1588-
1596. 
27. Wang C, Zhou ZG, Yu YY, et al. Patterns of lateral pelvic lymph node metastases and 
micrometastases for patients with lower rectal cancer. European Journal of Surgical Oncology 
2007;33:463-467. 
28. McMahon CJ, Rofsky NM, Pedrosa I. Lymphatic metastases from pelvic tumors: anatomic 
classification, characterization, and staging. Radiology 2010;254:31-46. 
29. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 
years: increased local control but no survival benefit in irradiated patients with resectable 
rectal carcinoma. Annals of Surgery 2007;246:693-701. 
30. Quirke P, Williams GT, Ectors N, et al. The future of the TNM staging system in colorectal 
cancer: time for a debate? Lancet Oncol 2007;8:651-7. 
31. Sobbin LH, Wittekind C. UICC TNM Classification od malignant tumours (5th edition). New 
York: Wiley-Liss, 1997. 
32. The Royal College of Pathologists. Colorectal cancer. http://www.rcpath.org/publications-
media/publications/datasets/colorectal-cancer.htm (Last accessed March 2012). 
33. The Royal College of Pathologists. Standards and datasets for reporting cancers. Dataset for 
colorectal cancer (2nd eddition), 2007. 
http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/G/G049-
ColorectalDataset-Sep07.pdf (Last accessed March 2012). 
34. Cancer Research UK; Bowel Cancer Survival Statistics 2010, 
http://www.cancerresearchuk.org/cancer-info/cancerstats/types/bowel/survival/bowel-cancer-
survival-statistics#one)  (Last accessed November 2012). 
35. Sant M, Capocaccia R, Coleman MP, et al. Cancer survival increases in Europe, but 
international differences remain wide. European Journal of Cancer 2001;37:1659-1667. 
36. Kudo SE, Tamura S, Nakajima T, et al. Diagnosis of colorectal tumorous lesions by 
magnifying endoscopy. Gastrointestinal Endoscopy 1996;44:8-14. 
37. Fu KI, Sano Y, Kato S, et al. Chromoendoscopy using indigo carmine dye spraying with 
magnifying observation is the most reliable method for differential diagnosis between non-
neoplastic and neoplastic colorectal lesions: A prospective study. Endoscopy 
2004;36:1089,1093. 
38. Kiesslich R, von Bergh M, Hahn M, et al. Chromoendoscopy with indigocarmine improves the 
detection of adenomatous and nonadenomatous lesions in the colon. Endoscopy 
2001;33:1001,1006. 
39. Huang Q, Fukami N, Kashida H, et al. Interobserver and intra-observer consistency in the 
endoscopic assessment of colonic pit patterns. Gastrointestinal Endoscopy 2004;60:520-526. 
40. Togashi K, Konishi F, Ishizuka T, et al. Efficacy of magnifying endoscopy in the differential 
diagnosis of neoplastic and non-neoplastic polyps of the large bowel. Diseases of the Colon & 
Rectum 1999;42:1602-1608. 
41. van den Broek FJC, Reitsma JB, Curvers WL, et al. Systematic review of narrow-band 
imaging for the detection and differentiation of neoplastic and nonneoplastic lesions in the 
colon (with videos). Gastrointestinal Endoscopy 2009;69:124-135. 
42. Thompson W, Halvorsen R, Foster W, et al. Preoperative and postoperative CT staging of 
rectosigmoid carcinoma. American Journal of Roentgenology 1986;146:703-710. 
171 
43. Thoeni RF. Colorectal cancer - Radiologic staging. Radiologic Clinics of North America 
1997;35:457-&. 
44. Freeny PC, Marks WM, Ryan JA, et al. Colorectal carcinoma evaluation with CT - 
preoperative staging and detection of postoperative recurrence Radiology 1986;158:347-353. 
45. Dighe S, Purkayastha S, Swift I, et al. Diagnostic precision of CT in local staging of colon 
cancers: a meta-analysis. Clinical Radiology 2010;65:708-719. 
46. Ravizza D, Tamayo D, Fiori G, et al. Linear array ultrasonography to stage rectal neoplasias 
suitable for local treatment. Digestive and Liver Disease 2011;43:636-641. 
47. Puli S, Bechtold M, Reddy J, et al. How good is endoscopic ultrasound in differentiating 
various T stages of rectal cancer? Meta-analysis and systematic review. Annals of Surgical 
Oncology 2009;16:254-265. 
48. Siddiqui A, Fayiga Y, Huerta S. The role of endoscopic ultrasound in the evaluation of rectal 
cancer. International Seminars in Surgical Oncology 2006;3:36. 
49. Bipat S, Glas AS, Slors FJM, et al. Rectal cancer: Local staging and assessment of lymph 
node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Radiology 
2004;232:773-783. 
50. Akahoshi K, Yoshinaga S, Soejima A, et al. Transit endoscopic ultrasound of colorectal 
cancer using a 12 MHz catheter probe. British Journal of Radiology 2001;74:1017-1022. 
51. Tseng LJ, Jao Y, Mo LR. Preoperative staging of colorectal cancer with a balloon-sheathed 
miniprobe. Endoscopy 2002;34:564-568. 
52. Matsumoto T, Hizawa K, Esaki M, et al. Comparison of EUS and magnifying colonoscopy for 
assessment of small colorectal cancers. Gastrointestinal Endoscopy 2002;56:354-360. 
53. Stergiou N, Haji-Kermani N, Schneider C, et al. Staging of colonic neoplasms by colonoscopic 
miniprobe ultrasonography. International Journal of Colorectal Disease 2003;18:445-449. 
54. Hünerbein M, Handke T, Ulmer C, et al. Impact of miniprobe ultrasonography on planning of 
minimally invasive surgery for gastric and colonic tumors. Surgical Endoscopy 2004;18:601-
605. 
55. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to 
inadequate surgical resection. Histopathological study of lateral tumour spread and surgical 
excision. The Lancet 1986;2:996-9. 
56. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in 
predicting curative resection of rectal cancer: prospective observational study. British Medical 
Journal 2006;333:779. 
57. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to 
pelvic recurrence? British Journal of Surgery 1982;69:613-6. 
58. Martling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of 
rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, 
Basingstoke Bowel Cancer Research Project. The Lancet 2000;356:93-6. 
59. Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus 
laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): 
multicentre, randomised controlled trial. The Lancet 2005;365:1718-1726. 
60. Braga M, Frasson M, Vignali A, et al. Laparoscopic resection in rectal cancer patients: 
outcome and cost-benefit analysis. Diseases of the Colon & Rectum 2007;50:464-71. 
61. Lujan J, Valero G, Hernandez Q, et al. Randomized clinical trial comparing laparoscopic and 
open surgery in patients with rectal cancer. British Journal of Surgery 2009;96:982-989. 
62. Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal 
cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an 
open-label randomised controlled trial. Lancet Oncology 2010;11:637-45. 
63. Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of laparoscopic-assisted resection of 
colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. Journal of Clinical 
Oncology 2007;25:3061-8. 
64. Jayne DG, Thorpe HC, Copeland J, et al. Five-year follow-up of the Medical Research 
Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. 
British Journal of Surgery 2010;97:1638-45. 
172 
65. Huang MJ, Liang JL, Wang H, et al. Laparoscopic-assisted versus open surgery for rectal 
cancer: a meta-analysis of randomized controlled trials on oncologic adequacy of resection 
and long-term oncologic outcomes. International Journal of Colorectal Disease 2011;26:415-
21. 
66. COLOR II: Laparoscopic Versus Open Rectal Cancer Removal, 2006. 
http://www.clinicaltrials.gov/ct2/show/NCT00297791 (Last accessed December 2012). 
67. Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, 
Stage IIIA, or Stage IIIB Rectal Cancer, 2008. http://clinicaltrials.gov/show/NCT00726622 
(Last accessed December 2012)  
68. Jayne DG, Brown JM, Thorpe H, et al. Bladder and sexual function following resection for 
rectal cancer in a randomized clinical trial of laparoscopic versus open technique. British 
Journal of Cancer 2005;92:1124-32. 
69. Parks AG, Stuart AE. The management of villous tumours of the large bowel. Br J Surg 
1973;60:688-95. 
70. You YN, Baxter NN, Stewart A, et al. Is the increasing rate of local excision for stage I rectal 
cancer in the United States justified? A nationwide cohort study from the National Cancer 
Database. Annals of Surgery 2007;245:726-33. 
71. Mellgren A, Sirivongs P, Rothenberger DA, et al. Is local excision adequate therapy for early 
rectal cancer? Diseases of the Colon & Rectum 2000;43:1064-71; discussion 1071-4. 
72. Nascimbeni R, Nivatvongs S, Larson DR, et al. Long-term survival after local excision for T1 
carcinoma of the rectum. Diseases of the Colon & Rectum 2004;47:1773-9. 
73. Ptok H, Marusch F, Meyer F, et al. Oncological outcome of local vs radical resection of low-
risk pT1 rectal cancer. Archives of Surgery 2007;142:649-55; discussion 656. 
74. Middleton P, Sutherland L, Maddern G. Transanal endoscopic microsurgery: a systematic 
review. Diseases of the Colon & Rectum 2005;48:270 - 284. 
75. van den Broek F, de Graaf E, Dijkgraaf M, et al. Transanal endoscopic microsurgery versus 
endoscopic mucosal resection for large rectal adenomas (TREND-study). BMC Surgery 
2009;9:4. 
76. Kunitake H, Abbas MA. Transanal endoscopic microsurgery for rectal tumors: a review. The 
Permanente Journal 2012;16:45-50. 
77. Bach SP, Hill J, Monson JR, et al. A predictive model for local recurrence after transanal 
endoscopic microsurgery for rectal cancer. British Journal of Surgery 2009;96:280-90. 
78. De Graaf EJR, Doornebosch PG, Tollenaar RAEM, et al. Transanal endoscopic microsurgery 
versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. 
European Journal of Surgical Oncology 2009;35:1280-1285. 
79. Lezoche E, Baldarelli M, Lezoche G, et al. Randomized clinical trial of endoluminal 
locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after 
neoadjuvant therapy. British Journal of Surgery 2012;99:1211-8. 
80. Tytherleigh MG, Warren BF, Mortensen NJ. Management of early rectal cancer. British 
Journal of Surgery 2008;95:409-23. 
81. Lee W, Lee D, Choi S, et al. Transanal endoscopic microsurgery and radical surgery for T1 
and T2 rectal cancer. Surgical Endoscopy 2003;17:1283-7. 
82. Winde G, Nottberg H, Keller R, et al. Surgical cure for early rectal carcinomas (T1). Transanal 
endoscopic microsurgery vs. anterior resection. Diseases of the Colon & Rectum 1996;39:969 
- 976. 
83. Stipa F, Giaccaglia V, Burza A. Management and outcome of local recurrence following 
transanal endoscopic microsurgery for rectal cancer. Diseases of the Colon & Rectum 
2012;55:262-9. 
84. Bretagnol F, Merrie A, George B, et al. Local excision of rectal tumours by transanal 
endoscopic microsurgery. Br J Surg 2007;94:627 - 633. 
85. Rasheed S, Bowley DM, Aziz O, et al. Can depth of tumour invasion predict lymph node 
positivity in patients undergoing resection for early rectal cancer? A comparative study 
between T1 and T2 cancers. Colorectal Disease 2008;10:231-237. 
86. Reza MM, Blasco JA, Andradas E, et al. Systematic review of laparoscopic versus open 
surgery for colorectal cancer. British Journal of Surgery 2006;93:921-8. 
173 
87. Lacy AM, García-Valdecasas JC, Delgado S, et al. Laparoscopy-assisted colectomy versus 
open colectomy for treatment of non-metastatic colon cancer: a randomised trial. The Lancet 
2002;359:2224-2229. 
88. The Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically 
assisted and open colectomy for colon cancer. New England Journal of Medicine 
2004;350:2050-9. 
89. Green BL, Marshall HC, Collinson F, et al. Long-term follow-up of the Medical Research 
Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal 
cancer. British Journal of Surgery 2013;100:75-82. 
90. Basse L, Hjort Jakobsen D, Billesbolle P, et al. A clinical pathway to accelerate recovery after 
colonic resection. Annals of Surgery 2000;232:51-7. 
91. Wilmore DW, Kehlet H. Management of patients in fast track surgery. British Medical Journal 
2001;322:473-6. 
92. Basse L, Jakobsen DH, Bardram L, et al. Functional recovery after open versus laparoscopic 
colonic resection: a randomized, blinded study. Annals of Surgery 2005;241:416-23. 
93. King PM, Blazeby JM, Ewings P, et al. Randomized clinical trial comparing laparoscopic and 
open surgery for colorectal cancer within an enhanced recovery programme. Br J Surg 
2006;93:300-8. 
94. Vlug MS, Wind J, Hollmann MW, et al. Laparoscopy in combination with fast track multimodal 
management is the best perioperative strategy in patients undergoing colonic surgery. Annals 
of Surgery 2011;254:868-875. 
95. NHS National Institute for Health and Clinical Excellence; Laparoscopic surgery for the 
treatment of colorectal cancer, 2006. http://www.nice.org.uk/ta105 (Last accessed November 
2012). 
96. Coleman MG, Hanna GB, Kennedy R. The National Training Programme for Laparoscopic 
Colorectal Surgery in England: a new training paradigm. Colorectal Disease 2011;13:614-6. 
97. National Training Programme in Laparoscopic Surgery (LAPCO), 2006. 
http://www.lapco.nhs.uk (Last accessed November 2012). 
98. Hompes R, Cunningham C. Colorectal cancer: management. Medicine 2011;39:254-258. 
99. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective 
postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG 
C016): a multicentre, randomised trial. The Lancet 2009;373:811-820. 
100. Cedermark B, Johansson H, Rutqvist LE, et al. The Stockholm I trial of preoperative short 
term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm 
Colorectal Cancer Study Group. Cancer 1995;75:2269-75. 
101. Martling A, Holm T, Johansson H, et al. The Stockholm II trial on preoperative radiotherapy in 
rectal carcinoma: long-term follow-up of a population-based study. Cancer 2001;92:896-902. 
102. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preoperative Radiotherapy Combined with 
Total Mesorectal Excision for Resectable Rectal Cancer. New England Journal of Medicine 
2001;345:638-646. 
103. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative 
chemoradiotherapy for rectal Cancer. New England Journal of Medicine 2004;351:1731-1740. 
104. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized 
trial comparing preoperative short-course radiotherapy with preoperative conventionally 
fractionated chemoradiation for rectal cancer. British Journal of Surgery 2006;93:1215-23. 
105. Garcia-Aguilar J, Smith DD, Avila K, et al. Optimal timing of surgery after chemoradiation for 
advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II 
prospective trial. Annals of Surgery 2011;254:97-102. 
106. Pettersson D, Cedermark B, Holm T, et al. Interim analysis of the Stockholm III trial of 
preoperative radiotherapy regimens for rectal cancer. British Journal of Surgery 2010;97:580-
7. 
107. Sanghera P, Wong DW, McConkey CC, et al. Chemoradiotherapy for rectal cancer: an 
updated analysis of factors affecting pathological response. Clinical Oncology 2008;20:176-
83. 
174 
108. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative 
radiochemotherapy. International Journal of Colorectal Disease 1997;12:19-23. 
109. Habr-Gama A, Perez RO, Wynn G, et al. Complete clinical response after neoadjuvant 
chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic 
findings for standardization. Diseases of the Colon & Rectum 2010;53:1692-8. 
110. UK Clinical Research Network Study Portfolio; Timing and Deferral of Rectal Surgery 
Following a Continued Response to Pre-operative Chemoradiotherapy, 2010. 
http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=8565 (Last accessed December 
2012). 
111. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre 
Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. The Lancet 1995;345:939-
944. 
112. Twelves C, Wong A, Nowacki MP, et al. Capecitabine as Adjuvant Treatment for Stage III 
Colon Cancer. New England Journal of Medicine 2005;352:2696-2704. 
113. André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, Fluorouracil, and Leucovorin as 
Adjuvant Treatment for Colon Cancer. New England Journal of Medicine 2004;350:2343-
2351. 
114. Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and 
leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. Journal of 
Clinical Oncology 2009;27:3109-16. 
115. Tournigand C, Andre T, Bonnetain F, et al. Adjuvant therapy with fluorouracil and oxaliplatin 
in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup 
analyses of the multicenter international study of Oxaliplatin, Fluorouracil, and Leucovorin in 
the adjuvant treatment of colon cancer trial. Journal of Clinical Oncology 2012;30:3353-60. 
116. Quasar Collaborative Group. Adjuvant chemotherapy versus observation in patients with 
colorectal cancer: a randomised study. The Lancet 2007;370:2020-2029. 
117. F. OxTROT Collaborative Group. Feasibility of preoperative chemotherapy for locally 
advanced, operable colon cancer: the pilot phase of a randomised controlled trial. The Lancet 
Oncology 2012;13:1152-1160. 
118. ISRCTN Register; Multicentre international study of capecitabine ± bevacizumab as adjuvant 
treatment of colorectal cancer (QUASAR 2), 2007. http://www.controlled-
trials.com/ISRCTN45133151/ (Last accessed October 2012). 
119. Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the faecal occult 
blood test, Hemoccult. Cochrane Database Systematic Review 2007:CD001216. 
120. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous 
polyps. Gut 2002;51:V6-V9. 
121. Logan RFA, Patnick J, Nickerson C, et al. Outcomes of the Bowel Cancer Screening 
Programme (BCSP) in England after the first 1 million tests. Gut 2011. 
122. Ellul P, Fogden E, Simpson CL, et al. Downstaging of colorectal cancer by the national bowel 
cancer screening programme in England: first round data from the first centre. Colorectal 
Disease 2010;12:420-422. 
123. Harrow P, Nayagam S, Stafford N, et al. A comparison of incidence of colorectal cancer and 
polyps in bowel cancer screening programme patients with symptomatic patients referred 
under 2 week wait in a demographically matched population. Gut 2011;60:A114. 
124. Lee TJ, Pascall G, Wood T, et al. Colonic polyps are different in the UK Bowel Cancer 
Screening Programme population compared to the symptomatic population. Gastrointestinal 
Endoscopy 2009;69:AB290-AB291. 
125. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in 
prevention of colorectal cancer: a multicentre randomised controlled trial. The Lancet 
2010;375:1624-1633. 
126. Newcomb PA, Storer BE, Morimoto LM, et al. Long-term efficacy of sigmoidoscopy in the 
reduction of colorectal cancer incidence. Journal of the National Cancer Institute 
2003;95:622-625. 
127. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with 
screening flexible sigmoidoscopy. New England Journal of Medicine 2012;366:2345-57. 
175 
128. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer 
screening: follow-up findings of the Italian Randomized Controlled Trial - SCORE. Journal of 
National Cancer Institute 2011;103:1310-22. 
129. Conio M, Repici A, Demarquay J-F, et al. EMR of large sessile colorectal polyps. 
Gastrointestinal Endoscopy 2004;60:234-241. 
130. Lim TR, Mahesh V, Singh S, et al. Endoscopic mucosal resection of colorectal polyps in 
typical UK hospitals. World Journal of Gastroenteroloy 2010;16:5324-8. 
131. Saito Y, Fukuzawa M, Matsuda T, et al. Clinical outcome of endoscopic submucosal 
dissection versus endoscopic mucosal resection of large colorectal tumors as determined by 
curative resection. Surgical Endoscopy and Other Interventional Techniques 2010;24:343-
352. 
132. Bories E, Pesenti C, Monges G, et al. Endoscopic mucosal resection for advanced sessile 
adenoma and early-stage colorectal carcinoma. Endoscopy 2006;38:231 - 235. 
133. Yoshida N, Naito Y, Inada Y, et al. Multicenter study of endoscopic mucosal resection using 
0.13 % hyaluronic acid solution of colorectal polyps less than 20 mm in size. International 
Journal of Colorectal Disease 2012. 
134. Nishiyama H, Isomoto H, Yamaguchi N, et al. Endoscopic submucosal dissection for laterally 
spreading tumours of the colorectum in 200 consecutive cases. Surgical Endoscopy 
2010;24:2881-7. 
135. Saito Y, Uraoka T, Yamaguchi Y, et al. A prospective, multicenter study of 1111 colorectal 
endoscopic submucosal dissections (with video). Gastrointest Endoscopy 2010;72:1217-25. 
136. Tajika M, Niwa Y, Bhatia V, et al. Comparison of endoscopic submucosal dissection and 
endoscopic mucosal resection for large colorectal tumors. European Journal of 
Gastroenteroly and Hepatology 2011;23:1042-9. 
137. Barendse RM, van den Broek FJ, van Schooten J, et al. Endoscopic mucosal resection vs 
transanal endoscopic microsurgery for the treatment of large rectal adenomas. Colorectal 
Disease 2012;14:e191-6. 
138. Park SU, Min YW, Shin JU, et al. Endoscopic submucosal dissection or transanal endoscopic 
microsurgery for nonpolypoid rectal high grade dysplasia and submucosa-invading rectal 
cancer. Endoscopy 2012;44:1031-6. 
139. Kiriyama S, Saito Y, Yamamoto S, et al. Comparison of endoscopic submucosal dissection 
with laparoscopic-assisted colorectal surgery for early-stage colorectal cancer: a retrospective 
analysis. Endoscopy 2012;44:1024-30. 
140. Gill M, Rutter M, Holtham S. Management and short term outcome of malignant colorectal 
polyps in the North of England. Colorectal Disease 2012. 
141. Feussner H, Wilhelm D, Dotzel V, et al. Combined endoluminal and endocavitary approaches 
to colonic lesions. Surg Technology International 2003;11:97-101. 
142. Winter H, Lang R, Spelsberg F, et al. Laparoscopic colonoscopic rendezvous procedures for 
the treatment of polyps and early stage carcinomas of the colon. International Journal of 
Colorectal Disease 2007;22:1377-1381. 
143. Franklin M, Leyva-Alvizo A, Abrego-Medina D, et al. Laparoscopically monitored colonoscopic 
polypectomy: an established form of endoluminal therapy for colorectal polyps. Surgical 
Endoscopy 2007;21:1650 - 1653. 
144. Wilhelm D, von Delius S, Weber L, et al. Combined laparoscopic-endoscopic resections of 
colorectal polyps: 10-year experience and follow-up. Surgical Endoscopy and Other 
Interventional Techniques 2009;23:688-693. 
145. Wood JJ, Lord AC, Wheeler JM, et al. Laparo-endoscopic resection for extensive and 
inaccessible colorectal polyps: a feasible and safe procedure. Annals of the Royal College of 
Surgeons of England 2011;93:241-5. 
146. Cruz RA, Ragupathi M, Pedraza R, et al. Minimally invasive approaches for the management 
of difficult colonic polyps. Diagnostic and Therapeutic Endoscopy 2011;2011. 
147. Yan J, Trencheva K, Lee SW, et al. Treatment for right colon polyps not removable using 
standard colonoscopy: combined laparoscopic-colonoscopic approach. Diseases of the Colon 
& Rectum 2011;54:753-758  
176 
148. Young-Fadok TM. Pro: A Large Colonic Polyp Is Best Removed by Laparoscopy. Am J 
Gastroenterol 2009;104:270-272. 
149. Franklin ME, Jr., Portillo G. Laparoscopic monitored colonoscopic polypectomy: long-term 
follow-up. World Jurnal Surgery 2009;33:1306-9. 
150. Cahill RA, Bembenek A, Sirop S, et al. Sentinel node biopsy for the individualization of 
surgical strategy for cure of early-stage colon cancer. Annals of Surgical Oncology 
2009;16:2170-2180. 
151. Saikawa Y, Otani Y, Kitagawa Y, et al. Interim results of sentinel node biopsy during 
laparoscopic gastrectomy: possible role in function-preserving surgery for early cancer. World 
J Surg 2006;30:1962 - 1968. 
152. Kelder W, Nimura H, Takahashi N, et al. Sentinel node mapping with indocyanine green (ICG) 
and infrared ray detection in early gastric cancer: An accurate method that enables a limited 
lymphadenectomy. European Journal of Surgical Oncology 2010;36:552-558. 
153. Tajima Y, Murakami M, Yamazaki K, et al. Sentinel Node Mapping Guided by Indocyanine 
Green Fluorescence Imaging During Laparoscopic Surgery in Gastric Cancer. Annals of 
Surgical Oncology 2010;17:1787-1793. 
154. Tajima Y, Yamazaki K, Masuda Y, et al. Sentinel node mapping guided by indocyanine green 
fluorescence imaging in gastric cancer. Annals of Surgery 2009;249:58-62. 
155. van der Pas MH, Meijer S, Hoekstra OS, et al. Sentinel-lymph-node procedure in colon and 
rectal cancer: a systematic review and meta-analysis. Lancet Oncology 2011;12:540-50. 
156. Kitagawa Y, Watanabe M, Hasegawa H, et al. Sentinel node mapping for colorectal cancer 
with radioactive tracer. Diseases of the Colon & Rectum 2002;45:1476 - 1480. 
157. Saha S, Seghal R, Patel M, et al. A multicenter trial of sentinel lymph node mapping in 
colorectal cancer: prognostic implications for nodal staging and recurrence. The American 
Journal of Surgery 2006;191:305-310. 
158. Bilchik AJ, DiNome M, Saha S, et al. Prospective multicenter trial of staging adequacy in 
colon cancer: preliminary results. Archives of Surgery 2006;141:527-534. 
159. Stojadinovic A, Nissan A, Protic M, et al. Prospective randomized study comparing sentinel 
lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma 
- Results from the United States Military Cancer Institute Clinical Trials Group study GI-01. 
Annals of Surgery 2007;245:846-857. 
160. Bembenek AE, Rosenberg R, Wagler E, et al. Sentinel lymph node biopsy in colon cancer - A 
prospective multicernter trial. Annals of Surgery 2007;245:858-863. 
161. Nissan A, Protic M, Bilchik A, et al. Predictive model of outcome of targeted nodal 
assessment in colorectal cancer. Annals of Surgery 2010;251:265-274. 
162. Des Guetz G, Uzzan B, Nicholas P, et al. Is sentinel lymph node mapping in colorectal cancer 
a future prognostic factor? A meta-analysis. World Journal of Surgery 2007;31:1304 - 1312. 
163. Nagata K, Endo S, Hidaka E, et al. Laparoscopic sentinel node mapping for colorectal cancer 
using infrared ray laparoscopy. Anticancer Research 2006;26:2307-2311. 
164. Watanabe M, Tsunoda A, Narita K, et al. Colonic tattooing using fluorescence imaging with 
light-emitting diode-activated indocyanine green: A feasibility study. Surgery Today 
2009;39:214-218. 
165. Cahill RA, Ris F, Mortensen NJ. Near-infrared laparoscopy for real-time intra-operative 
arterial and lymphatic perfusion imaging. Colorectal Disease 2011;13:12-17. 
166. Lips D, Koebrugge B, Jan Liefers G, et al. The influence of micrometastases on prognosis 
and survival in stage I-II colon cancer patients: the Enroute(+) Study. BMC Surgery 
2011;11:11. 
167. Liefers G-J, Cleton-Jansen A-M, van de Velde CJH, et al. Micrometastases and survival in 
stage II colorectal cancer. New England Journal of Medicine 1998;339:223-228. 
168. Bukholm IR, Bondi J, Wiik P, et al. Presence of isolated tumour cells in mesenteric lymph 
nodes predicts poor prognosis in patients with stage II colon cancer. European Journal of 
Surgical Oncology 2003;29:862-6. 
169. Faiz O, Warusavitarne J, Bottle A, et al. Laparoscopically assisted vs. open elective colonic 
and rectal resection: A comparison of outcomes in English National Health Service Trusts 
between 1996 and 2006. Diseases of the Colon & Rectum 2009;52:1695-1704. 
177 
170. Farhat S, Chaussade S, Ponchon T, et al. Endoscopic submucosal dissection in a European 
setting. A multi-institutional report of a technique in development. Endoscopy 2011;43:664-
670. 
171. Kantsevoy SV, Adler DG, Conway JD, et al. Endoscopic mucosal resection and endoscopic 
submucosal dissection. Gastrointestinal Endoscopy 2008;68:11-18. 
172. Almoudaris AM, Gupta S, Bottle A, et al. Surgery for benign colorectal polyps in England – 
trends and outcomes from 1997 to 2007. Gut 2011;60:A4-A5. 
173. Kennedy RH, Cahill RA, Sibbons P, et al. The "FLEX" procedure: a new technique for full-
thickness laparo-endoscopic excision in the colon. Endoscopy 2011;43:223-229. 
174. Benedix F, Kockerling F, Lippert H, et al. Laparoscopic resection for endoscopically 
unresectable colorectal polyps: analysis of 525 patients. Surgical Endoscopy and Other 
Interventional Techniques 2008;22:2576-2582. 
175. Zmora O, Benjamin B, Reshef A, et al. Laparoscopic colectomy for colonic polyps. Surgical 
Endoscopy 2009;23:629-632. 
176. Loungnarath R, Mutch MG, Birnbaum EH, et al. Laparoscopic colectomy using cancer 
principles is appropriate for colonoscopically unresectable adenomas of the colon. Diseases 
of the Colon & Rectum 2010;53:1017-22. 
177. Schwenk W, Haase O, Neudecker J, et al. Short term benefits for laparoscopic colorectal 
resection. Cochrane Database Systematic Review 2005:CD003145. 
178. Hauenschild L, Bader F, Laubert T, et al. Laparoscopic colorectal resection for benign polyps 
not suitable for endoscopic polypectomy. International Journal of Colorectal Disease 
2009;24:755-759. 
179. Dindo D, Demartines N, Clavien PA. Classification of surgical complications - A new proposal 
with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery 
2004;240:205-213. 
180. Rahbari NN, Weitz J, Hohenberger W, et al. Definition and grading of anastomotic leakage 
following anterior resection of the rectum: a proposal by the International Study Group of 
Rectal Cancer. Surgery 2010;147:339-51. 
181. Metz AJ, Bourke MJ, Moss A, et al. Factors that predict bleeding following endoscopic 
mucosal resection of large colonic lesions. Endoscopy 2011;43:506-11. 
182. Buddingh KT, Herngreen T, Haringsma J, et al. Location in the right hemi-colon is an 
independent risk factor for delayed post-polypectomy hemorrhage: a multi-center case-control 
study. American Journal of Gastroenterology 2011;106:1119-24. 
183. Bertelson NL, Kalkbrenner KA, Merchea A, et al. Colectomy for endoscopically unresectable 
polyps: how often is it cancer? Diseases of the Colon & Rectum 2012;55:1111-6. 
184. Alder AC, Hamilton EC, Anthony T, et al. Cancer risk in endoscopically unresectable colon 
polyps. American Journal of Surgery 2006;192:644-648. 
185. Brozovich M, Read TE, Salgado J, et al. Laparoscopic colectomy for apparently benign 
colorectal neoplasia: A word of caution. Surgical Endoscopy and Other Interventional 
Techniques 2008;22:506-509. 
186. Jang J, Balik E, Kirchoff D, et al. Oncologic Colorectal Resection, Not Advanced Endoscopic 
Polypectomy, Is the Best Treatment for Large Dysplastic Adenomas. Journal of 
Gastrointestinal Surgery 2012;16:165-172. 
187. Almoudaris AM, Burns EM, Mamidanna R, et al. Value of failure to rescue as a marker of the 
standard of care following reoperation for complications after colorectal resection. British 
Journal of Surgery 2011;98:1775-83. 
188. Burns EM, Bottle A, Aylin P, et al. Variation in reoperation after colorectal surgery in England 
as an indicator of surgical performance: retrospective analysis of Hospital Episode Statistics. 
British Medical Journal 2011;343:d4836. 
189. Faiz O, Brown T, Bottle A, et al. Impact of hospital institutional volume on postoperative 
mortality after major emergency colorectal surgery in English National Health Service Trusts, 
2001 to 2005. Diseases of the Colon & Rectum 2010;53:393-401. 
190. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in 
longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. 
178 
191. Burns EM, Naseem H, Bottle A, et al. Introduction of laparoscopic bariatric surgery in 
England: observational population cohort study. British Medical Journal 2010;341. 
192. The free 2013 medical coding reference. http://www.icd10data.com/ICD10CM/Codes/C00-
D49/D10-D36/D12-/D12.0 (Last accessed May 2013), 2013. 
193. The NHS Classifications Service. OPCS Classification of Interventions and Procedures 
Version 4.6 London: The Stationary Office, 2011. 
194. Church JM. Avoiding surgery in patients with colorectal polyps. Diseases of the Colon & 
Rectum 2003;46:1513-1516. 
195. Lipof T, Bartus C, Sardella W, et al. Preoperative Colonoscopy Decreases the Need for 
Laparoscopic Management of Colonic Polyps. Diseases of the Colon & Rectum 
2005;48:1076-1080. 
196. Brooker JC, Saunders BP, Shah SG, et al. Endoscopic resection of large sessile colonic 
polyps by specialist and non-specialist endoscopists. British Journal of Surgery 
2002;89:1020-1024. 
197. Swan MP, Bourke MJ, Alexander S, et al. Large refractory colonic polyps: is it time to change 
our practice? A prospective study of the clinical and economic impact of a tertiary referral 
colonic mucosal resection and polypectomy service (with videos). Gastrointestinal Endoscopy 
2009;70:1128-1136. 
198. Murata A, Brown CJ, Raval M, et al. Impact of short-course radiotherapy and low anterior 
resection on quality of life and bowel function in primary rectal cancer. American Journal of 
Surgery 2008;195:611-615. 
199. Olschewski M, Schulgen G, Schumacher M, et al. Quality of life assessment in clinical cancer 
research. British Journal of Cancer 1994;70:1-5. 
200. Peeters K, Velde C, Leer J, et al. Late side effects of short-course preoperative radiotherapy 
combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in 
irradiated patients - a Dutch colorectal cancer group study. Journal of Clinical Oncology 
2005;23:6199 - 6206. 
201. Vironen JH, Kairaluoma M, Aalto AM, et al. Impact of functional results on quality of life after 
rectal cancer surgery. Diseases of the Colon & Rectum 2006;49:568-578. 
202. Ramsey SD, Berry K, Moinpour C, et al. Quality of life in long term survivors of colorectal 
cancer. American Journal of Gastroenterology 2002;97:1228-1234. 
203. Rendtorff RC, Kashgarian M. Stool patterns of healthy adult males. Diseases of the Colon & 
Rectum 1967;10:222-8. 
204. Schoetz DJ, Jr. Postcolectomy syndromes. World Journal of Surgery 1991;15:605-8. 
205. Rouffet F, Hay J, Vacher B, et al. Curative resection for left colonic carcinoma: hemicolectomy 
vs. segmental colectomy. A prospective, controlled, multicenter trial. French Association for 
Surgical Research. Diseases of the Colon & Rectum 1994;37:651 - 659. 
206. Ho YH, Low D, Goh HS. Bowel function survey after segmental colorectal resections. 
Diseases of the Colon & Rectum 1996;39:307-310. 
207. Sato K, Inomata M, Kakisako K, et al. Surgical technique influences bowel function after low 
anterior resection and sigmoid colectomy. Hepato-Gastroenterology 2003;50:1381-1384. 
208. Adachi Y, Kakisako K, Sato K, et al. Factors influencing bowel function after low anterior 
resection and sigmoid colectomy. Hepato-Gastroenterology 2000;47:155-158. 
209. Forgione A, Leroy J, Cahill RA, et al. Prospective evaluation of functional outcome after 
laparoscopic sigmoid colectomy. Annals of Surgery 2009;249:218-224. 
210. Thorn M, Graf W, Stefansson T, et al. Clinical and functional results after elective colonic 
resection in 75 consecutive patients with diverticular disease. American Journal of Surgery 
2002;183:7-11. 
211. Temple LK, Bacik J, Savatta SG, et al. The development of a validated instrument to evaluate 
bowel function after sphincter-preserving surgery for rectal cancer. Diseases of the Colon & 
Rectum 2005;48:1353-1365. 
212. Vaizey CJ, Carapeti E, Cahill JA, et al. Prospective comparison of faecal incontinence grading 
systems. Gut 1999;44:77-80. 
179 
213. Pescatori M, Anastasio G, Bottini C, et al. New grading and scoring for anal incontinence. 
Evaluation of 335 patients. Diseases of the Colon & Rectum 1992;35:482-7. 
214. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 
1993;36:77-97. 
215. Neuman HB, Schrag D, Cabral C, et al. Can differences in bowel function after surgery for 
rectal cancer be identified by the European Organization for Research and Treatment of 
Cancer quality of life instrument? Annals of Surgical Oncology 2007;14:1727-1734. 
216. Maas M, Beets-Tan RGH, Lambregts DMJ, et al. Wait-and-See Policy for Clinical Complete 
Responders After Chemoradiation for Rectal Cancer. Journal of Clinical Oncology 
2011;29:4633-4640. 
217. Knowles G, Haigh R, McLean C, et al. Long term effect of surgery and radiotherapy for 
colorectal cancer on defecatory function and quality of life. European Journal of Oncology 
Nursing 2013. 
218. Temple LK, Patil S, Weiser MR, et al. Bowel dysfunction after sphincter-preserving surgery for 
rectal cancer. Gastrointestinal Cancers Symposium: American Society of Clinical Oncology, 
2010. 
219. Mastracci TM, Hendren S, O'Connor B, et al. The impact of surgery for colorectal cancer on 
quality of life and functional status in the elderly. Diseases of the Colon & Rectum 
2006;49:1878-1884. 
220. Sarli L, Cinieri FG, Pavlidis C, et al. Anorectal function problems after left hemicolectomy. 
Journal of Laparoendoscopic & Advanced Surgical Techniques 2006;16:565-571. 
221. Theodoropoulos GE, Papanikolaou IG, Karantanos T, et al. Post-colectomy assessment of 
gastrointestinal function: a prospective study on colorectal cancer patients. Techniques of 
Coloproctology 2013;17:525-36. 
222. Graf W, Ekstrom K, Glimelius B, et al. A pilot study of factors influencing bowel function after 
colorectal anastomosis. Diseases of the Colon & Rectum 1996;39:744-749. 
223. Sarli L, Pavlidis C, Cinieri F, et al. Prospective comparison of laparoscopic left hemicolectomy 
for colon cancer with laparoscopic left hemicolectomy for benign colorectal disease. World 
Journal of Surg 2006;30:446 - 452. 
224. Maas CP, Moriya Y, Steup WH, et al. Radical and nerve-preserving surgery for rectal cancer 
in The Netherlands: a prospective study on morbidity and functional outcome. British Journal 
of Surgery 1998;85:92-7. 
225. Carlstedt A, Nordgren S, Fasth S, et al. Sympathetic nervous influence on the internal anal 
sphincter and rectum in man. International Journal of Colorectal Disease 1988;3:90-5. 
226. Moszkowicz D, Peschaud F, Bessede T, et al. Internal anal sphincter parasympathetic-
nitrergic and sympathetic-adrenergic innervation: a 3-dimensional morphological and 
functional analysis. Diseases of the Colon & Rectum 2012;55:473-81. 
227. Irie M, Kajiyama Y, Enjoji A, et al. Changes in colonic motility in dogs after a resection of the 
inferior mesenteric ganglion and plexus. Surgery Today 1998;28:626-32. 
228. Dobrowolski S, Hac S, Kobiela J, et al. Should we preserve the inferior mesenteric artery 
during sigmoid colectomy? Neurogastroenterology and Motility 2009;21:1288-e123. 
229. Wilson TR, Alexander DJ, Kind P. Measurement of health-related quality of life in the early 
follow-up of colon and rectal cancer. Diseases of the Colon & Rectum 2006;49:1692-1702. 
230. Gracie DJ, Kane JS, Mumtaz S, et al. Prevalence of, and predictors of, bile acid 
malabsorption in outpatients with chronic diarrhea. Neurogastroenterology & Motility 
2012;24:983-e538. 
231. Pattni S, Walters JRF. Recent advances in the understanding of bile acid malabsorption. 
British Medical Bulletin 2009;92:79-93. 
232. Phillips SF. Functions of the large bowel: an overview. Scand Journal of Gastroenterology 
Supplement 1984;93:1-12. 
233. Szmulowicz UM, Hull, T. L. . Colonic physiology. The ASCRS Textbook of Colon and Rectal 
Surgery. 2nd Edition ed: Jointly published with The American Society of Colon and Rectal 
Surgeons, 2011. 
234. Harrel LE, Chang, E.B. Intestinal water and electrolyte transport Philadelphia: Sounders 
Elsevier, 2006. 
180 
235. Barendse RM, van den Broek FJ, Dekker E, et al. Systematic review of endoscopic mucosal 
resection versus transanal endoscopic microsurgery for large rectal adenomas. Endoscopy 
2011;43:941-9. 
236. Kopelman Y, Siersema PD, Bapaye A, et al. Endoscopic full-thickness GI wall resection: 
current status. Gastrointestinal Endoscopy 2012;75:165-173. 
237. Schurr MO, Buess G, Raestrup H, et al. Full thickness resection device (FTRD) for 
endoluminal removal of large bowel tumours: Development of the instrument and related 
experimental studies. Minimally Invasive Therapy & Allied Technologies 2001;10:301-9. 
238. von Renteln D, Schmidt A, Vassiliou MC, et al. Endoscopic full-thickness resection and defect 
closure in the colon. Gastrointestinal Endoscopy 2010;71:1267-73. 
239. Rajan E, Gostout CJ, Burgart LJ, et al. First endoluminal system for transmural resection of 
colorectal tissue with a prototype full-thickness resection device in a porcine model. 
Gastrointestinal Endoscopy 2002;55:915-20. 
240. Raju GS, Malhotra A, Ahmed I. Colonoscopic full-thickness resection of the colon in a porcine 
model as a prelude to endoscopic surgery of difficult colon polyps: a novel technique (with 
videos). Gastrointestinal Endoscopy 2009;70:159-165. 
241. Rieder E, Martinec DV, Dunst CM, et al. A novel technique for natural orifice endoscopic full-
thickness colon wall resection: an experimental pilot study. Journal of the American College of 
Surgeons 2011;213:422-9. 
242. von Renteln D, Kratt T, Rosch T, et al. Endoscopic full-thickness resection in the colon by 
using a clip-and-cut technique: an animal study. Gastrointestinal Endoscopy 2011;74:1108-
1114. 
243. Martin JP, Batt SC, Smith GV, et al. Malignant polyps removed from the bowel cancer 
screening programme in London. Gut 2011;60:A70. 
244. Memark VC, Anderson JB, Nau PN, et al. Transgastric endoscopic peritoneoscopy does not 
lead to increased risk of infectious complications. Surgical Endoscopy 2011;25:2186-91. 
245. Narula VK, Happel LC, Volt K, et al. Transgastric endoscopic peritoneoscopy does not require 
decontamination of the stomach in humans. Surgical Endoscopy 2009;23:1331-6. 
246. Nikfarjam M, McGee MF, Trunzo JA, et al. Transgastric natural-orifice transluminal 
endoscopic surgery peritoneoscopy in humans: a pilot study in efficacy and gastrotomy site 
selection by using a hybrid technique. Gastrointestinal Endoscopy 2010;72:279-83. 
247. Soweid A, Yaghi S, Kobeissy A, et al. Natural orifice transluminal endoscopic surgery 
(NOTES): assessment of peritoneal bacterial load after intraperitoneal antimicrobial wash and 
evaluation of hemodynamic changes in a porcine model. Minim Invasive Therapy Allied 
Technologies 2012;21:265-70. 
248. Fusaroli P, Grillo A, Zanarini S, et al. Usefulness of a second endoscopic arm to improve 
therapeutic endoscopy in the lower gastrointestinal tract. Preliminary experience - a case 
series. Endoscopy 2009;41:997-1000. 
249. Oyama T. Counter traction makes endoscopic submucosal dissection easier. Clinical 
Endoscopy 2012;45:375-8. 
250. Gotoda T, Oda I, Tamakawa K, et al. Prospective clinical trial of magnetic-anchor–guided 
endoscopic submucosal dissection for large early gastric cancer (with videos). 
Gastrointestinal Endoscopy 2009;69:10-15. 
251. Matsumoto K, Nagahara A, Ueyama H, et al. Development and clinical usability of a new 
traction device "medical ring" for endoscopic submucosal dissection of early gastric cancer. 
Surgical Endoscopy 2013;27:3444-51. 
252. Teoh AY, Chiu PW, Hon SF, et al. Ex vivo comparative study using the Endolifter(R) as a 
traction device for enhancing submucosal visualization during endoscopic submucosal 
dissection. Surg Endosc 2013;27:1422-7. 
253. Higuchi K, Tanabe S, Azuma M, et al. Double-endoscope endoscopic submucosal dissection 
for the treatment of early gastric cancer accompanied by an ulcer scar. Gastrointestinal 
Endoscopy 2013;78:266-73. 
254. U.S. Food and Drug Administration. ENSEAL®  510(k) submission. 
http://www.accessdata.fda.gov/cdrh_docs/pdf4/k043008.pdf (Last accessed January 2013), 
2003. 
181 
255. General Surgery News. Special Report: Clinical advancements with ENSEAL® energy 
delivery device. 
http://www.ethicon.com/sites/default/files/Product/Energy/Group%20landing%20page/ENSEA
L-clinical-advancements-special-report-DSL.11-0608.GSN_.SR_.pdf (Last accessed January 
2013). 
256. National Centre for the Replacement, Refinement and Reduction of Animals in Research. The 
ARRIVE guidelines: Animal ResearchReporting In Vivo Experiments. 2010. 
http://www.nc3rs.org.uk/downloaddoc.asp?id=1206&page=1357&skin=0. (Last accessed July 
2013). 
257. Bundy CA, Jacobs DM, Zera RT, et al. Comparison of bursting pressure of sutured, stapled 
and BAR anastomoses. International Journal of Colorectal Disease 1993;8:1-3. 
258. MacRae HM, McLeod RS. Handsewn vs. stapled anastomoses in colon and rectal surgery: a 
meta-analysis. Diseases of the Colon & Rectum 1998;41:180-9. 
259. Brigic A, Symons NR, Faiz O, et al. A systematic review regarding the feasibility and safety of 
endoscopic full thickness resection (EFTR) for colonic lesions. Surgical Endoscopy 
2013;27:3520-9. 
260. McCulloch P, Altman DG, Campbell WB, et al. No surgical innovation without evaluation: the 
IDEAL recommendations. The Lancet;374:1105-1112. 
261. Pokala N, Delaney C, Kiran R, et al. Outcome of laparoscopic colectomy for polyps not 
suitable for endoscopic resection. Surgical Endoscopy 2007;21:400-403. 
262. Hurlstone DP, Brown S, Cross SS, et al. High magnification chromoscopic colonoscopy or 
high frequency 20 MHz mini probe endoscopic ultrasound staging for early colorectal 
neoplasia: a comparative prospective analysis. Gut 2005;54:1585-1589. 
263. Nguyen-Tang T, Shah JN, Sanchez-Yague A, et al. Use of the front-view forward-array 
echoendoscope to evaluate right colonic subepithelial lesions. Gastrointestinal Endoscopy 
2010;72:606-610. 
 
 
  
